An investigation into the effects of dystrophin on the lateral mobility of muscle membrane components. by Dutton, Anna Louise
Durham E-Theses
An investigation into the effects of dystrophin on the
lateral mobility of muscle membrane components.
Dutton, Anna Louise
How to cite:
Dutton, Anna Louise (1999) An investigation into the effects of dystrophin on the lateral mobility of muscle
membrane components., Durham theses, Durham University. Available at Durham E-Theses Online:
http://etheses.dur.ac.uk/4576/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Office, Durham University, University Office, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
An investigation into the effects of dystrophin on the lateral 
mobility of muscle membrane components. 
Anna Louise Dutton. 
University ofDurham, Department of Biological Sciences 
South Road, Durham, DHl 3LE. 
The copyright of this thesis rests 
with the author. No quotation 
from it should be published 
without the written consent of the 
author and information derived 
from it should be acknowledged. 
A thesis submitted to the Department of Biological Sciences, University 
of Durham in accordance with the requirements for the degree of 
Doctor of Philosophy. 
1999. 
1 9 JUL 2000 
An investigation into the effects of dystrophin on the lateral mobility of 
muscle membrane components. 
Abstract. 
Anna L. Dutton 
University ofDurham, Department of Biological Sciences, 
South Road, Durham, DHl 3LE, U.K. 
Dystrophin is the product of the Duchenne Muscular Dystrophy gene locus, whose absence results in 
progressive skeletal muscle breakdown. Despite considerable work on the localisation of dystrophin 
and its associated complex, its role in muscle function remains unclear. In the light of the structural and 
mechanical instability of the dystrophic membrane, the idea was tested that dystrophin might impart 
membrane integrity and strength by anchoring membrane proteins and/or delineating the surface into 
specialised subcellular functional domains. Specifically, because dystrophin shows high sequence, 
structural and spatial similarities to the cytoskeletal protein spectrin; and because spectrin is proven to 
sterically restrict protein lateral diffusion through a subplasmalemmal network; the capacity of 
dystrophin to act as a 'molecular fence' to membrane diffusion was studied by comparing lateral 
mobility of membrane glycoproteins by fluorescence photobleach recovery in mdx and nomml tissue. 
Secondly, as dystrophin has been proven to interact directly with proteins of the dystrophin associated 
glycoprotein complex in vivo, experiments addressed whether specific binding and immobilisation of 
the complex by dystrophin at the membrane was essential for function. Finally, given the homology of 
dystrophin and spectrin, the presence of dystrophin at the neuromuscular junction, and the importance 
ofspectrins in immobilisation of voltage gated sodium channels in the nervous system, the role of 
dystrophin in regulating voltage gated sodium channel distribution at the neuromuscular junction was 
investigated. The results show that membrane glycoproteins were immobile in the presence and 
absence of dystrophin, suggesting dystrophin is not an essential molecular fence component. 
Alternatively, viability may have been the major influence on protein and lipid diffusion in these fibres 
and suggestions are made as to how this may be recognised and overcome for subsequent investigation. 
Three novel exon specific anti-dystrophin peptide antibodies were generated during the work that will 
be useful for studies into Duchenne muscular dystrophy in general, and dystrophin revertant fibres in 
particular. 
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€bapter 1. 
Introduction. 
Chapter l. Introduction. 
Chapter 1. 
Introduction. 
The objective of this thesis was to study the effects of the disorder Duchenne Muscular Dystrophy on 
the structure and organisation of the muscle fibre membrane. In this introduction to the experimental 
work I aim to explain the rationale behind the experiments that follow. In the first part I shall provide a 
brief overview of the diseased system that formed the basis of the study- Duchenne Muscular Dystrophy 
(DMD). Discussion will then move on to the more specific area of the domain structure and 
organisation of cell membranes- including why cells are divided into domains; how domains are formed 
and the experimental approaches that have provided this knowledge; and finally, why this thesis tested 
the idea that dystrophin could be involved in the formation of membrane domains and regulation of 
lateral mobility of membrane constituents. 
1.1 Duchenne muscular dystrophy. 
Duchenne Muscular Dystrophy is an X-linked genetic disorder affecting I in 3500 male births. The 
disease is characterised by progressive wasting of the skeletal muscles. Patients find walking 
increasingly difficult, leaving many wheelchair bound by the age of eleven. The disorder has been 
traced to deficiency of a single cytoskeletal protein, named dystrophin (Hoffinan et a/, 1987), which 
localises to the cytoplasmic face of the plasma membrane in normal skeletal muscle (Watkins et a/, 
1988). 
1.1.2 Mdx mice. 
Much of the experimental work on Duchenne Muscular Dystrophy has been performed using tissue 
from the mdx (muscular dystrophy, x-linked) mouse (Bulfield et a/, 1984). This mouse possesses the 
same primary biochemical defect as DMD patients, namely a lack of detectable dystrophin protein in 
the sarcolemma (Hoffinan, 1987). As in the human disease, elevated levels of muscle cytosolic proteins 
are found circulating in the serum indicative of muscle instability. Internally the skeletal muscle tissue 
shows evidence of rounds of regeneration within 3 weeks of birth, including atrophy of some fibres, 
variation in fibre size, degeneration of some fibres, centrally located nuclei and disruption of the 
plasmalernn1a and basal lamina (Bulfield et a/, 1984). However, in contrast to humans, the mouse only 
begins to show outward signs of muscle weakness at 12 months of age, believed to reflect the greater 
capacity of mouse muscle for regeneration over human muscle. 
Chapter I. Introduction. 
The experiments investigating the function of dystrophin that are outlined in this thesis were performed 
on tissue from male mdx mice (gift ofProfT. Partridge, Hammersmith Hospital, London) and normal 
control tissue from the C57 /BL 10 parental strain. As described by Bulfield et at ( 1984), these mdx 
mice showed no outward signs of muscle weakness until about 12 months after birth. However, mice 
born with a particularly severe phenotype (figure 1.1) have a lifespan of just a couple of months. 
1.1.2 Histology and Pathology of DMD. 
Pathologically DMD presents a classic pattern of muscle degeneration, regeneration and fibrosis 
(Dubowitz, 1985). Elevated serum levels of muscle proteins such as creatine kinase (CK) can be 
detected at an early stage (Hoffman et a/, 1987). If observed motor difficulties suggest a patient may 
possess DMD, serum CK concentration is used as an early diagnostic tool. However, elevated CK 
levels could also signify a metabolic disorder, therefore muscle biopsies are necessary to confirm a 
suspected DMD diagnosis. 
The appearance of dystrophic tissue at biopsy provides evidence for rounds of muscle degeneration and 
regeneration (reviewed in Turner et a/, 1997, Partridge, 1997). Pathological muscle fibres possess 
centrally located nuclei, compared with peripherally located nuclei in fibres of normal tissue. This 
suggests a high level of satellite cell activity to rebuild damaged muscle fibres- following division ofthe 
satellite cell the immature myoblast nuclei have yet to migrate towards the outside of the fibre. 
Myofibres are regularly sized in normal muscle but irregular in dystrophic tissue. This follows 
replacement of necrotic mature fibres by smaller new fibres. Extensive connective tissue proliferates 
between fibres in dystrophic muscle. In contrast connective tissue is found in just a narrow band 
around bundles of fibres in normal muscle. Dystrophic muscle has extensive fibrosis, with connective 
tissue proliferation between the individual fibres. As the disease progresses almost all the muscle fibres 
will be replaced by connective tissue and fat deposits. The deposition of connective tissue is 
understood to be a wound response. Disruptions to the integrity of the myofibre plasma membrane lead 
to the presence of myotube cytoplasmic components within the extracellular matrix. The ensuing 
damage repair cascade ultimately leads to connective tissue formation (Partridge, 1997). As the disease 
worsens and myofibres become fewer in number the tissue becomes weaker, damage becomes more 
frequent and connective tissue growth becomes more extensive. DMD is invariably fatal by the end of 
the third decade of life, usually following failure of the muscles in the respiratory system. 
2 
a) 
b) 
Chapter I. Introduction. 
1.1.3 Tbe dystropbin gene. 
The observed pathological defects of DMD are the result of mutations in the dystrophin gene. The 
gene is found as a single copy located on the X-chromosome. The dystrophin gene was the frrst gene to 
be identified by chromosomal linkage analysis of affected familie~(Hoffinan et a/, 1987). The 
dystrophin gene locus is presently the largest known gene in the human genome- spanning at least 
2.4Mb (compared with 30kb average gene size). The gene is not only big but also complex, with at 
least 85 exons (which are highly conserved throughout evolution). 98% of the locus is composed of 
introns which are also highly conserved and number at least 84 (reviewed in Amalfitano et a/, 1997). 
The 5' end and central portion of the dystrophin gene show high sequence homology to spectrin. The 
3' end is homologous to dystrobrevin- a postsynaptic protein found in the electric organ ofthe ray 
Torpedo (Hoffman et a/, 1988). The entire dystrophin gene is homologous to only one other known 
protein- Utrophin [also called Dystrophin Related Protein or DRP] (Love et a/, 1989). Utrophin is so 
called because it is ubiquitously expressed within the tissues of the body (Love et a/, 1991 ). 
Expression ofthe dystrophin gene is highly tissue specific. The size and complexity of the gene is 
reflected in the promoter region, where at least seven different promoters control expression of 
differentially spliced transcripts according to cell type. The M promoter, for example, controls 
expression of the 14kb dystrophin transcript in skeletal muscle and at low levels in glial cells. The C 
(cortical), G (glial cell) and P (Purkinje cell) promoters drive formation of different transcripts within 
the central nervous system. Furthermore, the transcripts undergo alternative splicing at the 3' end. The 
transcripts fall into at least 5 different classifications ofmRNA isoforms according to size. These vary 
from full length skeletal dystrophin, to the 4.6kb Dp71 C-terminal transcript (for a summary of the 
different transcripts, see Brown and Lucy, 1997, page 164). 
The size and complexity of the dystrophin gene contributes to the highest spontaneous mutation rate 
ever reported for a human gene. The mutations are predominantly point mutations, arising by chance 
within the large transcript. Single spontaneous point mutations which shift the reading frame of the 
gene result in a phenotype far more severe than larger in frame deletions. The statistical likelihood of 
such an event in a large transcript may explain why half of all DMD cases are due to new mutations. 
1.1.4 Tbe dystropbin protein. 
In normal healthy tissue dystrophin makes up approximately 0.002% of skeletal muscle protein 
(Hoffman et a/, 1987) and is located towards the periphery of skeletal muscle fibres. 
lmmunolocalisation clearly shows a continuous band of dystrophin protein at the cytoplasmic face of 
the plasma membrane (Watkins et a/, 1988, see also figure 3.2). This localisation pattern is 
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characteristic of cytoskeletal proteins such as spectrin, indicating dystrophin may have a cytoskeletal 
function. In the tissue of DMD patients there is no detectable dystrophin protein, suggesting the 
mutated gene product is unstable at either the mRNA or protein level (Hoffinan et a/, 1987). 
Dystrophin protein was isolated following the successful cloning of the gene. A bacterial fusion protein 
was generated using a fragment of the cloned cDNA, antibodies raised to the fusion peptide and the 
antibodies used to isolate dystrophin protein from human tissue (Hoffinan et a/, 1987). The full length 
skeletal dystrophin protein is big- 427 kD (Hoffinan et a/, 1987). 
N terminal domain Rod domain C-terminal domain 
(BMD/DMD). (BMD). (DMD). 
Figure 1.2 Schematic diagram of dystrophin protein. 
The three distinctive regional domains, together with the common disease phenotype arising from 
mutations in each region are written above. (DMD, Duchenne muscular dystrophy. BMD, Seeker 
muscular dystrophy). 
From N to C terminus: Hatched circle, N-terminal actin binding domain. Boxes, 24 spectrin-like 
coiled-coil repeats. Open circle, WW domain. Shaded rectangle, C-terminal cysteine rich domain, 
Dumbell, calcium binding EF hand. Diagram modified from Winder et al, 1997. 
The protein may be divided into three major functional domains, figure 1.2. The fU'St domain lies at the 
amino terminus and shows high homology at both the DNA and amino acid level to actin binding 
proteins such as 13-spectrin and a-actinin (reviewed in Ahn and Kunkel, 1993). 2D NMR studies 
confirmed the actin binding nature of the amino terminus (Levine et a/, 1992) as did kinetic binding 
studies (e.g. Ervatsi and Campbell, 1993a). Deletions within theN-terminus result in the lesser Seeker 
Muscular Dystrophy (SMD) phenotype. Similarly, insertion of anN-terminally deleted dystrophin 
transgene into an mdx mouse rescues the Duchenne mouse to a Seeker phenotype (Rafael et a/, 1996). 
The second major domain is the central rod domain, containing 24 spectrin rod domain like repeats. 
This regular repeating unit has been crystallised for dystrophin and shown to fold into an anti-parallel 
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triple helical repeat, as found in spectrin (Winder et al, 1997). The rod domain has 4 hinge regions 
believed to confer flexibility on the molecule. The C-terrninal end of the rod domain contains an EF 
hand homologous to that in calmodulin, ex actinin and 13 spectrin (see Ahn and Kunkel, 1993 for review 
of structure). This could suggest a possible calcium binding role for dystrophin. However, the EF hand 
is not believed to bind calcium at physiological calcium levels (Dubreuil et a/, 1991). The 
physiological significance of the different portions ofthe rod domain is seen in clinical data- mutations 
within the proximal rod domain are rarely severe, resulting in a mild phenotype. Mutations at the distal 
end of the rod domain result in a classic Becker phenotype. 
The third region of the dystrophin protein is the C terminal domain. This domain is cysteine rich and 
contains a leucine zipper dimerisation motif. The function of the C-terrninal domain is to interact with 
the dystrophin associated glycoprotein (DAG) complex. 
1.1.5 Dystrophin associated glycoprotein complex. 
If dystrophin, is considered to be analogous to the submembranous cytoskeletal protein spectrin, then 
the DAG complex may be thought ofas the transmembrane spanning ankryinlband 3. Together 
dystrophin and DAG complex link the underlying myofibrillar actin cytoskeleton to the extracellular 
matrix. 
A mixture of co-immunoprecipitation and protein crosslinking experiments lead to the current 
description of the components and associations within the DAG complex (Campbell and Kahl, 1989, 
Ervasti et a/, 1990, Matsumura et al, 1992, Reviewed in Tinsley et a/, 1994 and 1997, Ervasti and 
Campbell, 1991, Michalak and Opas, 1997), shown diagrammatically in figure 1.3. The DAG complex 
can be split into three subcomplexes of transmembrane and membrane associated proteins and 
glycoproteins according to their eo-purification upon separation and hence binding affinities to each 
other. 
The first complex- the dystroglycan complex of ex and 13 dystroglycan- links dystrophin to the 
extracellular matrix. ndystroglycan is a peripheral surface proteoglycan that binds the G domain of 
merosin, a component of the extracellular matrix. (Merosin is also called larninin 2). 13 dystroglycan is 
a transmembrane protein, shown to bind the C-terrninal domain of dystrophin (see later) and ex 
dystroglycan. 
The second complex is the sarcoglycan complex of ex (also known as adhalin, the term used throughout 
this text), 13, y and o sarcoglycans. These do not bind dystrophin directly, but indirectly through the 
DAG complex. 
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Finally the syntrophin complex, composed ofthe three similarly sized homologous proteins al, 131 and 
132 syntrophin, binds the C-tenninal domain of dystrophin and forms associations with other members 
of the DAG complex. Expression of the syntrophins is both spatially and temporally regulated. 132 
syntrophin, for example is found predominantly in utrophin-DAG complexes at the early stages of 
neuromuscular junction development. 
The significance of the DAG complex is clinically observed. Mutations within components ofthe 
complex give rise to forms of muscular dystrophy with varying clinical severity. For example, Limb 
Girdle Muscular Dystrophy type-2D is caused by mutations in adhalin. (For further examples see table 
7.2 Dystrophin; Gene, Protein and Cell Biology. p167) 
The DAG complex is absent in DMD patients as assessed immunohistochemically (Ohlendieck and 
Campbell, 1991 a), Ohlendieck et a/, 1993, Cullen et al, 1996). However, the genes for the DAG 
components are fully functional. In mdx mice, the insertion of a full length dystrophin transgene 
restores the DAG complex in dystrophic muscle (Rafael et a/, 1996). The absence of dystrophin 
appears to render the complex unstable. 
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Figure 1.3 Dystrophin and the dystropbin associated glycoprotein complex. 
Dystrophin covalently binds F-actin via its N-terminus and the DAG complex at the C-terminus. The 
DAG complex, in turn binds the extracellular matrix via the dystroglycans and merosin (laminin 2). 
The dystrophin I DAG complex therefore links the intracellular contractile apparatus of the muscle with 
the extracellular matrix. Dystrophin rod domain is shown truncated for simplicity. 
Figure modified from Tinsley et a/, 1997, Campbell, 1995, and the Novocastra Catalogue 1999, p65 
(Novocastra Laboratories, Newcastle, UK). 
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1.1.6 Dystrophin/DAG associations and muscle function. 
Binding of dystrophin 's C-tenninus to the DAG complex is critical for muscle function. To determine 
exactly which regions of the dystrophin molecule interacted with the DAG complex, Rafael et a/ (1996) 
generated a series oftransgenic mdx mice. The mice contained a series of dystrophin constructs with 
deletions of the carboxyl end of the protein. All transgenes were under the activity of the muscle 
creatine kinase promoter, thus ensuring tissue specific expression. The ability of the transgene to 
rescue the phenotype of the mdx mouse (including restoration of the DAG complex) indicated the 
functional importance of the deleted protein region. 
Deletion of two thirds ofthe central rod domain gave an almost fully functional dystrophin protein, 
whilst deletion of the N-tenninal actin binding domain converted the mouse to a Becker phenotype. C-
terminal mutations of dystrophin were shown to block interaction with the DAG complex and lead to 
the most severe dystrophic phenotype. Deletion ofthe C-terminal cysteine rich domain gave loss of the 
~-dystroglycan binding site with subsequent loss of ~-dystroglycan and the sarcoglycan complex from 
the sarcolemma and a severe DMD phenotype. Loss of the alternatively spliced and extreme C-
terminal domains had no effect on dystrophin function. These constructs successfully restored the DAG 
complex and gave a normal tissue phenotype, as did a construct lacking the leucine zipper dimerisation 
motif. In vitro, a I syntrophin binds exons 73-74 ofdystrophin. However, the deletion of this region in 
a transgenic mouse had no effect on syntrophin/DAG complex localisation in vivo. Expression of a C-
terminal domain construct (Dp71) is sufficient to restore the DAG complex to the plasma membrane, 
but not sufficient to rescue the DMD phenotype. 
From these experiments it may be concluded the critical function of dystrophin is binding of the DAG 
complex via ~-dystroglycan, as disruption of this link gave the most severe phenotype in the mice. In 
contrast, a direct link between dystrophin and the syntrophin complex was not critical for preventing a 
DMD phenotype. C-tenninal deletions lead to instability at either the protein or mRNA level, and a 
severe DMD phenotype. These experimental results mirror clinical observations. There is very little 
data available from patients with truncated C-terminal dystrophin, probably because such patients do 
not survive to the testing stage. In those cases where data is available, the DMD is invariably severe. 
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1.1. 7. Functions of dystrophin. 
1.1.7 a) Maintenance of intracellular Ca2+ 
It has been suggested that dystrophin regulates and maintains intracellular calcium levels in muscle 
fibres (Reviewed in Brown and Lucy, 1997, Ahn and Kunkel, 1993). Experimental evidence for the 
suggestion was obtained by staining fibres with fluorescent calcium probes such as Fura 2. Mdx fibres 
are less able to regulate intracellular calcium levels following influx. Mdx fibres possess widely 
ranging intracellular calcium, unlike non-dystrophic fibres which have more even calcium levels. 
Myotubes from mdx mice expressing a full length dystrophin construct have normal calcium levels. 
One hypothesis proposes the absence of dystrophin affects Ca2+ leak channels, leading to uncontrolled 
passage of calcium ions. However, it is not clear whether this is a direct consequence of a lack of 
dystrophin, or a secondary effect due to disruptions in the plasma membrane of dystrophic tissue. A 
direct link seems less likely given that, despite the absence of dystrophin, pre necrotic dystrophic tissue 
doesn't have a wide range of calcium levels. In addition, calcium levels do not gradually increase as 
the tissue dies. Calcium irregularities could arise from the absence of dystrophin retarding normal 
myotube differentiation with respect to calcium handling properties, and in particular the calcium leak 
channels. However, this does not explain the differences in calcium concentration between different 
fibres. 
An increase in intracellular calcium gives an increased rate of muscle protein degradation. In turn 
increased degradation would lead to an increase in calcium permeability, perpetuating the degradation 
cycle. This furthers the notion that calcium level fluctuation is a secondary rather than primary 
consequence of dystrophin absence. As discussed above, direct regulation of calcium by binding to 
skeletal muscle dystrophin seems unlikely, as the dystrophin EF hand domain doesn't bind calcium at 
physiological levels. 
1.1.7 b) Signal transduction. 
The DNA and protein sequences of dystrophin reveal a putative cAMP dependant protein kinase 
domain within the rod section (Reviewed in Brown and Lucy, 1997). Kinase activity, together with 
dystrophin's submembranous location could potentially play a role in signal transduction. In addition 
to acting as a kinase, dystrophin can itself be phosphorylated and dephosphorylated at protein kinase C 
target sites in the rod domain. Dystrophinopathies have been attributed to deficiencies in signal 
transduction mechanisms. In particular, Limb Girdle Muscular Dystrophy (LGMD) type 2A is due to a 
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mutation in the muscle specific calcium activated neural protease 3 (CANP3), a known signalling 
molecule. 
Finally, the N-terminal domain of dystrophin can be activated by calcium/calmodulin following a rise in 
intracellular calcium. The calmodulin bound NH2 domain triggers polymerisation of G actin monomers 
to form the F actin polymer. The contraction induced rise in intracellular calcium therefore leads to 
formation of extra actin fibres. The muscle fibre is strengthened via the actin cytoskeleton, thus 
combating the stress of contraction. 
1.1.7 c) Maintenance of muscle fibre structural integrity. 
The observation that the absence of dystrophin leads clinically to muscle degeneration lead to the 
conclusion the major function of dystrophin is to maintain structural integrity of muscle fibres. 
Based upon the evidence that the muscles most used in an eccentric manner (postural muscles) suffer 
the most rapid decline in force generation in DMD patients, and realising damage by mechanical factors 
could explain the muscular weakness in DMD, Karpati and Carpenter ( 1988) amongst others proposed 
that dystrophin was preventing mechanical damage in healthy tissue. More specifically, taking the 
subcellular localisation of dystrophin into account and it's proposed cytoskeletal structure, it was 
suggested dystrophin prevents disruption of the plasmalemma during eccentric contractions by 
anchoring the membrane to the cytoskeleton. Consequently dystrophin deficient muscle lacks this 
stability and is susceptible to shearing forces. 
This situation appears to be true in the XMD dog (X-linked muscular dystrophy) which experiences 
significant exercise induced muscle damage. In DMD patients, however, similar exercise induced 
effects have not been seen. An equivalent picture is drawn in mdx mice- there does not appear to be 
any increase in the susceptibility ofmdx fibres to contractile activity induced damage. On the other 
hand, muscle which already has substantial degeneration of fibres will be more susceptible to further 
damage than healthy fibres. This is due to the greater mechanical forces experienced by the reduced 
number of intact fibres and possibly explains the differences between XMD dogs and mdx mice- the 
mice having greater regenerational capacity (reviewed in Jackson, 1993). The role of the dystrophin-
DAG complex may therefore be to maintain the structural integrity of the myofibre and membrane. 
Ervasti and Campbell (1993 a) showed that dystrophin binds intracellular F-actin with its N-terminal 
domain and transmembrane spanning P-dystroglycan with the C-terminus. P-dystroglycan associated 
with a-dystroglycan which in turn binds merosin- a component of the extracellular matrix (figure 1.3). 
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The dystrophin!DAG complex consequently links the actin contractile fibres to the extracellular matrix 
(ECM) via the fibre plasma membrane. This intracellular link from fibre to ECM is proposed to 
maintain the integrity of individual fibres by modulating the shear forces generated during contraction 
(Petrof et a/, 1993, Ervasti and Campbelll993 a, reviewed in Ervasti and Campbell, 1993 b). 
Furthermore, adjacent bundles of fibres will be held together during contraction by binding to a 
common ECM. When dystrophin is absent, it is suggested the forces of contraction would shift the 
contractile fibres relative to the plasma membrane, shearing the membrane and disrupting its 
organisation. Small movements in the myofibrillar membrane could have a big effect on structure and 
integrity as the membrane is so well ordered. For example, ion permeability at sights of membrane 
lesions would dissipate action potentials, rendering the muscle less efficient at contraction- as would 
movement of ion channels relative to the sarcomere. The extra shear forces in dystrophic tissue and the 
subsequent membrane disruptions could account for the observed elevated serum creatine kinase levels 
and the greater susceptibility to osmotic stress. Dystrophin may therefore stabilise the muscle fibre 
membrane by modulating the contractile shear stress. 
1.1. 7 d) Stabilisation and organisation of the muscle fibre membrane. 
Dystrophin may indirectly stabilise the muscle fibre membrane by restricting the shear stresses imposed 
on the membrane during contraction. Alternatively, dystrophin may contribute directly to membrane 
stabilisation by organising the constituents of the muscle cell surface. 
1.2 Membrane organisation. 
1.2.1 Tbe cell membrane and subcellular domains. 
The plasma membrane of a differentiated cell is a far cry from the homogeneous mixture of proteins 
surrounded by lipid envisaged by Singer and Nicholson ( 1972). Instead, membranes are complex 
structures, organised and compartmentalised into distinct functional domains. The classic example of 
this compartmentalisation is the epithelial cell, whose membranes are polarised into two functionally 
separate domains- the upper apical domain and the lower basolateral domain. The presence of tight 
junctions between adjacent cells not only holds the epithelial cells together into a tissue sheet, but also 
forms an impermeable barrier to diffusion between compartments. Following specific vectorial 
targeting of membrane constituents to one or other domain, the tight junction prevents free diffusion 
into the other membrane domain (reviewed by Rodriguez-Boulan and Nelson, 1989}. 
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The membrane polarisation seen in epithelia is not just a curious side effect of cell-cell tethering. 
Instead, the maintenance of clearly defined subcellular domains is vitally important for celllular 
function. A clear example of membrane domain demarcation in a differentiated cell is seen in sperm. 
Though the spermatozoa is just one cell, immunostaining ofthe cell surface shows antigens to be 
present on the acrosome that are absent from the tail region and vice versa, for example the 
glycoprotein antigen PT -1 is confined to the posterior tail region prior to fertilisation (Myles et a/, 
1984). This subcellular regionalisation reflects essential domain functionality- enzymes needed for 
burrowing into the oocyte are unnecessary in the propulsion domain. 
Cells may form supramolecular complexes at the membrane to perform a particular function. In 
excitable cells, for example, effective and efficient propagation of the action potential and 
neurotransmission at the synapse and neuromuscular junction requires the correct spatial distribution of 
the constituent parts. Transmission of an action potential along the nodes of Ranvier in a neuron is 
mediated by and dependent upon high density clustering of sodium channels at the nodal regions. 
Formation of such complexes requires the correct spatial targeting of the constituents followed by a 
method oflocalisation or immobilisation at the target site (Kaplan et al, 1997). 
Regulation of the movement of membrane proteins is essential if a membrane is to contain regions with 
different functionalities. In the signal transduction for example, it would be disastrous if an activated 
receptor could diffuse throughout the membrane and trigger signal transduction cascades at random. 
Receptor and target may therefore be localised together on a cell. In addition to localising receptor and 
target together within a domain on one cell, the restriction of protein mobility can also permit direct 
communication between two adjacent cells. To facilitate inhibitory synaptic transmission for example, 
GABA receptors are localised in high density clusters on the neuronal cell body and dendrites, closely 
opposed to the sites of GABA release, where their mobility is restricted (V elasquez et a/, 1989). 
Similar restrictions are needed to allow formation of supramolecular complexes from their constituent 
parts. Trapping proteins at an active site increases the local concentration of component proteins, 
raising the likelihood of protein-protein interactions and complex formation. Assembly of the complex 
also consequently occurs at the desired subcellular location. 
1.2.2 Experimental methods for studying membrane domains. 
In polarised cells, the localisation and segregation of proteins into functional domains is controlled in 
part by imposed restrictions on the diffusion capabilities of the proteins, restricting their lateral mobility 
within the plane of the membrane. In neurons, for example, a specialised domain at the initial segment 
of the axon acts as a barrier to protein diffusion (Winckler et a/, 1999). Such barriers are highly 
selective- lipids are able to cross the diffusion barrier at the axon hillock but transmembrane spanning 
proteins are restricted (Winckler and Poo, 1996). By monitoring the movements of membrane proteins 
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in real time, possible mechanisms of organisation and distribution of membrane proteins and lipids are 
suggested, and insights are provided into associations with the underlying cytoskeleton. In order to 
study the diffusional behaviour of membrane species, two experimental techniques have been 
developed- fluorescence photobleach recovery (FPR), also known as fluorescence recovery after 
photobleaching or FRAP, and single particle tracking (SPT). 
1.2.2 a) Fluorescence photobleacb recovery. 
FPR is a technique which facilitates the real time study of membrane fluidity, providing quantitative 
measurements of the distribution and lateral mobility of a membrane species of interest. FPR has been 
employed in this thesis to study mobility of proteins and lipids in the muscle fibre membrane. 
To obtain mobility data, the studied molecule must first be specifically labelled in situ with a 
fluorescent marker. An argon laser is used to excite the fluorescent marker within a small region of the 
membrane defined by the laser beam. The intensity of fluorescence emitted is quantified by photon 
counting with a photomultiplier tube. The arrangement of apparatus is shown in schematic form in 
figure 1.4 a) and the actual experimental equipment is shown in figure 2.1. After normalising initial 
levels of fluorescence, the membrane patch is bleached rapidly (by 60-70%) with a 10,000 fold brighter 
pulse of laser light (figure 1.4 b, top centre). The attenuated monitoring beam is then used to track 
recovery of fluorescence (figure 1.4 b, top right). 
Fluorescence recovery is attributed to the outward diffusion of bleached molecules away from the 
bleached region and an inward diffusion ofunbleached molecules from the surrounding membrane. A 
stylised recovery curve is shown in figure 1.4 b, bottom. Using the diffusion equation, 
D-~/4To 
where, w is the e-2 beam radius and T 0 is calculated from the half time for recovery (t 112), it is possible 
to calculate the diffusion coefficient of the molecule, D (Axe !rod et a/, 1976). 
The fraction of the labelled molecules that are mobile, f, may be calculated from the recovery curve, 
f= I (c) - I ( o) I I (p) - I ( o ). 
I (p), I (o) and I (c) are the fluorescence intensities at the pre-bleach, post-bleach and steady state (time 
=infinity) levels respectively. The level of fluorescence recovery reflects the proportion of molecules 
that are mobile. If all the molecules are freely mobile within the plane of the membrane, the post-
bleach fluorescence intensity will return to pre-bleach levels. 
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Figure 1.4 a) Diagram of FRAP apparatus FPR equipment directs either low level ex citatory laser 
light onto a sample to monitor membrane fluorescence, or 10,000 fold brighter light through to bleach 
fluorescence in a small membrane region. 
Mirrors and beam steerers direct the laser beam onto the sample. In monitoring mode the bleach shutter 
(Sr2) is closed, and only the 0.01% oflaser light reflected back from the 4 prism/air interfaces is 
directed towards the sample. In bleach mode the shutter is opened for -50msec under control of a 
computer, and the full intensity laser beam passes through to the sample. The incoming excitatory 
beam is focused onto the sample surface with a microscope lens. The dichroic mirror reflects excitatory 
light onto the sample, and allows the longer wavelength emitted fluorescence up to the photomultiplier 
tube where light levels are digitally quantified. Key: neutral density filters, ND; mirrors, M; dichroic 
mirror, OM; steering mirror, SM; shutters, Sr; beam splitters, BS, and photomultiplier tube, PMT. 
1.4 b) Recovery curve for mobile species- the molecule of interest is fluorescently tagged. Initial 
levels of fluorescence F(l) are measured in the target area before the sample is briefly bleached F(O). If 
the labelled species is mobile, diffusion of fluorescent molecules into the target area will lead to 
recovery of fluorescence intensity over time F(t). 
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1.2.2 b) Typical diffusion characteristics of membrane components. 
The lateral diffusion rate of a molecule within a membrane is related to its size- the smaller the species, 
the faster it diffuses (Saffman and Delbruck, 1975, Peters and Cherry, 1982). D detennined by FPR for 
membrane proteins is typically of the order of- 10"10 to 10"11 cm2s-1• Lipids move more rapidly. D for 
membrane lipids is ofthe order of 10"9 cm2s" 1 (e.g. Jacobson et a/, 1987). 
The mobile fraction of membrane proteins and lipids is highly variable and dependant upon cell type 
(table 1.1 ). Typically, membrane lipids show 50-I 00% recovery in fluid membranes. Protein mobility 
ranges from 5 to 100% according to the mechanism of membrane/protein association (see later), with 
lower mobility in highly specialised differentiated cellular domains (e.g. Jacobson et a/, 1987, Kusumi 
and Sako, 1996, Axelrod et a/, 1976). 
Membrane components with a mobile fraction less than 15% are deemed to be 'immobile' by FPR. 
Membrane Cell type. D, diffusion f, mobile fraction. 
Component. coefficient (cm1s"1) 
(s.d.). 
NCAM (protein) 1 C2C12 muscle cell line. 6.9 ± 0.2 xJO·IO 51% 
Band 3 (protein) 2 erythrocyte 4.5 xJO·II 80% 
Di I (lipid analogue) 3 fibroblast 1-1.4xl0·8 >90% 
ODAF (lipid analogue) Bull spermatozoa 7-9 xl0"9 47-55% 
4 (midpiece domain) 
Table l.l Representative diffusion data for membrane proteins and lipids. 
In general, lipids show greater mobility than proteins, with faster diffusion and a greater mobile 
fraction. Protein diffusion is dependent upon cell type and method of protein anchoring to the 
membrane. (References, I, Simson et a/, 1998. 2, Sheets et a/, 1980. 3, Jacobson et a/, 1987. 4, 
Jarnes et a/, 1999.) 
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1.2.2 c) Limitations of FPR. 
There are two main limitations of FPR within these experiments. The first is timescale. The 25msec 
dead time between the bleach and first measurement will lead to some data loss, particularly of rapidly 
diffusing species. Additionally, molecules with D<l0" 12 cm2/sec will appear immobile. 
Secondly the resolution of an FPR experiment is severely limited by the relative size ofthe bleach spot 
to the diffusion domain of the fluorescently marked protein- if the bleached region is larger than the 
area in which the labelled molecule can freely diffuse, that molecule will always appear immobile by 
FPR, even if it is actually diffusing freely in a small confmed domain. Additionally, the size of 
bleached area relative to the total size of membrane will affect the magnitude of fluorescence recovery. 
The diffusion equations assume an infinite source of labelled molecules diffusing into the bleach area 
sink. In biological systems, and particularly within the confines of single cells the source oflabelled 
molecules is finite and therefore full recovery may not be seen- even if the species is freely diffusible 
(see Edidin, 1993 for a full explanation of domain size and FPR data interpretation, and Angelides et a/, 
1988 for the mathematics). 
1.2.2 d) Single particle tracking. 
Single particle tracking (SPT) is a modification of the FPR technique that allows the mobility ofa 
single molecule to be tracked on a cell surface (reviewed in Sheets et a/, 1995). In SPT the protein is 
labelled with either colloidal gold or a fluorescent latex bead which has been covered in antibodies to 
the molecule of interest. Mobility ofthe protein-bead complex can then be followed across the cell 
surface with a microscope and video camera in real time. SPT is advantageous over FPR in that free 
diffusion within smaller scale domains can be resolved- the size of bleach spot is not limiting. Single 
molecular information can be obtained at nanometer resolution. FPR measurements of diffusion refer 
to macro scale mobility, i.e. the time it takes for a molecule to diffuse over micrometers into the bleach 
spot. SPT provides both micro and macroscale diffusion measurements. With SPT it is possible to 
measure both how quickly a protein can diffuse within a confined domain, and also how frequently that 
protein can cross into adjacent diffusion domains. Rotation of a fixed protein about the point of 
tethering can also be resolved. 
A similar technique with single molecular resolution employs the use of optical tweezers (reviewed in 
Sheets et a/, 1995). As with SPT the antigen of interest is labelled with latex beads. The bead may 
then be held in an optical trap of crossed laser beams and pulled along the surface of the cell. The 
forces acting upon the protein and restrictions imposed upon its lateral mobility can be studied by 
monitoring the distances a bead can be pulled and the forces required to cross any barriers encountered 
(with piconewton accuracy). 
17 
Chapter I. Introduction. 
1.2.3 Micron scale domains as revealed by FPR. 
Early FPR comparisons of real and artificial lipid bilayer systems showed that proteins diffused far 
more slowly in a cell membrane than in an artificial model. There were clearly restrictions imposed 
upon the Brownian diffusion of proteins in the cell (reviewed in Jacobson et a/, 1987). The mobile 
fraction of fluorescent antibody labelled membrane proteins was found to relate to the size of FPR 
bleach spot area- the mobile fraction falling as bleach spot size increased. The same was true for the 
lipid analogue NBD-PC. This is contrary to expectations for a homogeneous cellular surface. In this 
case the same proportion of mobile proteins and lipids should be found across the membrane surface, 
irrespective of bleach area. This dependence of mobile fraction upon bleach spot size suggested the 
cell membrane is compartmentalised into regions ~2j.Ull in diameter. When the FPR bleach region was 
significantly smaller than a domain, free diffusion of mobile species into the bleached area was 
possible. When the bleach spot size covered several domains, the membrane species- though mobile 
within their own domains- could not cross the domain boundaries and the apparent FPR mobile fraction 
went down (Yechiel and Edidin, 1987). 
1.2.4 The role of the cytoskeleton in restricting protein lateral diffusion. 
It is clear that in terms of functionality and physical organisation, the cell membrane is divided into 
micrometer scale domains. The importance of the cytoskeleton to the construction and partitioning of 
these subcellular domains was elegantly demonstrated in red blood cells. The biconcave structure of an 
erythrocyte is maintained by the cytoskeleton. Spectrin tetramers cross link into a net-like structure 
beneath the membrane surface, with tetramers joined together at junctional complexes. The junctional 
complex, including ankyrin and the transmembrane protein band 3, links the underlying spectrin 
network to the membrane (reviewed in Bennet, 1985). Proteins diffuse faster within blebs in the 
membrane, where the membrane has been pulled away from the cytoskeleton, than they do in the main 
body of the cell (Tank et a/, 1982) therefore the cytoskeleton restricts protein mobility. 
Spherocytic erythrocytes develop their characteristic shape because of deficiencies in the cytoskeleton. 
Levels of ankyrin, spectrin, band 2.1 and band 4.1 proteins are all reduced. The lateral mobility of Con 
A receptors in the spherocytic erythrocytes was 50 fold higher than the mobility of the same receptors 
in the membranes of normal erythrocytes when measured by a modified FPR technique (~2.5xl0-
9cm2s-• for spherocytic erythrocytes and 4.5 xl0" 11cm2s-• for normal cells) (Sheetz et a/, 1980). The 
spectrin based cytoskeleton is therefore placing a restriction upon mobility of membrane proteins in 
normal red blood cells. 
Confirmation of the role of the cytoskeleton was obtained by following the rotational and lateral 
diffusion of band 3 protein in the membranes of erythrocytes. Lateral mobility of free band 3 was 
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dependent upon the spectrin association state (spectrin dimers or tetramers), with greater lateral 
mobility as the spectrin dimer/tetramer equilibrium was shifted towards dimers (Tsuji and Ohnishi, 
I986). The rotational mobility remained unchanged. The portion of band 3 immobilised to the 
cytoskeleton via ankyrin was constant throughout, so the observed changes in diffusion rates were not 
due to increased freely diffusing band 3. The rotation of the unbound band 3 showed it was free to 
diffuse, whatever the spectrin association state. The extent and rate of diffusion was determined by the 
cytoskeletal integrity. It was therefore proposed that spectrin and band 3 interacted physically beneath 
the surface of the membrane. Further evidence was provided by the 8 fold increase in lateral mobility 
following cleavage of the band 3 cytoplasmic domain (Tsuj i et a/, I988). 
The physical nature of the cytoskeletal interaction with diffusing membrane proteins is reflected in the 
correlation between diffusion rate and cytoplasmic domain size. In general, the larger the cytoplasmic 
region of a membrane protein, the more likely it is to encounter the cytoskeletal network. Similar 
evidence for a steric cytoskeleton I membrane protein interaction comes from domain swapping 
experiments. Restrictions imposed upon mobility correspond to the method of protein/membrane 
anchoring. Classical transmembrane spanning H-2 b class I MHC molecules are concentrated in 
domains within the membranes ofK78-2 hepatoma cells, whilst the GPI anchored non-classical class I 
related molecules Qa-2 can pass through the domain boundaries. The mobility profile depends upon 
the mode of anchoring the protein to the membrane. Swapping the anchoring regions resulted in the 
alternative pattern of mobility (Edidin and Stroynowski, 1991). Proteins with large cytoplasmic 
domains are therefore held up in the cytoskeleton to a greater extent than those with smaller 
cytoplasmic regions. Restrictions on mobility must be conferred by the inside of the cell membrane, not 
the outside, as the extracellular portion of the proteins was unchanged by the domain swap. 
Whether proteins are hindered by the cytoskeleton or not, interactions with other proteins in the plane 
of the membrane affect the rate of lateral diffusion. Rate of GPI anchored Thy-I mobility in membrane 
lipid analogues is as fast as the rate of lipid diffusion. Increasing the concentration ofmembrane 
proteins reduces the rate oflateral diffusion as protein-protein interactions increase the viscosity of the 
membrane (Jacobson et a/, 1987). The rate ofmobility ofGPI anchored proteins in the above domain 
swap experiment was impeded by high concentrations of membrane protein. 
Lateral mobility may be constrained in that all directions of diffusion may not be equally likely. Just as 
bulk flow effects in a membrane may move components laterally, diffusion may be anisotropic 
(Jacobson et a/, I987). 
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1.3 Tbe molecular fence model of membrane domains. 
Sako and Kusumi (1994) used video enhanced contrast optical microscopy to track the mobility of 
individual transferrin and o:2 -macroglobulin receptors labelled with nanometer sized ligand coated 
colloidal gold particles on the surfaces of cultured NRK fibroblasts. The motion of the particles was 
consistent with confined diffusion. Rapid free Brownian diffusion occurred on a micrometer scale 
within confined domains (D=10"9cm2/s). Slower long-range diffusion was seen following 
intercompartmental jumps (macroscopic diffusion coefficient =2.4x I 0" 11cm2/s). The location of the 
boundary domains was fixed over the measuring time of the experiment, suggesting domains have bard 
physical barriers at their edges. Lipid domains are unlikely as the edges of adjacent domains were very 
close- too close for apposing lipid fields with similar viscosities. Similarly, the boundary edges were 
fixed in place during the measurements, but lipid domain edges would fluctuate during the measuring 
period. The underlying cytoskeletal network was important for the formation of the domain 
boundaries- disruption with cytochalasin D or vinblastin decreased the extent of confmed diffusional 
mode and increased the simple diffusion mode {Sako and Kusumi, 1994). 
The elastic nature of the boundaries was seen when laser optical tweezers were used to drag colloidal 
gold labelled proteins across the cell surface. The beads were released from the optical trap and sprang 
back into the centre of the domain at the boundaries. The barrier free path for bead motion was related 
to the size of protein cytoplasmic domain- 8.5J.llll for GP1 anchored molecules c.f. 3.5j..lm for a 
transmembrane spanning receptor- as with FPR measured diffusion (Edidin et a/, 1991). Variation in 
bead size from 40-21 Orun diameter has no effect on observed dragging rate, but disruption to the 
cytoskeleton does- again indicating the boundaries are cytoplasmic and cytoskeletal, not extracellular 
(Sako and Kusumi, 1995). 
The confmed diffusional modes observed, the physical nature of the boundaries and the importance of 
the cytoskeleton to these observations lead Sako and Kusumi (1994) to propose the 'membrane 
skeleton fence model' (molecular fence) of membrane organisation (later refmed by Simson et a/, 
1998). This model proposes that the spectrin based cytoskeletal network beneath the cell surface 
restricts mobility of membrane proteins by forming a steric barrier to protein diffusion. Membrane 
proteins with large cytoplasmic domains are more likely to encounter the cytoskeleton and be restricted 
in their motion than proteins with small cytoplasmic components (figure 1.6, a). The fast micro scale 
diffusion rates are due to free Brownian motion within the confmes of a domain boundary. The slower 
macroscale diffusion reflects the time taken to hop from one confined diffusion domain to the next 
(figure 1.5). The rate of intercompartrnental transfer is predominantly influenced by the length of the 
cytoplasmic tail of the molecule; the integrity of the cytoskeleton (spectrin dimers are more 'open' than 
tetramers, so proteins can pass more easily between diffusion domains {Tsuji and Ohnishi, 1986), 
dissociation of the cytoskeleton by cytochalasin allows passage between domains); and the distance 
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between the membrane and the cytoskeletal network (hence the increased mobility in blebbed 
membranes). 
Figure 1.5 The molecular fence model of membrane organisation: mobility pattern of molecule 
undergoing constrained diffusion as seen by SPT. 
The protein (dark spot) is free to diffuse rapidly within the confines of a cytoskeletal domain (broad 
lines) (D microscate-10"9 cm2s"1). lntercompartmental transfer is slower (D mucroscate-10" 11 cm2s·1 ) and 
depends upon the integrity of the cytoskeleta1 boundary, cytoskeleton-membrane distance, cytoplasmic 
domain size and kinetic energy of the diffusing molecule. Figure after Sako and Kusumi, (1994). 
1.4 Other modes of restricting membrane protein mobility. 
The membrane skeleton fence model is one way in which mobility of membrane proteins can be 
restricted, but it is not the only way to control membrane protein mobility. Five different modes of 
protein motion have been observed by SPT(Kusumi et al, 1993)- free Brownian diffusion, constrained 
diffusion (molecular fence), stationary phase (immobile), oscillation about a fixed point and directed 
motion (figure 1.6). Directed motion is believed to reflect either bulk flow, such as towards a leading 
edge in migrating fibroblasts, or motion along cytoskeletal motors (reviewed in Sheets et a/, 1995). In 
order to explain these other variations in mobility, modes of protein confinement have been proposed 
that may be employed in conjunction with the cytoskeletal membrane fence model (discussed in 
Kusumi and Sako, 1996, Sheets et al, 1995). 
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1.4.1 Oligomerisation. 
Oligomerisation of membrane proteins would not necessarily reduce their lateral mobility in a matrix of 
uniform viscosity, although there is some dependence of size upon lateral diffusion rates (Vaz et a/, 
1982). However, large protein complexes will be restricted in their ability to cross the boundaries 
between adjacent cytoskeletal domains, especially where breaks in the cytoskeleton or increased 
membrane/cytoskeletal distance are essential for passage (reviewed in Kusumi and Sako, 1996). 
Inclusion of a protein with a large cytoplasmic domain into the complex would restrict mobility of other 
more freely diffusing members (figure 1.6 b). The entrapment of a couple of members of a protein 
complex within a confined region can facilitate formation of large multirnolecular assemblies on the cell 
surface as other members of the complex diffuse and hop between compartments into the domain, but 
once bound cannot diffuse out. 
1.4.2 High localised concentration of proteins. 
A high local concentration of proteins can restrict diffusion of a protein molecule through a region 
(reviewed in Sheets et a/, 1995). Firstly, proteins increase the viscosity ofthe membrane lipid bilayer. 
Secondly, the greater the protein concentration, the greater the extent of protein-protein interactions. 
Such interactions could be steric, forming a physical barrier to diffusion. Specific and non-specific 
electrostatic interactions will influence diffusion, as will interactions with the surrounding lipid phase. 
Such crowding effects on diffusion are understood to account for the transient confinement of GPI 
anchored proteins which cannot directly interact with the cytoskeletal meshwork (figure 1.6 c). 
1.4.3 Localised lipid domains. 
Localised variations in the lipid bilayer could account for the differences in protein diffusion across the 
cell surface (figure 1.6 d). Firstly, local changes in bilayer viscosity would affect rates of protein 
diffusion. Secondly, specifically enriched lipid or cholesterol domains could regulate GPI anchored 
protein diffusion. GPI anchored proteins are found in cholesterol dependent submicron domains on the 
cell surface (Varma and Mayor, 1998, Friedrichson and Kurzchalia, 1998). In liposomes, GPI 
anchored proteins eo-localise to the detergent inextractable lipid fractions. It was suggested the 
saturated acyl chains of the phosphatidylinositol anchor may preferentially partition into more ordered 
lipid domains , enriched in glycosphingolipids, sphingomyelin and cholesterol, thus localising the GPI 
anchored protein (Schroeder et a/, 1994). Differences in boundary lipid composition could similarly 
affect diffusion rate (Jacobson et a/, 1987). 
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1.4.4 Protein anchoring. 
FPR experiments very rarely reveal lOO% mobility of membrane proteins. A portion of the proteins are 
invariably immobile on the timescale of the FPR measurement. Immobile proteins may be anchored in 
place on the membrane, usually through specific binding interactions with members of the spectrin 
based cytoskeleton. The portion of band 3 molecules with no rotational mobility, for example were 
bound to ankyrin in the cytoskeleton (Tsuiji et a/, 1988). Single particle tracking has directly shown 
proteins in a stationery phase (reviewed in Sheets et a/, 1995). Such proteins are either completely 
immobile, or oscillate about a fixed point. The extent of oscillation is controlled by the flexibility of 
the cytoskeletal linkage- rather as a dog tied to a lamppost can move, but only within a radius defined 
by the length of lead. 
1.4.5 Membrane compartmentalisation- summary. 
In summary, it has been shown that cellular plasma membranes are compartmentalised and 
compartmentalisation is essential for cellular function. In terms of large scale domains as found in 
spermatozoa or epithelial cells, the domain boundaries are clear and immutable. ln addition, all cell 
membranes contain microscale domains. These domains may result from localised variation in 
membrane lipid or protein concentration. Alternatively, the underlying ankyrin and spectrin based 
cytoskeleton may form a steric barrier to protein diffusion by formation of a submembranous 
'molecular fence'. Boundaries of the molecular fences may be crossed, depending upon the mode of 
anchoring of the protein to the membrane, the size of the cytoplasmic domain of the diffusing protein, 
the association/disassociation state of the spectrin lattice and the distance between the membrane and 
cytoskeleton. Aggregation of proteins into complexes can hinder diffusion across the cytoskeletal 
boundaries. This can localise molecules to a surface domain and facilitate macromolecular complex 
formation. eo localising components of a signal transduction cascade can speed up the rate of 
transmission. Finally, proteins may be bound specifically and directly to the cytoskeleton. Diffusion is 
prevented altogether, but some oscillation about a ftxed point is possible. 
1.5 Dystrophin and membrane integrity. 
Organisation of the protein and lipid constituents of a cell membrane is vital for proper cellular 
function. The evidence outlined below suggests that the structure of the muscle membrane is 
compromised in the muscular dystrophies and therefore indicates that a possible function of dystrophin 
is organisation of muscle fibre membrane constituents. 
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Duchenne muscular dystrophy patients possess elevated levels of muscle cytosolic proteins in their 
serum. Hoffinan and Gorospe { 1992) proposed that the serum enzyme abnormalities in Duchenne 
muscle arose from leakage of the muscle cytoplasmic constituents into the blood through defects in 
plasma membrane integrity. [At the time they hypothesised that the reverse passage of calcium into the 
cell could lead to death, though since then the absence of measurable calcium influx found in mdx 
myotubes in vitro (reviewed in Jackson, 1993), argues against this.] As dystrophin is the key missing 
protein in DMD, the leaky membranes suggested dystrophin somehow maintains muscle membrane 
integrity. 
An absence of dystrophin affects membrane stability under applied osmotic stress. Mature muscle 
fibres and cultured myotubes from mdx mice show greater sensitivity to imposed hypo-osmotic stress 
than C57/BIIO strain control muscle {Menke and Jockusch, 1991). This whole cell experiment 
contradicts the fmdings of an earlier study carried out on domains the size of a few micrometers where 
membrane stability was measured with the application of suction through microelectrodes. No 
difference was found in the resistance to applied stretch between ofmdx and normal fibre membranes 
(Franco and Lansman, 1990). 
Dystrophin deficiency has also been shown to affect the mechanical stifthess/deformability of the 
muscle fibre membrane as measured by 'cell poking'. Prior to differentiation the stifthess of normal 
and mdx myotubes was comparable. Post differentiation {following induction of dystrophin expression) 
normal myotubes were found to be four fold stiffer than mdx myotubes. Dystrophin therefore 
mechanically reinforces the muscle membrane (Pasternak et a/, 1995). 
1.6. Organisation of the muscle fibre membrane at the neuromuscular junction. 
The neuromuscular junction {NMJ) is the site of nerve-muscle intra-cellular communication. The 
junctional region ofthe myofibre membrane possesses a highly specialised assembly of proteins, in an 
arrangement directly related to function. The junction consists of three regions- the presynaptic nerve 
terminal, the highly convoluted postsynaptic muscle fibre membrane and the intervening basal lamina. 
These three regions are unique in terms of protein composition and spatial assembly. Biochemically, 
the muscle membrane at the NMJ has high concentrations of two particular proteins. The first, the 
nicotinic acetlycholine receptor (AChR), is found at the crests of the folds- juxtaposed with the 
presynaptic motor ending. The second protein is the voltage gated sodium channel {NaCh), responsible 
for the membrane depolarisation that ultimately leads to contraction. NaChs are found at the depths of 
the postsynaptic folds (Fiucher and Daniels, 1989) (figure 1. 7). 
25 
0 
0 
0 
0 
Chapter l. Introduction. 
Figure 1.7 Schematic representation of the neuromuscular junction. N, synaptic ending of motor 
neuron. BL, basal lamina. M, muscle fibre. Regions of high acetylcholine receptor density at the tops 
of the postsynaptic folds are shaded, regions ofhigh voltage gated sodium channel density at the pits of 
the folds are open. Diagram modified from Sealock and Froehner, 1997, p.140. Scale bar is 
approximate. 
AChR are located at the tops ofthe folds of the muscle membrane, at an almost crystalline density of 10 
000 molecules/J.Lm2 (Fertuck and Salpeter, 1976). None of the complex structure is present prior to 
innervation- pre-existing AChR diffuse to the site of neural contact (Anderson and Cohen, 1977) where 
they become immobilised. AChR must be specifically anchored in place at the NMJ crests, since the 
receptors are capable of free diffusion in muscle fibre membranes prior to innervation. Axelrod et al 
(1976) frrst showed that receptors cluster and immobilise at the NMJ by following the mobility of 
AChRs by FPR. The receptors fell into two classes. The first were mobile receptors undergoing 
apparently free diffusion. These were uniformly distributed across the muscle cell surface. The second 
class of receptors were immobile. These had formed dense, highly granular clusters. Clustering of 
AChRs therefore gave rise to immobilisation of the receptors. Further experiments looking at the re-
formation of the clusters showed clustering to be a constant process. Mobile receptors from outside the 
NMJ diffused towards existing clusters where they are trapped and immobilised (Stya and Axelrod, 
1983). lt was proposed that a mechanism must exist to immobilise the AChRs clusters and this could 
come from a submembranous anchoring network. 
The precise anchoring mechanism ofreceptors at the crests remains unknown. However, most of the 
evidence suggests involvements from cytoplasmic protein constituents of the crest membrane and 
possibly the basa1lamina (Bloch and Pumplin, 1 988; Froehner, 1991; Apel and Merlie, 1995). 
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A comparable situation is found with localisation of the muscle NaCh. NaCh are diffusely distributed 
and freely mobile within the sarcolemma ofun-innervated muscle. Upon innervation ofthe muscle 
fibre, the channels become localised to the NMJ where they are immobilised (Angelides, 1986). 
The mature NMJ, in common with pre and post-synaptic specialisations on all excitable cells, has ion 
channels localised to specific domains on the cell surface. AChRs and NaChs are able to undergo free 
diffusion in immature myoblasts prior to innervation. The question must be addressed of how these 
channels and other specialised proteins become localised as they do to specific specialised subcellular 
domains, rather than remaining in a state of free diffusion on the cell surface. In neurons, sodium 
channels become clustered at axon hillocks, initial segments and the nodes of Ranvier. In muscle 
fibres, AChRs and NaChs cluster at NMJs. 
1.6.1 The spectrio based cytoskeleton and muscle sodium channel localisation. 
Electron microscopic evidence suggests that, as in the central and peripheral nervous systems, an 
ankyrin/spectrin based system may immobilise NaChs in muscle. NaChs and ankyrin colocalise at the 
depths of the folds ofneuromuscular junctions (Fiucher and Daniels, 1989). 
Different spectrin isoforms exhibit differential subcellular localisation in muscle tissue. Erythroid ~­
spectrins, for example, localise at the costameric junction between Z-Iines and the sarcomere, whilst 
non-erythroid spectrin colocalises with the erythroid forms at the Z-lines but is also found 
homogeneously distributed across the membrane surface (Vybiral et a/, 1992). This would suggest that 
different isoforms of spectrin perform different functions in different domains of the muscle membrane. 
Just as the cytoskeletal constituents ankyrin and spectrin are proven to be necessary for localisation and 
immobilisation of ion channels in the brain and peripheral nervous system, and possibly involved at the 
NMJ, the presence ofthe homologous proteins dystrophin and utrophin at the NMJ is consistent with a 
potential involvement in regulating ion channel distribution. Considering the homology between 
dystrophin and ~-spectrin, dystrophin may have a similar specialised function in subcellular domains to 
isoform specific spectrins. 
1.6.2 Utrophio and the NMJ. 
Utrophin exists exclusively at the NMJ of skeletal muscle (Khurana et a/, 1991 ), and specifically with 
AChRs and rapsyn at the crests ofthe post-synaptic folds (Bewick et a/, 1992). Utrophin, together with 
~-dystroglycan eo-localises to sites of AChR clustering from early development throughout the 
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postnatal maturation ofthe NMJ (Bewick et a/, 1996), suggesting some role in cluster formation or 
stabilisation. 
Agrin is the signalling molecule released by the motor neuron that induces formation of the NMJ 
specialisations on the muscle fibre (Nitkin et a/, 1987). The only known agrin binding molecule within 
muscle fibres is dystroglycan- in the case of the muscle NMJ this is a-dystroglycan (Gee et a/, 1994 
amongst others). AChRs colocalise with utrophin at the tops of the folds, therefore clustering of the 
AChRs could be via agrin, dystroglycan and utrophin. 
Rapsyn, rather than utrophin, is believed to be the main player in AChR clustering. Rapsyn, a 43kDa 
peripheral membrane protein, is sufficient to induce formation of AChR clusters (Froehner et a/, 1990) 
and colocalises precisely with AChRs from the earliest stages of synaptogenesis. Rapsyn knockout 
mice fail to assemble post-synaptic specialisations at their NMJs (including utrophin localisation, 
suggesting rapsyn induces the entire post-synaptic cytoskeletal apparatus) (Gautam et a/, 1995). A 
stabilisation role seems most likely for utrophin since it is not essential for formation of AChR clusters. 
Although utrophin eo-localises with AChRs, utrophin knockout mice show no major differences in 
NMJ structure and organisation compared to normal mice, though a reduction in the total numbers of 
AChRs and the extent of post-synaptic folding is observed (Deconinck et a/, 1997). It is believed this 
reduction in folding leads directly to the reduction in AChRs, as there is less space for the receptors to 
occupy. 
1.6.3 Dystropbin and the NMJ. 
It is unlikely that dystrophin is involved in clustering of AChRs, especially as mdx mice possess normal 
AChR clusters at endplates (Lyons and Slater, 1991). Utrophin is still present in mdx muscle and 
could contribute to AChR clustering via DAGs (present, though down-regulated) at the crests of the 
folds. Instead, dystrophin, like spectrin in neurons, may have a role in the localisation of sodium 
channels at the depths of the junctional folds. 
Dystrophin, in contrast to utrophin, can be seen throughout the muscle plasma membrane. The 
exception lies at the NMJ, where dystrophin is excluded from the utrophin/AChR rich domains and is 
found at high concentration in the membrane region immediately adjacent to the AChRs in the depths of 
the j unctional folds (Sealock et a/, 1991, Byers et a/, 1991 ), the same region as the voltage dependent 
sodium channels. P-spectrin immunostaining is similarly found alongside dystrophin and NaChs at the 
depths of the junctional folds and outside the region of AChRs (Bewick et a/, 1992). 
Localisation of dystrophin to the folds of the junction is developmentally regulated and after AChRs 
have begun to aggregate. Early on in development of the NMJ, dystrophin is present but at no greater 
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density than elsewhere. By P 14 (approximately the same time as formation of extensive junctional 
folding and NaCh accumulation), dystrophin concentration is enhanced at NMJs relative to the 
remainder of the membrane, and reduced at AChR rich regions. Similarly, ~-spectrin concentration 
rises at the junction in parallel with development of the post-synaptic folds and accumulation of NaChs 
(Bewick et a/, 1996). 
All four proteins ~-spectrin, utrophin, dystrophin and ~-dystroglycan are found at the NMJ before the 
junction obtains denervation stability, therefore whilst they may all contribute to formation of the NMJ, 
they cannot confer total stability on the NMJ structure (Bewick et a/, 1996). 
The physiological role of dystrophin at the NMJ is not clear, especially as dystrophin is not essential for 
junctional formation. Mdx mice have normal NMJs, although some reduction in the extent of folding 
has been noticed (Lyons and Slater, 1991). Dystrophin may therefore be maintaining the complex 
folded nature of the motor end plate via interactions with the basal lamina. However, dystrophin is also 
found in specific synaptic structures in the brain, e.g. Purkinje cells of the cerebellum. Here there is no 
specialised basal lamina, therefore dystrophin is either redundant or it is involved in ordering the post-
synaptic apparatus in a non-basal lamina dependent fashion (Lidov et a/, 1990, 1993). 
1. 7 Aims and Objectives. 
Given that DMD is linked to defects in muscle membrane integrity, dystrophin shows high sequence, 
structural and spatial similarities to the cytoskeletal protein spectrin- a proven organiser of membranes 
and regulator of membrane protein lateral mobility; and an absence of dystrophin affects the mechanical 
stability of the muscle cell membrane, the experiments presented in this thesis attempted to quantifY the 
contribution made by dystrophin protein to membrane organisation. 
1.7.1 Dystrophin as a non-specific barrier to membrane diffusion- a molecular fence. 
The dystrophin gene shows high homology to the cytoskeletal proteins spectrin and a-actinin. The 
large central rod domain has 24-spectrin like repeats, whilst the adjacent amino terminal actin-binding 
domain is highly homologous to the actin binding domains of a-actinin and spectrin (Koenig et a/, 
1988). This high homology suggests a cytoskeletal role for the dystrophin protein, a suggestion 
reinforced by the ultrastructural observation that dystrophin possesses the distribution pattern of a 
cytoskeletal network protein (Porter et a/, 1992). 
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The importance of spectrin and spectrin-like proteins in maintaining membrane organisation and for 
mechanical integration of the cell membrane is well documented. In both mice and humans an 
increasing number of genetic diseases are being traced to mutations in members ofthe erythrocyte 
spectrin-based cytoskeletal protein family. For example, human neurofibromatosis type 2 is caused by 
defects in a protein related to protein 4.1 of erythrocytes (Bianchi et a/, 1994); whilst an ankyrin 
deficiency seen in the brain as well as erythrocytes ofnb/nb mice (with associated reduction in spectrin 
levels) leads to degeneration of a population of Purkinje cell neurons, development of ataxia and signs 
of cerebellar dysfunction (Peters et a/, 1991 ). Medical defects have correlated with a compromised 
'molecular fence' in these cells- the original experiments to illustrated the role of spectrin in restricting 
protein lateral mobility were performed on the red blood cells of patients with spherocytic anaemia 
(Sheetz et a/, 1980). 
It may be considered optimistic to suggest dystrophin, like spectrin, is an essential structural component 
of the membrane skeleton. In terms of total protein dystrophin is a very minor component of skeletal 
muscle, making up just 0.002% of the protein of muscle fibres (Hoffinan et a/, 1987). On the other 
hand, the plasma membrane is a small fraction of the total components of a muscle fibre, the bulk of the 
protein residing in the contractile fibres. Dystrophin makes up 4.8±0.8% of the protein in isolated 
sarcolemma, a 2400 fold enrichment compared to muscle as a whole, and comparable with the density 
ofspectrin in brain membranes (Ohlendieck and Campbell, 1991 b). Dystrophin is therefore a major 
component of the membrane cytoskeleton. 
In the light of the apparent instability of the dystrophic membrane; the high sequence homology 
between dystrophin and spectrin; the similar subplasmalemmal localisation of dystrophin and spectrin; 
and the proven importance ofspectrin to restriction of membrane protein lateral mobility, the frrst set of 
experiments presented in this thesis measured the capacity of dystrophin to regulate membrane protein 
mobility through formation of a submembranous 'molecular fence' (chapter 4). Such regulation is by 
nature non-specific- a molecular fence barrier sterically restricts protein diffusion according to size but 
not by functionality. Additionally, the membrane molecular fence is not impenneable. Though the 
physical barrier may restrict protein diffusion, variations in distance from the membrane to the 
cytoskeleton together with breaks in the cytoskeletal lattice can allow the occasional passage of 
otherwise hindered proteins through the membrane. Restriction of proteins is therefore subject to some 
fluctuation. 
To monitor the role of dystrophin as a steric and non-specific regulator of membrane protein lateral 
diffusion as part of a cytoskeletal 'molecular fence' the lateral mobility of membrane surface 
glycoproteins was compared in both normal and dystrophic muscle tissue. Mobility measurements were 
obtained by FPR, using fluorescent lectins as non-specific markers of membrane surface glycoproteins. 
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1.7.2 Dystrophin as an organiser/anchor of specific membrane proteins. 
The final part of this study investigated the ability of dystrophin to regulate distribution of two 
membrane proteins which dystrophin is known to either bind to or closely associate with in vivo- i.e. to 
specifically regulate lateral mobility of membrane glycoproteins by tethering or crowding mechanisms. 
As outlined above, as an alternative to the indirect mode of segregation by a membrane skeleton fence, 
proteins may be held in place by direct binding to underlying cytoskeletal constituents. Binding of 
band 3 protein to the spectrin binding protein ankyrin links band 3 to the spectrin cytoskeleton. Once 
bound to ankyrin/spectrin the band 3 is unable to diffuse laterally in the plane of the membrane or 
undergo rotational movement (Tsuiji et a/, 1988). Proteins undergoing confmed diffusion may slowly 
traverse the membrane by intercompartmental hopping. Tethered proteins on the other hand are bound 
at their tethered site (unless the binding affinity for protein and cytoskeletal tether is weak enough to 
permit dissociation). The tethering mechanism is therefore particularly important for cell- cell 
communication, where localisation of receptors at the site of signal transduction is essential for 
effective information transfer. 
Direct binding and anchoring of proteins to the spectrin based cytoskeleton is required for efficient 
action potential propagation in the central and peripheral nervous systems. Localisation of neuronal 
sodium channels involves both ankyrin and spectrin. An Ankyrin 0 isoform is found at the nodes of 
Ranvier in the central nervous system, suggesting it could interact with NaChs and spectrin to 
immobilise the channels at the node (Kordeli et a/, 1995). Brain ankyrin immobilises sodium channels 
by binding directly to their cytoplasmic domain and linking the channel to the underlying spectrin 
cytoskeletal network (Srinivasan et a/, 1988). The ankyrin binding is of high affinity and 
stoichiometric. It is also sodium channel specific, neither GABA receptors nor DHP receptors co-
immunoprecipitated with anti-ankyrin antibodies. Once the NaChs were bound to ankyrin, their 
rotational and lateral diffusion was restricted. The linkage of sodium channels to the cytoskeleton in 
neuronal tissue has the potential to either stabilise the channels after assembly of the subunits and/or to 
place the channels at the nodes of Ranvier and axon hillock. 
1.7.2 a) Dystropbin and regulation ofDAG complex mobility. 
As discussed in section 1.1.5, dystrophin binds the DAG complex at the plasma membrane of skeletal 
muscle (figure 1.3). Despite considerable work to illustrate the subcellular locations of, and 
associations between, dystrophin and the DAGs, the role of this complex in muscle function is unclear. 
Specific dystrophin mediated immobilisation of the DAGs would localise the DAG complex to a fixed 
site on the membrane. 
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Membrane immobilisation of the DAGs by dystrophin has implications for function of the complex. 
Immobilisation of the DAGs would preventing their internalisation, and may account for the reduction 
in DAG levels in DMD. Complex immobility lends weight to the modulation of shear stress theory for 
dystrophin function, as the relative positions of contractile apparatus and muscle membrane would be 
maintained following contraction. Furthermore, cross linkage of membrane proteins can give rise to an 
increase in cell rigidity- binding of a monoclonal antibody to glycophorin A induces immobilisation of 
the glycophorin in the red blood cell membrane and an increase in the rigidity of the cell surface 
(Knowles et a/, 1994). Cross linking ofthe DAGs could therefore be important for muscle cell rigidity. 
Finally, given the large size ofthe DAG complex, restriction ofDAG complex mobility would hinder 
lateral mobility of other membrane proteins through crowding effects. 
In order to quantify the ability of dystrophin to bind directly to the DAGs and immobilise them on the 
muscle cell surface, mobility of the DAGs was followed by FPR. Considering the tight associations 
between adhalin and the other DAGs, mobility of adhalin was measured and taken to be representative 
of the DAG complex as a whole. 
1.7.2 b) Dystrophin and regulation of sodium channel lateral mobility. 
The function of dystrophin at the NMJ is presently unknown. Dystrophin is found at the depths of the 
folds ofNMJs in skeletal muscle fibres, alongside NaChs and 13-spectrin. The importance ofspectrin 
for immobilisation of sodium channels in the central and peripheral nervous system is well established. 
Dystrophin shows homology to spectrin both in terms of gene/protein sequence and subcellular 
localisation. A direct link between dystrophin and NaCh localisation is yet to be proven, but it is 
possible that dystrophin is localising ion channels, directly or indirectly, by maintaining structural 
domains within the membrane. Domains could require binding to NaChs, or restriction ofNaCh 
mobility through crowding effects of the DAG. Formation of the domains may stabilise the folding of 
the membrane at the NMJ (considering the reduced folding in mdx mice). 
Since this project was started, reports suggest 13-spectr">./precisely eo-localises with NaChs in the NMJ 
and dystrophin does not (Wood and Slater, 1998). Nevertheless, dystrophin may still be important for 
reinforcing the 13-spectrin cytoskeleton and/or stabilising NaCh clusters at the NMJ, or for creating a 
boundary domain at the edge of the junction. Such roles may still influence sodium channel lateral 
mobility and organisation. 
The question was therefore asked whether dystrophin specifically associates with muscle-specific 
voltage gated sodium channels and immobilises them in place at the NMJ, just as 13-spectrin specifically 
immobilises the sodium channels of the nervous system. 
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t:-7.2 c) Measuring specific dystropbin~membrane protein interactions. 
The most infonnative method ofmonitorinwthe mode of diffusion/vibration of anchored:and closely 
confined' proteins woulg be SPT .. The -size ofbleach spot i_n FPR is ,such that distinctions can b~ drawn 
·~etween \rnobile' and 'imn10bile' with respect to macro.scale motion 'in an!area significantly greater 
:than the bleached spot (i.e. over the whole cell: sili:face ), but rotation about a fixed:point in an area 
smaller than the bleach spot cannot. be resolved. SPT on the other·hand' would I distinguish between 
proteins undergoing free Brownian diffusion in a small confined domain and a' protein, rotating aroundl a 
fixed axis. For the sake of this ,study the FPR approach is adequate to distinguish whether specific 
proteins are or are,not.tethered/restricted in ·the presence of dystrophin,,as untethered proteins are 
expected to'lindergo free diffusion on a macro scale. 
The ability•of dystrophin,to maintain the:structural integrity ofthe muscle fibre membrane by 
as!)ociating specifically with membrane protein!) of the OAG/NMJand anchoring the proteins in place. 
on .the inetnbrarte, was measured by comparing theOiaterali mobilities ofthe proteins in nonnal and 
dystrophic tissue by 'FPR. Fluorescent markers to adhalin arid the muscle voltage gated NaCh ate not 
available commercially; therefore,specific FPR probes had;to be generated ·before dystrophin•i111posed 
restrictions on· lateral' mobility couldJbe quantified! (chapter 5), 
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Chapter2. 
Materials and Methods. 
2.1 Materials. 
The anti-dystrophin antibody MANDYS-1 was a gift from Prof. G.E. Morris, MRIC, North East Wales 
Institute, Wrexham, UK. The anti-adhalin antibody Adl/20A6 was a gift from Or L.V.B. Anderson, 
Dept of Neurobiology, University ofNewcastle Upon Tyne. Anti-rat brain spectrin antibodies were a 
gift ofEun-Hye Joe, Baylor College of Medicine, Houston, Texas, U.S.A. 
BODIPY Fl conjugates were purchased from Molecular Probes; J.L-Conotoxin GIIIB came from 
Alomone Labs, (Jerusalem, Israel); fluorescent polyclonal goat anti-rabbit antibodies were from 
Kirkegaard and Perry Laboratories (Gaithersburg, MD, USA); resin immobilised MAP peptides came 
from Genosys, (Cambridge, UK); Nitrocellulose membranes and Enhanced Chemiluminescence (ECL) 
reagents from Amersham; Tissue-Tek OCT compound from Sakura Finetek; (U.S.A.), Titremax Gold 
from Stratech Scientific (Bedford, UK). All other reagents were purchased from Sigma or BDH. All 
chemicals were of analytical or molecular biology grade. 
2.2 Solutions. 
Antibody dilution buffer 
l mg/ml Bovine serum albumin 
l 0% heat inactivated goat serum 
0.5% TRITON-X100 
in PBS/sucrose. 
Coomassie blue protein gel -stain 
Me0H:H20 ( l: I v/v) 
10% glacial acetic acid (v/v) 
0.25% coomassie brilliant blue (w/v). 
Coomassie blue protein gel -destain 
MeOH:H20 (1: 1 v/v) 
10% glacial acetic acid (v/v). 
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0.5%gelatine (w/v} 
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!0;05% Chromium(IIl)1potassiumsulphate (w/v); in distilled water. 
Krebs' buffer 
,Il9mMNaCI 
25inM NaHCG3 
,ll mM,glucose 
4.7mMKO 
PBS 
2,5mM CaC12.2H20 
11.2mM Kl-l:zP04 
1.2mM MgS04. ?H20. 
137mMNaCl 
8.5mM NaH2PO.t.l2H20 
1.5mM KH2P04 
2.7mMKCl 
iPBS/Sucrose 
PBS plus 35mM sucrose. 
PBS~ifween 
1PBS' plus'0:1l% Twee1120: 
2x Protein gel loading buffer 
l OOmM nis-CI pH6.8 
200mM dithiothreitol 
4% SOS :~w/v) 
'0.2.%·bromophenol•blue,(w/v) 
20% ,glycerol.( v/v). 
5% ~ mercaptoethanol1(v/v). 
Protein extraction buffer 
'0.1M NaCI, lOfuM 
Tris-CI 1pH 7:6 
lmMEDTApH8 
:liJlg/ml aprotinin, 
TJ.!g/ml pepstatin 
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I'J.Lg/mi ieupeptin 
I OOJ.Lg/ml PMSF. 
Resolving polyacrylamide gel 
4.5% or 7.5% acrylamidelbis-acrylamidet(w/v) 
'0>1%SDS (w/,v) 
'0;07%.ammonium persulphate (w/v) 
0.375M l'ris HCI pH 8.8. 
Stacking gel 
3% or 5% acrylamidelbis-acrylamide (w/v} 
O.rJ%SDS (wlv> 
0.07% afuin6nitim :persulphate (w/v) 
0.125 M Tris HCl:pH6; 9: 
Gels were polymerised with lJ.LITEMED/mLgel. 
Tris glycine protein! gel running buffer 
25mM Tris base 
250mM glycilie:pH 8.3' 
0.]%SDS{w/v). 
Western :transfer buffer 
48mM Tris :base 
39mM glyCine 
0:037% SIDS (w/v) 
20% MeOH (v/v}. 
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Methods. 
General molecular biological methods were performed as described in Sambrook et al, ( 1989). 
2.3 Immunisation of rabbits. 
New Zealand White Rabbits were immunised following a modification of Butz et al, (1994). One 
rabbit was exposed to the mid regional peptide alone (DURD M), one to just the c-terminal peptide 
(DURD C) and a third to an equal concentration of both the mid regional and c-terminal peptides 
simultaneously (DURD MIC). 
For initial immunisation and intermediate boosts, 500 !lg of 17mer peptide MAP beads were suspended 
in 300!!1 deionised water, briefly sonicated until cloudi, then emulsified with a I: I (vol/vol) ratio of 
Titremax gold. 200!!1 of suspension was injected intramuscularly into each hind limb, and the 
remainder injected subcutaneously. Boosts were at -4 week intervals (three boosts for DURD C and 
two for DURD M and DURD MIC antibodies). Final boosts were as above, but with a 2:1: I ratio of 
peptide/deionised water: Titremax gold: Freunds complete adjuvanf. Exsanguination was from a 
marginal ear vein, followed by cardiac puncture. 
Serum isolation followed the protocol in Harlow and Lane (l988a). Briefly, blood was clotted at 37ac 
for 1 hour. The clot was 'ringed' with a pipette, then left at 4 a C overnight to contract. Serum was 
removed by centrifugation at 10,000g for 10 minutes at 4°C and stored at 4°C in the presence of 
0.02% sodium azide. 
2.4 Immunohistochemistry. 
Hind limb muscles were removed from adult animals and cryofrozen in Tissue-Tek OCT compound at -
l96°C. The tissue was cut into 8!lm sections using a cryostat and placed onto gelatine coated slides. 
The sections were washed several times with PBS/sucrose and blocked for 30 minutes with 10% heat 
inactivated goat serum. Sections were incubated for an hour with 1175 anti-dystrophin, and 1/50 anti-
1 Sonication is essential to crack the resin beads and so increase the surface area of exposed 
immobilised peptide. 
2 Whilst the sole use ofTitre-max gold is safer for the animal, this adjuvant alone failed to raise 
sufficient titre of antibodies. Freunds Complete Adjuvant was therefore added to the final 
immunisation. The short time (4 weeks) between Freunds immunisation and exsanguination prevented 
formation of granulomas, and no subcutaneous irritation was observed. The Titre-max gold was 
adequate for initial sensitisation and boosts of the animal. This procedure, using Freunds Complete 
adjuvant in the final immunisation, is in accordance with Home Office Guidelines and would be 
recommended for future production of antibodies. 
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rat brain spectrin (fodrin) rabbit polyclonal antibodies (Vybiral et a/, 1992) diluted in antibody dilution 
buffer. All slides were washed with PBS/sucrose then stained for I hour with 1/100 fluorescein 
conjugated polyclonal goat anti-rabbit antibodies. After washing, slides were visualised and 
photographed under a MicroRadiance confocal microscope (Bio-Rad) using a 50x oil immersion 
objective, 488nm excitation light and 500nm longpass filter. 
2.4.1 Gelatine coating of slides. 
Glass microscope slides were flamed in ethanol, then soaked in 0.5% gelatine (w/v), 0.05% Chromium 
(Ill) potassium sulphate (w/v) solution in distilled water for five minutes. Excess solution was poured 
off and slides dried at 37°C overnight. 
2.4.2 Human muscle tissue. 
Human skeletal muscle was obtained during routine hip joint replacement surgery at the 
Middlesborough General Hospital, Middlesborough, UK. The procedure was approved by the 
University of Durham Ethical Advisory Committee and the Medical Director of South Tees Acute 
Hospitals NHS Trust. Samples were embedded in Tissue-Tek OCT compound in dry-ice cooled 
isopentane immediately after removal, then stored at -80 o C. 
2.5 Protein analysis. 
2.5.1 SDS Polyacrylamide gel electrophoresis. 
SOS polyacrylamide gel separation of proteins was perfonned according to the method ofSambrook et 
a/, (1989) in a Bio-Rad Mini Protean 11 apparatus. The equipment was assembled and run according to 
manufacturers instructions. 
Resolving gels were made from either 4.5% (dystrophin gels) or 7.5% (lower molecular weight 
proteins) acrylamide/bis-acrylamide depending on protein size. Likewise, stacking gels were made 
from either 3% (dystrophin gels) or 5%(lower molecular weight proteins) acrylamidelbis-acrylamide. 
Gels were polymerised with lj.!l TEMED/ml gel. Proteins were boiled for 5min in an equal volume of 
2x protein gel loading buffer then spun at top speed in a microfuge for 2 min before loading. Gels were 
run in tris-glycine running buffer for 30min at 60 volts than 1-2 hours at 100 volts. 
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2.5.2 Dystrophin protein extraction. 
Hind limb skeletal muscle was removed from adult mice and homogenised with a Polytron homogeniser 
in 1: I ratio of protein extraction buffer: SOS PAGE loading buffer. 4J.lg of protein/lane was run on a 
4% polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane over 2 ~ hours in 
western transfer buffer at 20volts and 4 °C. 
2.5.3 Coomassie blue staining of proteins. 
Gels were simultaneously fixed and stained by shaking overnight in a minimum 5 gel volumes 
methanol:water (I: I vlv), 10% glacial acetic acid (vlv), 0.25% coomassie brilliant blue (wlv). Proteins 
were visualised by destaining for 4-8 hours in 3 changes of 5 volumes methanol:water (1: I vlv), 10% 
glacial acetic acid (vlv). 
2.5.4 Transfer of proteins to nitrocellulose filters. 
Following SOS PAGE separation, proteins were transferred to nitrocellulose membrane using a Bio-
Rad Trans-blot SO semi-dry transfer cell. Gel, membrane and filter paper were soaked in western 
transfer buffer then assembled in the apparatus. High molecular weight proteins were transferred at 20 
volts for 2-3 hours at 4 °C, lower molecular weight for 40 min at room temperature. 
2.5.5 Ponceau S staining of proteins on Nitrocellulose filters. 
To confirm adequate and even transfer of proteins, Bio-Rad Mini Protean 11 gel sized nitrocellulose 
filters were incubated for 15min in 5ml 0.2% Ponceau Sin 3%TCA whilst shaking, until filters were 
uniformly stained red. Filters were destained in 3 changes of30ml distilled, de-ionised water. 
2.5.6 Western analysis. 
Filters were blocked for an hour in 5% non-fat milk I PBS-Tween then left for two hours in primary 
antibodies diluted 1135 in 5% non-fat milk I PBS-Tween. Filters were washed three times for 5 min in 
5% non-fat milk I PBS-Tween, then incubated with a 112000 dilution of horseradish peroxidase 
conjugated secondary antibody in 5% non-fat milk I PBS-Tween for 1 hour. Filters were washed twice 
for five minutes in PBS-Tween, then three times in de ionised water. Proteins were visualised using 
enhanced chemiluminescence (ECL) reagents. 
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2.5.7 Coupling of dystrophin peptides to BSA. 
Peptides were coupled to BSA using a modification ofHarlow and Lane (1988 b). lmg linear peptide 
was added to 3mg BSA in a total volume of2ml PBS. An equal volume ofO.l% glutaraldehyde in PBS 
was added slowly whilst shaking, and the reaction left shaking for 2hrs. IM glycine, pH7.2 was added 
to 200mM final concentration and the pH brought to neutral with 2M NaOH. The reaction was left for 
one hour, then dialysed overnight at 4°C against 3 changes ofPBS. 
For SOS PAGE, -2.5Jlg linear peptide/BSA was loaded per lane with an equal volume ofSDS gel 
loading buffer and run on a 7.5% polyacrylamide gel. 120Jlg BSA was run alongside in the control 
lane. Proteins were transferred to a nitrocellulose filter for 45mins at room temperature. 
2.6 Fluorescence recovery after photobleaching (FPR). 
2.6.1 Dissection. 
12-18 month old adult male mice were sacrificed by cervical dislocation according to Home Office 
guidelines. The calf muscle was removed and teased apart in Krebs' buffer freshly perfused with 95% 
oxygen/5%C02. 
2.6.2 Tissue labelling. 
2.6.2 a) Labelling of muscle membrane glycoproteins. 
The fibres were washed in Krebs and incubated with 25nmol fluorescein isothiocyanate (FITC) 
conjugated lectin for 25 minutes in the dark. 
2.6.2 b) Labelling of membrane lipids. 
The fibres were washed well in oxygenated Krebs buffer and labelled for 15 minutes in the dark with a 
1: I ratio of oxygenated Krebs buffer: 3.5J.!M 5-(N-octa-decanoyl) aminofluorescein (ODAF) in I% 
ethanol/oxygenated Krebs buffer (w/v). 
The fibres were washed well after labelling, transferred to a petri dish of freshly oxygenated Krebs 
buffer and held in place with Blu-tack. 
40 
Chapter 2 Materials and Methods. 
2.6.3 Photobleach recovery. 
The mobility of fibre surface components was measured using the spot photobleaching technique. The 
apparatus is illustrated in figure 2.1. A Zeiss Universal fluorescence microscope was used with a 63x, 
1.2 NA water immersion lens placed directly into the dish containing the fibre (Angelides et a/1988). 
The monitoring argon-ion laser (Coherent lnnova 90. 488nm, 5W) was focused through the microscope 
to a beam radius of0.85J..Lm. An 80msec, 5mW laser pulse was used to bleach approximately 70% of 
the fluorescence, and the attenuated monitoring beam used to monitor the time course of the recovery. 
Photon counting was done using a photomultiplier tube (PMT). (Products for research, Inc, St Danvers, 
MA, USA.) and modified IBM-XT PC. Following photobleaching the fibres were photographed under 
a Nikon fluorescence microscope. 
Non-ambient temperature data was obtained by heating the stage of the microscope by conduction. A 
brass heat block coupled to a 70°C circulating water bath was placed on the microscope stage at least I 
hour before data collection (figure 2.1 d). The sample was placed in a glass petri dish on a glass slide 
on the stage, adjacent to the heating device. Circulating water was switched off during data collection 
to minimise vibrations. Heat loss was reduced by surrounding the equipment in bubble wrap. 
2.6.4 Analysis, terminology and interpretation of FPR data. 
Diffusion coefficients (DL) and the mobile fractions (f) were detennined by curve fitting procedures 
(Axelrod 1983). DL was detennined in cm2 /s from DL = ~ /4T0 where T0 is the halftime for recovery 
and w is the e·2 beam radius. (The e·2 radius relates diffusion to the size of bleached circle. This value 
is used in preference to ~, as the intensity of the laser light across the circular bleached region is 
gaussian in distribution i.e. the laser is brighter in the middle of the spot than it is towards the edges. 
The e·2 radius is therefore smaller than the total area of the laser beam, encompasing ~95% of the total. 
For the 63x water immersion objective used in these experiments with a 0.85J..Lm beam radius, the e·2 
value corresponds to a bleached area of ~2J..Lffi2). To reduce the significance of fibre-fibre variations a 
number of measurements (>I 0) were taken for each fluorophore. The diffusion time To and the degree 
of fluorescence recovery,/, were obtained for each FPR curve. Results were analysed statistically to 
obtain the mean values and standard deviation off, DL and T 0 . Values are given in the tables, figures 
and text with the standard error of the mean. 
The word 'significant' is applied to the FPR data with respect to changes in FPR mobility patterns and 
not in a statistical sense. For example, the difference between 4 ± I % and 7 ± 1.5% mobile fractions 
may be 'significantly different' statistically. However, in tenns ofFPR, all mobility with <15% 
recovery of fluorescence is classed as 'immobile'. Therefore, the difference between 4% and 7% is not 
'significant' here as the molecules are immobile in both cases. A 'significant' change in mobility 
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patterns would be from 5/10% mobility up to 20% or higher: F'ot example; the lateral mobility 
charaderistics,of,free·~ 3 subunits,ofGABAA receptors.on the surface ofCos 7 cells are: ID, ,J8.9 ± 3 
X JQ'1° Cn}2s" 1; f, 43 ± J3%. When .the U1 SUbimit is present, there isa 'significant' reduction in 
mobility of the ~3 :subunit: D, ·13 ±'0:4 x 10'10 cm2s·f, f, 8 ± 4% (Peran et a/,~submitted). 
In cases where .the mobile fraction is low ( <1'5%), the accuracy .of ctitve fitting is compromised~ fine 
mathematical algorithms used during data•anaiysis fit the·obsewed·recovery curves to the diffusion 
equation; DL = ~ /41\0 . When recovery is small, the 'curves' are flat lines,(e.g. ;figure, 4'.4): l'he 
curves therefore·do not accurately fit. the diffusion: equation(,/> 1x l o;4, and the values of DL have large 
errors. 
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Figure 2.1 FPR equipment. (q.v. figure 1.4) 
a) Water cooled argon ion laser light is reflected by mirrors towards the beam splitters. 
b) Beam splitting apparatus. From left to right, diaphragm, prism I, bleach shutter, prism 2 and mirror. 
The prisms and bleach shutter direct either the full intensity bleaching laser beam (shutter open) or 
the 10,000 fold attenuated monitoring beam (reflected light from the prism glass/air interfaces only, 
shutter closed) towards the sample. The mirror sends the light path towards the beam steerer (B.S.) 
which then directs the beam into the side of the microscope. 
c) Microscope and photon counting apparatus. Light directed by the beam steerer enters the 
microscope optics via a focusing lens and a dichroic mirror reflects the excitatory beam down 
towards the sample. Emitted fluorescent light passes up through the dichroic mirror and a series of 
longpass light filters within the microscope, cutting out the excitatory wavelength light and allowing 
the emitted light through into the photomultiplier tube (PMT). 
d) Modified apparatus to increase measuring temperature. Circulating water from 70°C bath passes 
through the insulated pipes and heats the stage by conduction. Surrounding insulating bubble wrap 
removed for clarity. 
Light paths are shown by red arrows. 
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2.7 Synthesis of fluorescent probes for pbotobleacb recovery. 
2. 7.1 Preparation of fluorescently labelled muscle sodium cbannel specific probe. 
11-conotoxin GIIIB was labelled with 4,4-difluoro-1 ,3,5, 7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-
propionic acid, succinimidyl ester (BODIPY (FI) -SE), using a modification of Joe and Angelides 
(1993) and protocol supplied on request from Molecular Probes. Reactions used a 2:1 molar ratio of 
amino groups to succinimidyl ester to maximise modification of the toxin. 
19 nmol11- conotoxin GIIIB was dissolved in 200111 0.1 M Na2HC03 buffer, pH 9. 190 nmol BODIPY 
(FI) SE was dissolved in 200111 DMSO, then added to the toxin and the reactants left for 1*-3 hours in 
the dark at room temperature, vortexing occasionally. 
2.7.2 HPLC purification of products. 
The labelled toxin was purified using C4, C 18 and CN reverse-phase HPLC columns. The solvent 
system was solvent A: 5-95% (by volume) acetonitrile for 30 minutes, then 100% acetonitrile for 5 
minutes. Solvent B: 0.1 M TEAA (triethylarnmonium acetate) pH7. 100-200111 reaction mixture was 
added per HPLC run, depending upon the size of column loop. Products were monitored at 214 and 
493nm using a SMART flow cell, 3mrn path length, 0.7111 volume. 
2.7.3 Gel purification of products. 
A 1ml, 25cm long sephadex G10 column was made up in a lml disposable blow out plastic pipette and 
equilibrated prior to reactant addition with 4 column volumes of PBS. 300!-11 of 11-cgtx!BODIPY -SE 
reaction mixture was added to the top of the column. Fractions were eluted with PBS. 3 minute 
fractions were collected over 8 hours. Fractions were pooled into 9 minute aliquots and analysed 
spectroscopically at 514 and 260nm using a Pharmacia Biotech Ultrospec 2000 UV /visible 
spectrophotometer. 
2. 7.4 Fluorescent modification of anti-adbalin monoclonal antibody. 
600!-11 of tissue culture supematant, reconstituted from lyophilised form at 4x original concentration in 
mQ H20 (equivalent to -Q.18mg IgG) was reacted with 6011g BODIPY -SE at I Omg!ml in DMSO. The 
pH of the mixture was adjusted to~ pH 8.5 and the mixture left for 4 hours at RTP in the dark. 
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Modified and unmodified antibody was separated from :&ee1dye by spinning the reaction mixfure:at 
lOOOg for 15 seconds through a 2ml sephadex,GIO column, assembled'iMhe body of a disposable 
plastic syringe. The supematantwas:collected:and the dye!(bound,to thewlumn) discarded. 
45 
Chapter 3. 
Generation of Anti-dystrophin Antibodies. 
Chapter 3 Generation ofanti-dystrophin antibodies. 
Cbapter3. 
Generation of anti-dystrophin antibodies. 
3.1 Introduction. 
In order to confinn the presence or absence of dystrophin within the experimental membranes, a 
reliable and unambiguous test for dystrophin was needed. Commercially available antibodies proved 
unsuitable for the task of immunohistochemical analysis of dystrophin protein. At present all 
commercially available antibodies to dystrophin are mouse monoclonal in origin. The need for anti-
mouse secondary antibodies to visualise the monoclonals gave rise to high background signals on 
mouse tissue. The staining of the secondary antibodies appeared to be specific, forming rings around 
the outside of the mouse muscle fibres (data not shown). This cross reactivity may arise as a 
consequence of injecting crude mouse serum into a goat to generate the secondary antibody- due to the 
unrefined nature of the serum, the goat raises specific antibodies to a highly immunogenic serum 
component (possibly a fragment of extracellular matrix in origin), in addition to the mouse Ig. This 
component is then detected by the secondary antibody in samples of mouse tissue. Goat anti-mouse 
IgG F(ab)2 fragment secondary antibodies were not specific enough to cut out the background. 
Blocking with unlabelled goat anti-mouse antibody as an alternative approach proved unreliable and 
non-reproducible (data not shown). 
The apparent specificity of the background staining to components of the extracellular matrix, and the 
proximity of this staining to the site of dystrophin localisation rendered anti-mouse secondary antibody 
staining- and hence anti-dystrophin mouse monoclonal antibodies- uninterpretable and unsuitable for 
the determination of dystrophin in experimental mouse tissue. To enable a more accurate and reliable 
assignment of the dystrophic status of the tissue, rabbit polyclonal antibodies were generated. 
The suitability of the synthesised antibodies for detection of dystrophin revertant fibres was revealed 
during their characterisation. This is discussed separately in part 2, following the characterisation data. 
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• Part 1. Production and characterisation of anti-dystrophin peptide 
antibodies. 
3.1.1 Dystrophin MAP peptides. 
As dystrophin protein is large, unstable and difficult to extract and purify, antibodies were raised 
against 17 amino acid long synthetic dystrophin peptides. To increase the surface area and secondary 
structural permutations of the peptides, resin-immobilised branched Multiple Antigen Presenting 
(MAP) peptides were synthesised. The peptides were injected in their native immobilised resin bead 
state to a) avoid the need for coupling to carrier peptides prior to injection and b) simplify the process 
of affinity purification ifrequired- the peptide beads could be used directly in a colwnn. 
The two chosen peptides corresponded to amino acids 2371-2399 inclusive (mid-region) and 3619-
3635 inclusive (at the c-tenninal region) of human skeletal muscle dystrophin. This is equivalent to 
amino acids 2367-2392 (mid) and 3613-3629 (c-terminal) ofthe murine sequence, with just one amino 
acid change in the mouse mid regional sequence, shown in figure 3.1 below. These regions show high 
conservation between species, but little homology to utrophin, spectrin or other characterised proteins. 
Regions of the C-tenninal peptide showing sequence conservation with utrophin are shown beneath the 
mouse peptide sequence. There was no significant dystrophin/utrophin homology for the mid region 
peptide. Peptides were chosen primarily on the basis of their uniqueness to dystrophin, so that any 
potential cross reactivity could be limited. Additionally, the presence of proline residues within the 
sequence was chosen to provide some secondary structure. 
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Human dystrophin 2371 2399 
LSKGQHLYKEKPATQPV 
+ 
LSKGQHLYKEKPSTQPV 
Murine dystrophin 2376 2392 
a) Dystrophin mid-region MAP peptide, DURD M. 
Human I murine dystrophin 
3619 I 3613 3635 I 3629 
QRSDSSQPMLLRVVGSQ 
Q +++ Q 
QLAENGQ 
Utrophin 
532 538 
b) Dystrophin C-tenninal MAP peptide, DURD C. 
Figure 3.1. 17mer MAP Peptide sequences used to generate antibodies to a) the mid region, DURD 
M and b) the C-tenninus, DURD C, of skeletal muscle dystrophin. 
The extent of utrophin homology is shown for the C-tenninus. There was no significant utrophin 
homology in the mid region. + represents like-for like amino acid substitutions. Numbers correspond 
to amino acid residues as designated by SwissProt. Succession numbers: Human, 
spiP11532IDMD_HUMAN DYSTROPHIN. Murine, spiP11531IDMD_MOUSE DYSTROPHIN. 
Utrophin, gn 1 I PID I e303 779. 
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Results. 
3.2 Production of anti-dystrophin antibodies. 
New Zealand White rabbits were injected intramuscularly and subcutaneously with 17mer peptides 
corresponding to amino acids 2371-2399 (mid-region, DURD M) and 3619-3635 (C-terminal region, 
DURD C) inclusive of the human dystrophin sequence. Rabbits were exposed to either one or both 
peptides. 
3.3 Characterisation of antibodies. 
The presence of antibodies in the sera was tested initially by immunohistochemistry on unflxed frozen 
skeletal muscle sections. To illustrate the location of the sub-sarcolemmal cytoskeleton, membrane 
integrity, section quality, and provide a positive staining control, sections were stained in parallel with 
anti-spectrin antibodies. This particular antibody was raised to an isoform of rat brain spectrin, also 
called fodrin (Vybiral et a/, 1992). Although the epitope was neuronal in origin, the antibody detects 
spectrin within muscle. Staining for the spectrin isoform is documented at locations throughout the 
subsarcolemmallattice, with particularly bright staining at costameres, sarcomeres and neuromuscular 
junctions (Vybiral et a/, 1992 ). 
3.3.1 Immunohistochemistry. 
The DURD M, DURD C and DURD MIC antibodies all stain sections ofC57/Bl control skeletal 
muscle tissue, figure 3.2. The location of staining was comparable with that found for rat brain spectrin 
i.e. the antibodies recognised an epitope found at the plasma membrane. The bright costameric staining 
of the spectrin antibodies was not repeated to the same intensity with the dystrophin antisera. Pre 
immune sera from the rabbits did not highlight the membranes. Staining was detected at up to 11100 
dilution of crude anti-sera, although optimal staining was obtained at a 1175 dilution. No affinity 
purification was necessary for this application. The staining at the plasma membrane was, generally, 
evenly distributed as previously reported by Arahata et a/, ( 1988) for skeletal muscle dystrophin. 
No equivalent staining was observed on sections ofmdx muscle. Staining of serial sections from the 
same mdx animals with the anti- rat brain spectrin antibodies produced bright signals at the plasma 
membranes. The lack of signal from the dystrophin antisera was therefore due to the absence ofthe 
protein epitope, rather than due to poor integrity of the membranes in the sections. This staining of 
C57/BI10 tissue but not mdx tissue, combined with the positive spectrin stain is consistent with 
production of antibodies to dystrophin. 
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Figure 3.2 Immunohistology of anti-dystrophin peptide antibodies. 
3.2a. DURDC anti-dystrophin C-terminal peptide antibody immunoreactivity . 
Immunohistochemistry of81J.m transverse sections ofunfixed fast frozen quadriceps muscle with 
DURD C antibodies against dystrophin c-terminal peptide (1 /75 dilution) and antibodies to rat brain 
spectrin (I /40 dilution) (Vybiral et a/, 1992). 
C57/bl- C57/Bl dystrophin positive mouse tissue, DURDC antibody; 
C57/bl, Pre immune serum- C57/Bl dystrophin positive mouse tissue, DURDC antibody pre-
immune serum. 
Mdx mouse- mdx muscle, DURDC antibody. 
mdx mouse-spectrin mdx muscle, anti-rat brain spectrin antibody. 
human- human muscle, DURDC antibody. 
rat- rat muscle, DURDC antibody. 
The anti-dystrophin antibody can be seen to stain at the plasma membrane ofC57/Bl mouse, human and 
rat muscle, but not mdx tissue. No immunoreactivity was seen from the rabbit serum prior to 
sensitisation (pre-immune serum). The absence of staining in mdx tissue reflects an absence of 
dystrophin, rather than proteolysis or poor tissue/cytoskeleton integrity, as sections from the same 
muscle stained clearly for the presence of spectrin. Scale bar I OO!J.m. 
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Figure 3.2 b. DURD M anti-dystrophin mid regional peptide antibody immunoreactivity. 
Immunohistochemistry of 8Jlm transverse sections ofunfixed fast frozen quadriceps muscle with 
DURD M antibody against dystrophin mid-regional peptide (1175 dilution) and antibody to rat brain 
spectrin (1140 dilution) (Vybiral et a/, 1992). 
C57/Bl- C57/Bl dystrophin positive mouse tissue, DURDM antibody; 
C57/Bl, Pre immune serum- C57/Bl dystrophin positive mouse tissue, DURDM antibody pre-
immune serum. 
Mdx mouse- mdx muscle, DURDM antibody. 
mdx mouse-spectrin mdx muscle, anti-rat brain spectrin antibody. 
human- human muscle, DURDM antibody. 
rat- rat muscle, DURDM antibody. 
The anti-dystrophin antibody can be seen to stain at the plasma membrane ofC57/BI mouse, human and 
rat muscle, but not mdx tissue. No immunoreactivity was seen from the rabbit serum prior to 
sensitisation (pre-immune serum). The absence of staining in mdx tissue reflects an absence of 
dystrophin, rather than proteolysis or poor tissue/cytoskeleton integrity, as sections from the same 
muscle stained clearly for the presence of spectrin. Scale bar 1 OOJ.lm. 
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Figure 3.2 c. DURD MIC anti-dystrophin mid regional and C-terminal peptide antibody 
immunoreactivity. 
Immunohistochemistry of 8Jlm transverse sections of unfixed fast frozen quadriceps muscle with 
DURD MIC antibody against both dystrophin mid-regional and C-tenninal peptides (1175 dilution) and 
antibodies to rat brain spectrin (1/40 dilution) (Vybiral et al, 1992). 
C57/Bl- C57/BI dystrophin positive mouse tissue, DURDM/C antibody; 
C57/BI, Pre immune serum- C57/BI dystrophin positive mouse tissue, DURDM/C antibody pre-
immune serum. 
Mdx mouse- mdx muscle, DURDM/C antibody. 
mdx mouse-spectrin mdx muscle, anti-rat brain spectrin antibody. 
human- human muscle, DURDM/C antibody. 
rat- rat muscle, DURDM/C antibody. 
The anti-dystrophin antibody can be seen to stain at the plasma membrane ofC57/Bl mouse, human and 
rat muscle, but not mdx tissue. No immunoreactivity was seen from the rabbit serum prior to 
sensitisation (pre-irnmune serum). The absence of staining in mdx tissue reflects an absence of 
dystrophin, rather than proteolysis or poor tissue/cytoskeleton integrity, as sections from the same 
muscle stained clearly for the presence of spectrin. Scale bar l0011m. 
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In light of the highly conserved nature of dystrophin at the chosen peptide regions, the antibodies were 
tested for their additional ability to detect dystrophin in human and rat tissue. All three antibodies 
recognised a plasma membrane localised component ofunfixed frozen transverse sections of human 
and rat skeletal muscle (figure 3.2). The subcellular site of immunoreactivity was comparable with the 
sub-plasmamembraenous location of spectrin staining in the same tissue (data not shown). The staining 
pattern was consistent with the observations of dystrophin staining in C57/Bl and mdx mice- suggesting 
all three antibodies are able to detect native skeletal muscle dystrophin in a range of species. 
3.3.2 Skeletal muscle protein western blots. 
The DURD M and DURD MIC antibodies detect a protein of -400KDa on an immunoblot ofC57/bl 
mouse quadriceps muscle proteins. There was no corresponding reactivity of mdx quadriceps muscle 
tissue. The immunogenic species appeared to have the same 427 kDa molecular weight as dystrophin, 
as seen by immunobloting the adjacent lanes with MANDYS-1 (gift from Prof. G.E.Morris, NEWI), a 
mouse monoclonal antibody to exons 31 and 32 of the dystrophin gene (Nguyen thi Man and Morris, 
1993), (figure 3.3). 
The DURD C antibody did not detect the same -400kDa species as the DURD M and DURD MIC 
antibodies on an immunoblot. This could be a consequence of proteolysis. The epitope is at the 
extreme C- terminus and may therefore be particularly susceptible to proteolytic cleavage. The DURD 
C antibody did detect a protein of -140kDa in C57/bl muscle tissue extracts that was absent from mdx 
muscle. This 140kDa species could be the proteolytically cleaved C-terminus of dystrophin. On the 
other hand, it could be that the C-terminal epitope is no longer recognisable in the SDS denatured form 
of dystrophin protein. Cytoskeletal proteins are particularly prone to this phenomenon- their native 
structures are susceptible to disruption by SDS, possibly reflecting the importance of polar residues in 
cytoskeletal constituents (H. Epstein, personal communication). 
The immunohistochemical data and skeletal muscle extract immunoblot show the antibodies to 
recognise a species present in C57/bl control mouse but not mdx mouse skeletal muscle tissue. 
Furthermore, the immunoblot data suggests the detected molecule is of approximately 427kDa 
molecular weight- the accepted size of dystrophin (Hoffinan et a/, 1987). These data together support 
the assertion that the antibodies recognise dystrophin protein. 
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3.3.3 Anti-dystrophin peptide western blots 
To confinn the epitope specificity of the antibodies, 2.5!-lg of linear dystrophin peptide coupled to BSA 
was run per lane on a 7.5% polyacrylamide gel. Each peptide was subjected to western analysis with 
the three anti-peptide antibodies. 1201-1-g ofBSA alone was run alongside to confinn that any observed 
immunoreactivity was due to the peptide component and not the BSA carrier molecule. 
The DURD C peptide antibody recognises the 66kDa C-tenninal peptide-BSA construct at a 
1/603dilution. There was no immunoreactivity to the mid-regional peptide-BSA construct. 
Immunoreactive species at 120, 180 and 240kDa are dystrophin C-tenninal peptide coupled to two, 
three or four crosslinked BSA molecules, figure 3.4. 
The DURD M antibody detected the mid-regional peptide-BSA construct at 1/60 dilution, but did not 
detect the dystrophin C-tenninal peptide-BSA construct. 
The DURD MIC antibody raised by eo-injection of both the mid regional and C-tenninal peptides 
recognised both BSA coupled peptides on a western blot. The immunoreactivity observed from this 
antibody on tissue sections is therefore a reflection of antibody binding to both regions ofthe 
dystrophin molecule. There was some observed difference in intensity between the chemiluminescence 
signals from the two peptide lanes. However, ponceau S staining of the filter suggested uneven loading 
of the different peptides was the primary cause of the discrepancies, rather than significant differences 
in epitope immunoreactivity (data not shown). 
The three antibodies therefore bind exclusively to the peptide they were raised against and do not cross 
react with the other epitope. 
3. In the cases of all three antibodies, the sensitivity of detection of native peptide is such that the 
antibodies could be used at far greater dilution than the 1/60 of this experiment. The film in figure 3.4 
was exposed to the filter for just 3 seconds and was still over exposed. 
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P.I.S . P.I.S. P.I.S. Anti-rabbit DURDC DURDM/C DURDM/C DURDC secondary antibody DURDM DURDM 
c 
M M c M c M B B c M Mar c M B B c M Me· c 
Figure 3.4. Immunoblot analysis of anti-dystrophin antibody epitope specificity. 
7.5% SDS polyacrylamide gels oflinear 17mer dystrophin peptides coupled to BSA carrier protein, 
western blotted and probed with 1160 dilution of anti-dystrophin polyclonal antibodies. Mar, molecular 
weight markers in kDa, C, dystrophin c-tenninal peptide, M, dystrophin mid-regional peptide, B, 
bovine serum albumin (BSA). For full sequence ofpeptides, q.v. figure 3.1 
The DURD M antibody detects the mid regional peptide-BSA construct but shows no immunoreactivity 
towards either the c-terminal peptide construct or BSA alone. The antibody raised against the anti-
dystrophin c-terminal peptide, DURD C, demonstrates immunoreactivity towards the c-terminal peptide 
alone, whilst the DURD MIC antibody recognises both epitopes. Note bands are observed at 66, 132, 
198 and 264 kDa, corresponding to oligomers of BSA cross linked to the peptides. Pre-immune sera 
(P.I.S.) from the rabbits has no significant immunoreactivity at the same sera concentration; and no 
reactivity is observed from the horse radish peroxidase conjugated anti-rabbit secondary antibody 
alone. 
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3.4 Discussion, Part 1. 
Generation of anti-dystropbin antibodies. 
It has been shown by both immunohistochemistry and western blotting that three different rabbit 
polyclonal antibodies have been generated. The subsarcolemmal distribution, absence of 
immunoreactivity in mdx mice, and molecular weight of the detected species in skeletal muscle all 
suggest the antibodies recognise 427kDa skeletal muscle dystrophin. The antibodies specifically 
recognise the region of dystrophin that they were raised against- they do not cross react. Furthermore, 
the OURD MIC antibody raised against both the mid regional and c-terminal peptides recognises both 
epitopes equally, rather than one epitope preferentially. 
The high affinity of the unpurified antibodies for dystropbin protein in mouse tissue, together with their 
rabbit polyclonal origin makes them a suitable tool for detection of dystrophin in mdx and C57/BI 
experimental mouse tissue. The additional reactivity with human dystrophin may make them suitable 
for diagnostic as well as research use. Ideally to enable successful detection and analysis of dystrophin, 
antibodies should detect dystrophin protein in both the native and SOS denatured states. Both detection 
methods are currently used in the clinical diagnosis ofOMD. The ability ofthe OURD C antibody to 
fulfil this function may therefore be limited. It is not uncommon for small peptide specific antibodies to 
be capable of detecting either native or SOS denatured protein, but not both forms e.g. as reported by 
Nguyen thi Man et a/, (1992). This reflects the lack of sufficient secondary structural recognition that 
arises from using peptides. 
3.5 Summary 
The aim of this experiment was to generate anti-dystrophin polyclonal antibodies that could be used to 
determine the presence or absence of dystropbin in the experimental tissue from FPR mobility studies. 
Three such antibodies have been raised, characterised and found to be dystrophin specific. 
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• Part 2. Dystrophin revertant fibres. 
3.6 Immunoreactivity of anti-dystropbin peptide antibodies with revertant fibres. 
In order to test the specificity of the anti-dystrophin peptide antibodies, transverse sections of mouse 
quadriceps muscle fibres were stained with the antisera. Negative staining was expected in mdx tissue, 
consistent with the accepted absence of dystrophin. It was observed firstly with DURD MIC that in 
some animals, fibres within the mdx background were staining strongly with the antisera. Initially this 
was attributed to an incomplete blocking step prior to primary antibody addition. Multiple repetitions 
with extended blocking steps made no detectable difference to the intensity of staining in these fibres 
and staining was observed with too great a frequency to be coincidental. The pre-immune sera from the 
same rabbits gave no signal, nor did secondary antibody alone. This suggested firstly that blocking had 
been successful and secondly the staining was a specific event following epitope recognition by the 
primary antibodies. The antibody was binding dystrophin or a related protein in the mdx tissue. 
The pattern of positively stained fibres in the tissue was distinctive. The fibres were either isolated 
single fibres (figure 3.5a) or patches of adjoining positive fibres (figure 3.5b). Where patches of fibres 
were found, they varied in size from 2 to ~20 myotubes. In all cases every fibre in the patch stained 
positively- there were no negative fibres within the patches and no clusters of mixed positive and 
negative fibres. This pattern suggested the clusters of positive fibres arose by means of clonal 
expansion. 
3.7 Somatic reversion in mdx mice/DMD. 
The fibres detected by the DURD MIC antibody are mdx revertant fibres. Strongly staining dystrophin 
positive fibres have been reported in both mdx mice and DMD patients (Hoffinan et a/, 1990, 
Nicholson et a/, 1989). For example, antibodies to the C-terminal region of dystrophin showed a small 
proportion of dystrophin positive fibres are found in >50% of DMD patients (Nicholson et a/, 1989). 
These fibres arise by a somatic mechanism which restores the original reading frame of the dystrophin 
gene, overriding the effects of the original mutation. 
Commonly the initial mutation in DMD gives rise to a shift in the dystrophin reading frame (reviewed 
in Amalfitano et a/, 1997). This results in premature termination of transcription, and either no 
dystrophin or production of an N-terminally truncated dysfunctional protein. Generally the exon 
boundaries in dystrophin do not correspond with the ends ofhelicies or of automonously folding units, 
so the sequence surrounding the site of mutation is likely to become disrupted too (Koenig and Kunkel, 
1990). The sites of these deletions are not evenly distributed throughout the genome. Instead, there are 
two main deletion prone areas. The first is around exon 45 and the second towards the 5'end ofthe 
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gene (Worton and Thompson, 1988). In revertant fibres these genetic mutations are removed by a 
differential pattern of exon splicing. Splicing of additional exons produces a truncated mRNA. As the 
boundaries of the exons do not necessarily align with the start of a codon, the differentially spliced 
truncated mRNA may revert back to in-frame mRNA and so functionally correct the frameshift 
mutation. Regions of the genome flanking the genomic mutation can be missing in revertant fibres 
(Klein et a/, 1992). Revertant fibres therefore produce a functional dystrophin protein which lacks the 
regions of the molecule encoded by the original genetic mutation. 
The reversion of the fibres could be due to a somatic deletion mutation- removing extra exons from the 
dystrophin gene, or it could be a splice site mutation- splicing out extra exons from the mRNA. To 
establish which of these options is the case would require sequencing the genome of the revertant fibres. 
This is difficult due to the low frequency ofthe fibres. However, as the age of a DMD patient 
increases, the proportion of revertant fibres increases (Fanin et a/, 1992). This is consistent with the 
notion of a stable but infrequent somatic mutation giving rise to dystrophin positive fibres. These 
positive fibres are stronger than their dystrophic counterparts and are therefore preferentially selected 
for over time (dystrophin negative fibres succumbing to greater shearing forces and dying off). 
Such a mechanism of dystrophin restoration was reported by Thiet Thanh et a/ ( 1995 a) as having 
occurred in the muscle tissue of a patient with DMD. The patient possessed a frameshift deletion 
within exon 45 of the dystrophin gene which gave rise to the initial dystrophic phenotype. 
Immunostaining muscle tissue from the patient with exon specific monoclona1 antibodies, together with 
RT -PCR across the exons demonstrated that deletion of exon 44 and/or exon 46 was sufficient to 
override the mutation. In order to remove the additional exons and restore dystrophin expression, 
satellite cell nuclei in the revertant fibres had undergone somatic mutation. 
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Figure 3.5 Mdx revertant fibres. 
Transverse serial sections of quadriceps muscle from mdx mouse, irnmunostained with DURD MJC 
antibody. Dystropbin positive fibres are found a) singly and b) in patches. Scale bar represents IOOf.lm. 
Figure 3.6 Exon specificity of anti-dystrophin antibodies. 
Revertant dystrophin positive fibres from serial sections of mdx quadriceps muscle, immunostained 
with a) DURD C, b) DURD M and c) DURD MJC. Positive staining of the tissue with antibodies to 
both exons 49 (M) and 76 (C) indicates expression of both exons was restored by the somatic mutation 
in these fibres. Scale bar represents lOOf.!m. 
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3.8 Exon specificity of anti-dystrophin peptide antibodies. 
The primary mutation in mdx mice is a C to T base change at position 3185 in exon 23. This mutation 
causes premature termination (Sicinski et a/, 1989). Given that the DURD MIC antibody had detected 
the presence of revertant dystrophin, the question was asked which epitopes had the antibody 
recognised, and therefore, which exons were transcribed in the revertant fibres. The DURD M peptide 
corresponds to a region of exon 49 in the human dystrophin gene and the DURD C peptide is 
transcribed from exon 76 (Roberts et a/, 1993). In particular, it was asked whether one or other exon 
had been spliced out during the reversion process. 
To enable dissection of the exon specificity of the dystrophin expression in revertant fibres, transverse 
serial sections of mdx muscle were immunostained with antibodies DURD C and DURD M, and the 
presence or absence of revertant fibres investigated. In this particular experimental animal, just one 
small patch of revertant fibres was found in the muscle. From the location ofthe fibres in the serial 
sections, it was clear that the same fibres were expressing both exons 49 and 76 (figure 3.6). Neither 
exon was spliced out in order to correct the original mutation. The somatic event must therefore have 
occurred elsewhere in the dystrophin gene. 
3.9 Discussion, Part 2-
Mdx reversion. 
It is clear that the exon splicing event in the fibres of this particular animal was outside the two exon 
regions analysed in this study. It is also apparent that such an event, wherever it may have been, 
successfully restored the reading frame in these two regions of the protein. 
3.9.1 Significance of revertant patch size. 
The number of fibres in the revertant patch reflects the stage of development in which the mutation 
arose. The revertant mutation must frrst arise in a single satellite cell nucleus. If that satellite cell 
mutates early on in the development of the fibre, the cell will undergo many further rounds of cell 
division, forming a whole cluster of dystrophin positive myofibres. Hoffinan et a/ ( 1990) reported that 
it's possible to observe dystrophin expression at the level of each individual revertant nucleus. The 
relatively large dystrophin mRNA undergoes restricted diffusion. Expression of dystrophin is therefore 
patchy along the length of the myotube, with strongest expression near to revertant nuclei. In the case 
of the patch observed here the mutation occurred at a late developmental stage, so far fewer nuclei 
contain the revertant molecule and the patch is small. 
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3.9.2 Uses for exon specific antibodies. 
In DMD patients the expression of revertant fibres in skeletal muscle can reduce the severity of the 
DMD phenotype (Nicholson et a/, 1993). As these antibodies can detect the presence of revertant 
fibres, they could be used to predict the severity of DMD in a patient and therefore assist with planning 
an appropriate clinical strategy. 
The ability to detect revertant fibres may also be of use to quantify the success of induced somatic 
reversion. Given that revertant fibres are reported to reduce the severity of DMD, investigations are 
underway to see if natural dystrophin reversion has potential therapeutic benefits (T. Partridge, personal 
communication) In mdx mice, the numbers of revertant fibres increases following irradiation of the 
muscle tissue. This is believed to reflect an increase in the rate of somatic mutation induced by the 
irradiation (Hoffinan et a/, 1990). Whilst irradiation carries its own risks, the results are encouraging. 
The negative staining ofC-terminal antibodies in the muscle tissue ofDMD patients (who may possess 
some N-terminally truncated dystrophin) allows for simple immunohistochemical diagnosis. In the case 
of Becker MD, dystrophin protein is present in skeletal muscle tissue. The protein is truncated and 
therefore functionally compromised, with severity corresponding to the site and extent of deletion. A 
crude test for the presence or absence ofdystrophin will not indicate the underlying cause ofmyopathy 
in BMD. Furthermore, the moderatly reduced levels of dystrophin protein are easily confused with a 
limb girdle MD phenotype. Southern blotting and PCR are the preferred techniques for BMD analysis 
at present. Large deletions are detectable on a western blot if the deletion produces an observable 
difference in molecular weight. Exon specific monoclonal and polyclonal antibodies such as these are 
preferential to antibodies directed against large bacterial fusion proteins when characterising the site of 
deletion in BMD. Small deletions can be detected by studying which epitopes are recognised from a 
large panel ofhighly specific antibodies (Thiet Thanh et a/, 1995 b). The site ofmutation and the 
deletion boundaries can be narrowed down specifically. 
On the other hand, the potential for these antibodies is limited when tracing the transplantation success 
of dystrophin positive myoblasts into dystrophic tissue (e.g. Beauchamp et a/, 1999 ). In this case it is 
desired that the transplanted fibres can be detected in the host tissue and their viability traced. It would 
be preferable if revertant fibres were not detected too, and therefore antibodies specific to the spliced 
out exons are desired. 
3.9.3 Future potential. 
Full elucidation of the site of somatic rearrangement within dystrophin revertant tissue requires a far 
greater selection of exon specific antibodies than were generated for this FPR study. Ideally a whole 
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panel of exon specific antibodies iis needed to harroW. down the exact natili'e ofthe mutations,and 
pattern; of exon splicing. To this:end these antibodies have been made IJ.Vailable tO Profs G. E. Morris 
and TA Partridge, to compliment their own collections of antibodies fo~ the study. of dystrophin 
revertant· fibres. 
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Cbapter4 
The role of dystropbin as a 'molecular fence'-
a non-specific regulator of membrane protein distribution. 
4.1 Introduction. 
The subplasmamembranous cytoskeleton forms a regular latticework beneath the plasma membrane of a 
cell. This lattice work may restrict and confine mobility of integral and peripheral membrane proteins 
by forming a steric barrier to their diffusion- the so called 'molecular fence' proposed by Kusumi et a/, 
(1994) (Simson et a/, 1998), discussed in detail in section 1.3. Such regulation of protein distribution is 
essential for delineation of the cell surface into specialised functional domains. 
The cytoskeletal constituent spectrin is a proven regulator of membrane protein mobility within many 
cell types including red blood cells and neurons (Tsuji and Ohnishi, 1988, Joe and Angelides, 1993). 
Dystrophin, the protein produced by the Duchenne Muscular Dystrophy locus, is a cytoskeletal 
component with a high level of sequence and structural homology to spectrin, including 24 spectrin-like 
repeats and an amino terminus capable of actin binding (Koenig et a/, 1988). Dystrophin, like spectrin, 
has been localised to beneath the plasma membrane (Porter et a/, 1992). 
Immunolocalisation studies in muscle fibres have shown the organisation of membrane glycoproteins to 
be severely affected by an absence of dystrophin, specifically the glycoproteins of the DAG complex 
(Ohlendieck and Camp bell, 1991 ). Clinical findings of muscle cytosolic constituents free within the 
serum of DMD patients and the evidence for extensive wound healing activity (q. v. section 1.1.2) 
suggest the absence of a functioning dystrophin/DAG complex results in sarcolemmal membrane 
instability. The rigidity and deformability ofthe membrane are also affected (Pastemak et a/, 1995). 
As stability of the dystrophic membrane is compromised, dystrophin has sub-plasmalemmal 
distribution; is homologous to spectrin and is known to interact with glycoproteins of the DAG 
complex; this study addressed whether dystrophin could organise membrane structure by regulating 
lateral mobility of membrane glycoproteins; either by forming a 'molecular fence' to membrane protein 
diffusion or as a direct tinker of surface glycoproteins. To examine the role of dystrophin in 
organisation of the muscle cell membrane and illustrate the interactions between the membrane 
constituents and cytoskeleton, fluorescence photobleach recovery (FPR) studies were conducted into 
the mobility of general classes of membrane glycoproteins in mdx and normal mouse muscle fibres. 
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• Part 1. The effects of dystrophin deficiency on glycoprotein mobility. 
In order to quantify the true physiological contribution of dystrophin to restriction of membrane protein 
mobility, fluorescence photobleach recovery experiments were performed on the surface of live teased 
muscle fibres. Fluorescently coupled lectins were used as probes to label general classes of surface 
glycoproteins. Lectins are not believed to perturb the membrane or affect the mobility of the labelled 
proteins (Axelrod et a/, 1976), so the photobleaching approach should provide a good indication of 
real-time protein diffusional behaviour. 
All the lateral mobility data presented in the tables, graphs and figures of this chapter was compiled 
from multiple individual photobleach curves. Data from the individual curves is contained in the 
appendix, together with the means, standard deviations and standard errors of the mean for the 
compiled data sets. The diffusion coefficient (D) and mobile fraction (f) values given here are the mean 
±standard error of the mean (s.e.m.). 
4.2 Results. 
4.2.1 Tissue buffer and fibre viability pilot study. 
From early studies of live muscle tissue labelled with lectin and bathed in PBS, during the FPR 
experiments marked and characteristic shifts in glycoprotein behaviour were observed during the later 
stages of data acquisition (approximately I hour to I hour 20 min after tissue removal- equivalent to 
around 30min into data collection). These changes were reproducible. Following early signs of 
glycoprotein immobility, a sudden rapid recovery was observed. The rapid phase made way within 
minutes for slow but complete recovery behaviour, which slowed in its rate of recovery as acquisition 
time progressed (figure 4.1). The initial stage pattern of mobility was stabilised and lengthened by 
changing to oxygenated Krebs buffer. The rapid recovery shift was therefore taken as a sign of fibre 
necrosis and care was taken to obtain all glycoprotein FPR data prior to any sudden irregular shifts in 
protein mobility patterns. 
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Figure 4.1 Changing pattern of fluorescence recovery with increasing experimental time. 
Stylised FPR recovery curves obtained from muscle fibres labelled with FITC conjugated lectins in 
PBS buffer system. y-axis represents fluorescence intensity as a percentage ofnonnalised pre-bleach 
levels. x-axis, time post-bleach in seconds. tl/2, half time for recovery in seconds. Time scales at 
which the curves were obtained are approximate. 
4.2.2 Lens culinaris receptor mobility. 
Mobility of the tenninal a-D-mannosylated and a-D-glucosylated classes of glycoproteins was 
monitored by labelling live, teased soleus muscle fibres with fluorescein isothiocyanate (FITC) coupled 
lectin from Lens culinaris and following the pattern of fluorescence recovery after photobleaching 
(Figure 4.2). The appearance of post-bleach fibres suggested that tissue integrity had been maintained 
throughout the experiments (Figure 4.2 a,b). 
Lens culinaris binding glycoproteins were found to be immobile in the sarcolemma of both mdx and 
control C57/BL 10 (C57/Bl) mouse calf muscle fibres within the time frame limitations of the 
experiment (Dimmobite<I o-12cm2/sec), figures 4.2, 4.3, and table 4 I. A small mobile fraction of Lens 
culinaris binding glycoproteins (f::::8%) was detected in both mdx and nonnal C57/BI tissue systems. 
Whilst there was inevitably some fibre-fibre and tissue-tissue variation, this was smoothed out by the 
large sample size. For each lectin, data was collected from a minimum of two different animals of each 
genotype, >I 0 measurements taken per animal. 
The large errors in the data are a feature of the curve fitting equations rather than the quality of data 
itself. The smaller the recovery, the less the data mirrors free diffusion into a unifonn circular area 
from an infmite sink and therefore the harder the curves are to fit to the data and the greater the errors. 
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Were the recovery larger, the errors would be smaller. The magnitude of the errors should not detract 
from the consistent observation that there was no mobility in the systems. 
After conducting the photobleach experiments, the presence or absence of dystrophin within the tissue 
was confirmed by immunostaining fast frozen unfixed quadriceps muscle sections from the animal with 
anti-dystrophin polyclonal antibodies (figure 4.2 e,f). To confirm that genetic absence of dystrophin 
was the cause of negative tissue staining and not insufficient secondary antibody, poor section integrity 
or degradation of cytoskeletal proteins, serial sections were stained in parallel with anti-rat brain 
spectrin polyclonal antibody as a positive control (figure 4.2 g and h) (gift of E-H Joe. Vybiral et al, 
1993). 
4.2.3 S Con A receptor mobility. 
Succinyl-concanavalin A (S Con A), like Lens culinaris, binds to terminal a-D-mannosylated and a-D-
glucosylated residues on glycoproteins. S Con A data therefore acted as an internal control for 
instrument sensitivity. As for Lens culinaris, S Con A-FITC binding glycoproteins are largely 
immobile on the timescale of the experiment, table 4.1, figure 4.3. There is no significant4 difference in 
mobility between mdx and normal sarcolemmal glycoproteins, the mobile fraction of glycoproteins 
being ~10% in each case. These mobile species possessed diffusion coefficients ofthe order of5xlo· 
10cm2/sec, comparable with published data for the free Brownian diffusion of large proteins within a 
phospholipid bilayer [for example, D=3.7xl0"10cm2/sec for free Brownian diffusing NCAM isoforms 
expressed in C2Cl2 muscle and NIH 3T3 cells (Simson et al, 1998)]. 
4 
'significant' is used here in an FPR sense, not a statistical sense. For details, q.v. section 2.6.4. 
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Figure 4.2 . Representative data set from the recovery of glycoproteins on normal and 
dystrophic muscle. 
a) b) Fluorescence photobleach recovery curves from live C57/Bl (left hand column) and live mdx 
(right hand column) soleus muscle fibres labelled with 25mM Lens cu/inaris-FITC. Vertical line 
represents the point ofphotobleaching; y-axis, light intensity as a percentage of normalised pre-bleach 
levels; x-axis, time pre- and post bleach (s). The fibres appeared intact following completion of 
photobleach experiment, c) d) . The presence or absence of dystrophin in the fibres was confirmed by 
staining transverse sections of quadriceps muscle from the same animal with DURD C anti-dystrophin 
C-terminal antibody e) f) ; whilst staining with anti- spectrin antibodies indicated sarcolemmal 
cytoskeletal proteins were intact in the sections h) g). 
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4.2.4 Ricinus communis agglutinin receptor mobility. 
Ricinus communis agglutinin 120 (RCA120) is known to bind to a 370kDa component ofthe DAG 
complex ('I oit et a/, 1989), amongst other N-acetly-glucosamine containing glycoproteins. The FPR 
data in table 4.1 indicates the RCA 120 lectin binding glycoproteins are largely immobile in the 
sarcolemma ofmdx and control mouse muscle (recovery ~11%), with no significant difference in 
mobility between the two systems 
Lectin. Mouse n f, Fluorescence To. recovery DL, Diffusion 
Genotype. sample recovery(%). (sec). coefficient 
size x10'10cm1/sec. 
S-Con A. C57 normal 28 10.50 ± 2.32 4.39 ± 1.34 4.13 ± 1.21 
mdx 38 9.03 ± 1.87 4.18 ± 2.02 5.68 ± 3.00 
Lens C57 normal 28 8.11 ± 1.63 3.79 ± 1.82 10.6 ± 10.4 
culinaris. 
mdx 36 7.69±2.13 2.69 ± 1.19 8.77 ± 5.22 
RCA no C57 normal 31 10.38 ± 2.46 3.30 ± 1.19 6.03 ± 2.29 
mdx 21 11.71 ± 1.82 4.31 ± 1.73 4.13 ± 1.89 
Table 4.1. Summary of glycoprotein mobility. There was no significant differences in mobility of 
the glycoprotein classes in mdx and C57/Bl muscle fibres. 
Diffusional behaviour oftluorescently labelled glycoproteins on the surface ofC57/BL 10 and mdx 
dystrophic mouse muscle fibres, as determined by FPR. Fluorescence recovery is given as a % of 
normalised pre-bleach levels. Values are mean ±s.e.m. for all pooled data curves. 
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•1, SConAmdx 
•2. SconA C57 
•3, LensC mdx 
•4, LensC C57 
•5. RCA120 mdx 
•s. RCA120 C57 
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Figure 4.3 Comparison of glycoprotein mobility in C57/BL 10 and mdx muscle fibre 
membranes. 
There was no significant difference in mobility of any of the investigated classes of glycoproteins as 
measured by FPR. Live fibres were labelled with 25nM FITC conjugated lectins S Con A, Lens 
culinaris and RCA 120, and the mobility of labelled glycoproteins tracked by fluorescence recovery after 
photo bleaching. Sarcolemmal glycoproteins were immobile in both tissues, f <11% within the 
limitations of detection (DL ~ 1x10- 1 2cm2/s) [' immobile' c. f. f~80% for free band 3 protein in 
erythrocytes (Tsuj i et a/, 1988)]. f, fluorescence recovery as a % of normalised pre-bleach levels; DL, 
diffusion coefficient (cm2/s) and T 0 , half time for recovery (s). All values are mean± s.e.m. Column 
numbering runs from left to right. 
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4.3 Discussion, Part 1. 
The experiments here addressed the notion that dystrophin, with its structural and sequence homology 
to cytoskeletal proteins, was acting as a constituent of the membrane skeleton fence in accordance with 
the "membrane skeleton fence model" ofKusumi et a/, (1993). This model proposed that 'the 
membrane associated cytoskeleton (membrane skeleton) provides a barrier to free diffusion of 
membrane proteins due to steric hindrance, thus compartmentalising the membrane into many small 
domains for diffusion of membrane proteins'. 
4.3.1 Dystrophin and regulation of glycoprotein lateral mobility. 
It has been seen that there is little appreciable difference in the mobility of sarcolemmal glycoproteins 
in dystrophic and normal tissue. This suggests that dystrophin is not vital for the setting up of 
sarcolemmal membrane domains or the restriction of sarcolemmal glycoprotein diffusion. This 
observation does not unequivocally rule out a fencing action of dystrophin in healthy tissue. 
Immunohistochemistry of the mdx fibres showed the underlying spectrin network to be present and 
apparently intact within dystrophic tissue, and so the spectrin network could be retaining proteins 
regardless of the presence of dystrophin. Although it would have been possible to add cytochalasin or 
brefeldin A to the fibres to remove the spectrin cytoskeleton, their effects on protein mobility is well 
documented (e.g. Sako and Kusumi, 1994) and the dystrophin network may also be disrupted. It is 
possible that dystrophin may complement the existing cytoskeletal network in healthy fibres. Extra 
rigidity will be imparted to the network in the presence of dystrophin through a more dense, more 
highly cross linked array of cytoskeletal proteins. Given the proximity of dystrophin to the 
sarcolemmal membrane and the sizes of the dystrophin molecule and DAG complex, it is likely that 
dystrophin will form a steric barrier to the diffusion of some membrane species. All these actions 
would reinforce an existing cytoskeletal system, but due to the presence of the remaining cytoskeleton, 
would not necessarily give rise to an altered mobility phenotype if that reinforcement were removed. 
The results do suggest, however, that a membrane fence role is not a primary function of skeletal 
muscle dystrophin. 
4.3.2 Redundancy within the membrane skeleton. 
On the other hand, the observed similarities in glycoprotein mobility in the presence and absence of 
dystrophin could reflect the high levels of redundancy found within cytoskeletal and extracellular 
matrix protein complexes (discussed in Gorski and Olsen, 1998). The presence of cytoskeletal and 
ECM proteins with some regional sequence and structural homology to dystrophin!DAG complex 
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components may be sufficient to compensate for the lack of dystrophin!DAGs in MD tissue in the non-
contractile resting state. Such homologous constituents could maintain sarcolemmal glycoprotein 
distribution and restrict membrane diffusion through similar (though lower affinity) protein-protein 
interactions. Under the resting conditions of an FPR experiment such a system would seem correctly 
organised with imposed restrictions on protein mobility. However, under conditions of shear stress the 
failings of this pseudo complex could then become apparent. The protein-protein links ofhomologous 
proteins, though adequate for protein immobilisation and diffusion restriction, may then prove 
inadequate to prevent stress induced destruction of the tissue and a diseased state would follow. 
The extracellular matrix (ECM) remained in place throughout the acquisition of recovery data. 
Considering the interrelationship of the membrane surface glycoproteins and the ECM components, the 
effect of the ECM on surface glycoprotein immobility must be considered. A densely packed, highly 
cross linked matrix on the surface of a muscle fibre could corral membrane surface proteins as 
effectively as a submembranous barrier. If this is the case in muscle fibres, removal of cytoskeletal 
components such as dystrophin will have a limited impact on the mobility of membrane components, 
even though structural integrity of the fibre has been compromised. 
The contribution of the ECM to restriction of cell surface protein mobility was investigated by FPR in 
Rous sarcoma virus transformed chick embryo fibroblasts by Boullier et a/ ( 1992). Transformation 
with the virus induces breakdown ofthe cellular exoskeleton. To investigate the effects of such ECM 
decomposition, cells were treated with trypsin to remove their exoskeleton (primarily composed of 
fibronectin in this cell line), resulting in rounded non-adherent cells. The fluidity of the lipid phase was 
unchanged by this procedure as shown by Di-I mobility. The diffusion rate ofS Con A receptors by 
contrast was 3x I 0" 10cm2s-•, approximately 2 to 4 times faster than in untreated cells. The tibronectin 
based ECM was consequently proposed to make a significant contribution to restriction of surface 
glycoprotein mobility, and therefore viral induced fibronectin loss contributed to the increased surface 
protein mobility observed in the cell line following viral transformation. (Although the authors did 
acknowledge break down of other ECM and surface proteins in addition to fibronectin is possible by 
trypsin). 
It would be possible to treat these muscle fibres with trypsin to remove the ECM and see if the ECM 
had the main influence on surface glycoprotein immobility in this system. The danger with this 
approach is that the membrane glycoproteins themselves could also be affected by the degradation. 
Disruption of specific protein-protein linkages on the surface would affect mobility ofthe surface 
proteins involved, perhaps freeing them of their true constraints. Similarly disaggregation of large 
complexes could increase rates of diffusion of the constituent parts. Stripping away all but the 
submembranous cytoskeleton would show what role the cytoskeleton can play- and perhaps how 
dystrophin is essential in such a role- but the physiological significance of such an experiment must 
then be questioned. 
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4.4 Experimental artefacts. 
There was one further possible explanation for the apparent lack of protein mobility in the fibres 
studied- that the observed data was artefactual, rather than a true representation of membrane 
glycoprotein behaviour. Previous reports of muscle glycoprotein mobility have described recovery of 
fluorescence. For example Schlessinger et a/, (I 976) observed approximately 66% recovery of Con A 
labelled glycoproteins on myoblasts. Whilst several of the curves published in earlier papers show 
moving tissue samples rather than true recovery (the published recovery curves possessing kinks instead 
of smooth increases in% fluorescence e.g. Axelrod et a/, 1976), the probability that something was 
amiss in the collection of the data in this study- and that therefore a proportion of the glycoproteins are 
mobile in the tissue could not be ruled out. Instrumentation failure or sensitivity was not believed to be 
a problem. The replacement oflabelled tissue with slides of free fluorescein dye diluted in 100% 
glycerol gave detectable and complete fluorescence recovery. Additionally, once the glycerol was 
replaced by 80% glycerol I 20% water the rate of recovery increased, suggesting the bleach shutters and 
detector was functioning and that all optical beams were in line. 
The simplest method to determine whether fluorescence recovery behaviour of the labelled probe was a 
true reflection of membrane glycoprotein diffusion or actually artefactual was to increase the 
experimental temperature and look for an effect on mobility of membrane constituents. 
• Part 2. The effects of temperature upon glycoprotein mobility in this study. 
4.5 Introduction. 
FPR measurements of glycoprotein mobility showed three different classes of glycoprotein were 
immobile in normal and dystrophic mouse muscle membranes. The immobilisation of membrane 
glycoproteins could be representative of physiological behaviour in mouse muscle. Alternatively, the 
data may have been influenced by experimental conditions and therefore not reflect the physiological 
situation. 
It was possible that the lack of glycoprotein mobility in the two systems was a consequence of the 
experimental temperature affecting membrane fluidity and behaviour, rather than the tethering or 
constraining action of the cytoskeleton and/or extracellular matrix. The lectin based glycoprotein study 
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was conducted at an ambient temperature range of 18-22 °C. In most cases the mdx/C57 Bl 
comparisons were perfonned on the same or consecutive days, so temperature variation between 
experiments was kept to 1 or 2°C. Data was pooled from several animals in each case, so effects of 
any minor temperature fluctuations on diffusional behaviour will have been smoothed out in the 
analysis. 
20±2 ° C is not physiological temperature for the tissue in this system. This was not believed to 
compromise the study or hinder comparison of mobility as many FPR experiments have been conducted 
at either non-regulated ambient temperature or with no reference to temperature at all, with no reported 
difficulties or unexplained membrane rigidity. For example Edidin and Stroynowski (1991) 
successfully compared mobility of conventional and inositol phospholipid-anchored membrane proteins 
in K78-2 hepatoma cells by FPR at 20°C. 
4.5.1 Effects of temperature on diffusion. 
For molecules undergoing free Brownian diffusion, the rate of translational diffusion is related directly 
to temperature according to the linear diffusion equation: 
Dr = ksTbr 
Where DT is the translational diffusion coefficient, k8 is Boltzmann's constant, T the absolute 
temperature and bT translational velocity under unit force. 
4.5.2 GeVfluid phase transitions in biological membranes. 
In complex matrices such as cell membranes, the linear relationship of diffusion with temperature no 
longer holds over comparatively large distances. Membranes constitute a panoply of co-existing 
phases. Depending upon the temperature and protein/lipid/cholesterol constituents of the system there 
may be a mixture of gel and fluid phases of differing melting points. Proteins may be in a free moving 
fluid environment at one end of the cell and in a semi-rigid gel phase just micrometers away. 
Hydrodynamic theory predicts that the diffusion coefficient for a membrane constituent, D, should 
increase with increasing membrane temperature. The membrane fluidity of all cells is directly affected 
by temperature to a greater or lesser extent. In some specialised plant cells, however, the magnitude of 
temperature effects are significantly restricted compared with animal cells and reconstituted bilayer 
systems. 
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4.5.2 a) Gel and fluid phases in plant membranes at low temperature. 
At low temperatures the membranes of plants and many heterotherms consist of a melee of co-existent 
gel and fluid phases. Metcalf et a/ ( 1986), suggested the plasma membranes of soybean cells may be a 
composite of stable immiscible domains of fluid and gel-like lipids after measuring the lateral mobility 
of phospholipid and lipid probes in the protoplast membrane by FPR. At 18°C the membrane probes 
possessed two parallel and independent patterns of recovery. The fluorescent markers either partitioned 
into a slow moving phase ofD-5x10" 10cm2s"1 (-30% of total membrane fraction)- representing a gel 
phase- or into a fast diffusing fluid phase ofD-3 xl0"9cm2s"1 (40% of membrane labelled fraction). At 
37°C the gel phase had melted and a single mobile lipid phase was found (D- x10-acm2s·•, recovery 
-60%). Changes in temperature of the system produced large irregular changes in the diffusion 
coefficients of membrane lipids. The magnitude of changes in D with temperature was significantly 
greater then the smooth gradual increase in fluidity expected for decreasing lipid phase viscosity with 
increasing temperature (46 fold increase in Ddi-l from 18 to 37°C, compared with 2 fold increase 
expected from of fluid viscosity), providing further evidence for a series of co-existing gel and fluid 
membrane domains at low temperature. Functionally, this adaptation is believed to ensure constant 
provision of active fluid phase membrane in the protoplast without sharp phase transitions and 
irrespective of external temperature. 
Similarly, in chill-sensitive maize roots the plasma membrane contains a variety of gel and fluid 
domains which stabilise membrane fluidity over a range of temperatures- the diffusion coefficient of 
phospholipid probes within the membrane underwent no significant change with varying temperature, 
and the temperature sensitive plant membranes remained fluid at low temperature (Kioster et a/, 1994). 
Non-chill sensitive protoplasts did undergo significant changes in lipid diffusion rate at temperatures 
below 1 0 o C. Protein diffusion on the other hand showed onJy slight changes from 2 to 21 o C in both 
cell types, suggesting the different phase lipid domains regulate protein fluidity over a range of 
temperatures. The corresponding membrane lipid mobile fraction showed slight increase over that 
range but was consistently less than 100%, therefore gel and fluid phases existed throughout. 
As many proteins favour a fluid lipid environment, it was proposed the decreased mobile fraction of 
proteins at lower temperature (albeit with similar D values) occurred as fewer of the membrane lipids 
were in a fluid state, thus allowing less of the protein to diffuse. Alternatively, aggregation of 
membrane proteins at lower temperatures could also have reduced the mobile protein fraction. The 
increasing mobile fraction of lipids with temperature pointed to progressive gel phase melting as 
temperature increased. 
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Some specialised plant membranes are therefore a mixture of gel and fluid domains across a range of 
temperatures. This adaptation is important to regulate membrane fluidity and function under fluctuating 
environmental conditions. 
4.5.2 b) Gel and fluid phases in animal cell membranes. 
This situation of gel and fluid phases is not seen as commonly in animal cells, particularly those of 
homoeothermic organisms. In general, the cells of mammals do not need to maintain fluidity over such 
a wide range of temperatures as plant cells therefore in the majority of mammalian cells, the 
requirement of complex multiple phases within membranes is avoided. The comparatively lower levels 
of negatively charged phospholipid and reduced sterol levels in animals give rise to more uniform and 
greater overall membrane fluidity at RTP. At lower temperatures the increased cholesterol 
concentration keeps the membranes fluid. 
There are some temperature dependent phase transitions in mammalian cells. The mobility ofDi-1 in 
the membranes of human fibroblasts undergoes a sharp shift in mobility at woe corresponding to a 
phase transition. Mobility then increases smoothly with temperature, apart from at 25 oe when a kink is 
observed in the curve (Jacobson et a/, 1981 ). The extracted and reconstituted plasma membrane lipid 
systems from the same cell lines are more complex. Here, above the woe discontinuity one 
component diffusion was observed, but below woe two component diffusion was seen- in accordance 
with a lateral phase separation of the membrane lipids as the membrane cools to form a multi phase 
equilibrium. In the true cell membrane, the presence of cholesterol smoothed out the two phases such 
that a simple one phase system was observed, increasing membrane fluidity with increasing 
temperature. 
4.5.2 c) Membrane composition and fluidity. 
The presence of cholesterol within animal cell membranes restricts the extent of rapid temperature 
dependent shifts in fluidity and maintains fluidity at lower temperatures. The consequences of 
cholesterol depletion on membrane lipid fluidity was highlighted by Thompson and Axelrod (1980). At 
low temperatures ( -5 to 5o C), the diffusion of a fluorescent lipid probe was 50% slower in the 
membranes of cholesterol depleted human erythrocytes than in the membranes of non-depleted 
e1ythrocytes. Above the phase transition temperature of the membrane lipids, the presence or absence 
of cholesterol made no difference to fluidity {though fluidity was still temperature dependent). 
The ratio of lipid to protein (L:P ratio) in a membrane has significant impact on the fluidity. At 
temperatures above the phase transition temperature of the lipid matrix, both protein and lipid diffusion 
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coefficients decrease as the L:P ratio decreases. It is argued that at high L:P ratios this is probably 
controlled by the temperature dependent viscosity of the membrane whilst at low L:P ratios steric 
crowding and protein-protein interactions slow diffusion. Below the transition temperature of the 
membrane the opposite occurs. The presence ofhigh levels of protein maintains the fluidity of the 
membrane and removes the large abrupt change in diffusion coefficients at the transition temperature 
(Peters and Cherry, 1982). 
Though animal cell membranes generally have just one fluid phase, there are exceptions. Sperm cells 
have a fraction of non-diffusing lipid in their membranes as a result of lipid-lipid interactions, providing 
an equivalent to co-existent gel and fluid domains. Differential scanning colorimetry revealed the 
anterior region of the sperm plasma membrane undergoes two major endothermic phase transitions at 
~26 and ~ooc, consistent with the models of gel/fluid transitions and in accordance with a partially 
melted bilayer at physiological temperature (Wolf et a/, 1990). It was suggested such ability to 
maintain fluidity over a range of temperatures was necessary as sperm pass through a range of 
temperature environments during maturation and fertilisation. 
4.6 Temperature and muscle membrane fluidity. 
In plant and animal cells adapted for temperature fluctuations the cell membranes may retain fluidity 
over a range of temperatures via a co-existent mix of gel and fluid phases. In general, temperature 
phase transitions in animal cells are less complex and more linear, following the basic trend of lower 
temperature, lower fluidity. It is possible that the immobility of muscle membrane glycoproteins at 
20°C is a consequence of reduced membrane fluidity at sub-physiological temperatures. To investigate 
whether temperature was limiting mobility in the glycoprotein FPR study, experiments were repeated at 
a higher temperature. 
Whilst it has been proven that membrane lipids may undergo a series of complex temperature 
dependent gel/fluid changes, the characterisation of such phase transitions in muscle fibres was 
unnecessary to demonstrate whether temperature was limiting. A simple increase in protein mobility at 
greater temperature would be sufficient to indicate lack of fluidity in the cold is the main explanation 
for immobility of glycoproteins at ambient conditions, rather than cytoskeletal or other imposed 
restrictions. 
4. 7 Results. 
It is well accepted from both experiment and casual day to day observations that the fluidity of 
lipid/cholesterol rich environments is subject to temperature fluctuations. To investigate whether 
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surface glycoproteins were immobile in the ambient temperature muscle plasma membranes studied by 
FPR because of the presence of a semi-solid gel matrix, or whether it was a result of cytoskeletal 
effects, the mobility ofthe glycoproteins was re-measured at the higher temperature of30°C, and the 
results compared with the ambient data. 
4.7.1 Equipment temperature modifications and limitations. 
Increasing the measuring temperature required modification of the traditional FPR apparatus. In the 
absence of a heated microscope stage, a crude but adequate heated water bath arrangement was 
assembled (figure 2.1 d). A circulating water bath at 75 oc provided the heat. The water passed 
through a brass block placed on top of the stage to heat the apparatus by conduction. The sample sat in 
a glass (rather than tissue culture grade plastic to improve conduction) petri dish placed on a glass slide 
on the stage and was likewise heated by conduction. The block was too tall to fit underneath the sample 
directly under the microscope objectives. Positioning the sample adjacent to the brass heating block 
rather than directly on it allowed the sample to be viewed under phase before photobleaching. The 
apparatus was insulated with polystyrene and bubble wrap. 
The equipment modification gave adequate heating up to 29±1 °C. Due to heat loss and the multiple 
heat transfer steps this equipment will go no higher. Ladha et a/ (1997) extrapolated mobility of a 
fluorescent lipid analogue in the plasma membrane ofbull spermatozoa at 30°C to be approximately 
twice that at 20°C, but still about one fifth the diffusion rate at 37°C. 29°C was therefore not expected 
to heat the membranes to a position of full fluidity, but should induce measurable differences over the 
20°C situation. Additional difficulties with the heating apparatus came from vibrations of the 
circulating water. The flow of water through the block caused the tissue sample to vibrate, preventing 
the acquisition of interpretable recovery data. To overcome this the waterbath was switched off during 
data collection and on between experiments. This gave a stable sample temperature for up to 20 
minutes. Sample temperature was monitored at intervals with a digital thermometer. 
4. 7.2 The effects of temperature on mobility of membrane glycoproteins. 
The effects of temperature on the mobility of terminal a-D-mannosylated and a-D-glucosylated 
glycoproteins on the surface of experimental muscle fibres was measured by FPR of S Con A-FITC 
labelled mouse muscle fibres at 29± I o C. It was assumed that the behaviour of S Con A labelled 
glycoproteins was representative of protein behaviour and hence membrane fluidity as a whole, and 
therefore experiments were not repeated using other fluorescent lectin probes. To see if a contribution 
from dystrophin to regulation of membrane glycoprotein mobility could be detected at the greater 
temperature, all experiments were conducted in parallel with tissue from C57/BL and mdx mice. 
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Due to the small levels of fluorescence recovery obtained during many of the individual experiments, 
the recovery data could not be fitted to the diffusion equation within the limits of statistical tolerance 
(q.v. section 2.4.4). In these cases the% recovery was determined by eye from the experimental 
curves. Diffusion coefficients could not be calculated where this was a problem, therefore noL <n101a1 and 
the diffusion coefficients given in table 4.2 have large errors. 
4.7.2 a) Temperature and dystrophic muscle membranes. 
-90% of S Con A-FITC labelled membrane surface glycoproteins were found to be immobile in the 
sarcolemma ofmdx mouse muscle fibres at 29±1 oc, as summarised in table 4.2 and figures 4.4, and 
4.6. The small portion of proteins that were mobile (-9.%) had diffusion coefficients of the order of 
-3xl0" 10cm2s"l, as expected for freely mobile proteins. 
The 9% recovery of fluorescence I 91% immobility of proteins at 30°C was equivalent to the 
membrane state at ambient temperature for mdx fibres labelled with S Con A-FITC. At ambient 
temperature 90% of the labelled membrane glycoproteins were immobile in mdx tissue. Therefore 
heating the fibres had no effect on the portion of mobile proteins in the membranes. Similarly within 
the margins of experimental error the rates of diffusion for the small percentage of mobile species was 
comparable in mdx tissue at both temperatures. 
4.7.2 b) Temperature and normal muscle glycoproteins. 
The pattern of glycoprotein mobility at 30°C in C57/Bl muscle fibres is shown in figure 4.5. The 
effects of temperature on surface glycoprotein mobility in C57/Bl tissue were similar to mdx fibres. An 
increase in temperature of -9°C produced no significant increase in either the proportion of mobile 
membrane glycoproteins (f-10% in both cases) or the rate of diffusion of the mobile fraction 
(Dur2.95xl0" 10cm2s" 1 c.f. Du0-4.l3xl0-10cm2s-1 ) when compared with 20°C values for both S Con A 
and Lens cu/inaris-FITC conjugated lectins (table 4.2 and figures 4.2, 4.5 and 4.6 ). 
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Figure 4.4 Effects of increased temperature on glycoprotein mobility. 
Increasing experimental temperature had no significant effect on the mobility of surface membrane 
glycoproteins in mdx mouse muscle. 
Above. FPR recovery curves from live mdx muscle fibres labelled with 25mM S Con A-FITC and 
photobleached a) at 20°C and b) at 29°C. The point ofphotobleach is represented by the vertical line. 
y-axis, fluorescence recovery as a percentage of normalised pre·bleach levels. x-axis, time post-bleach 
in seconds. 
Rigbt. Live- The teased live muscle fibres photographed by fluorescence microscopy following the 
photobleach experiment. 
Dys. Confll1llation ofthe dystrophic nature ofthe tissue. Transverse sections ofunfixed frozen 
quadriceps muscle from the experimental animals immunostained with 1/75 dilution ofDURDC anti-
dystrophin c-terminal peptide antisera and anti-rabbit-FITC secondary antibody. 
Spec. Control stain for cytoskeletal integrity in the tissue sections. 1/40 anti-rat brain spectrin 
antibody. Scale bar represents lOOJ!m. 
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Figure 4.5 Mobility of S Con A receptors in normal muscle at 30°C. 
S Con A binding glycoproteins were immobile on the surface ofC57/BL 10 muscle tissue at 29±1 °C. 
Above. FPR recovery curve from live C57/BL 10 muscle fibre labelled with 25mM S Con A-FITC 
and photobleached at 29±1 °C. The point ofphotobleach is represented by the vertical line. y-axis, 
fluorescence recovery as a percentage of normalised pre-bleach levels. x-axis, time post-bleach in 
seconds. 
Right. Live S Con A -FITC. The photobleached tissue, photographed under fluorescence illumination 
at completion of the photobleach experiment. 
Dystrophin. Confmnation of the presence of dystrophin in the tissue. Transverse sections of 
quadriceps muscle from the experimental animal, immunostained with 1175 dilution ofDURDC anti-
dystrophin c-terminal peptide antisera and anti-rabbit-FITC secondary antibody. 
Spectrin. Control stain for cytoskeletal integrity in the tissue sections. l/40 anti-rat brain spectrin 
antibody. Scale bar represents l OOJ.Ull, all photographs to the same scale. 
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Temperature Mouse D f, Fluorescence To. recovery Jh, Diffusion 
Genotype. sample recovery (% ). (sec). coefficient 
size xl0-10cm2/sec. 
20±2°C C57/BL 10 28 10.50 ± 2.32 4.39 ± 1.34 4.13 ± 1.21 
mdx 38 9.03 ± 1.87 4.18 ± 2.02 5.68 ± 3.00 
29±1 °C C57/BL 10 7 10.1 ±3.84 9.85 ± 6.15 2.95 ± 1.96 
(immobile) 
(mobile) 17 68.4 ± 6.79 0.97 ± 0.42 24.8 ± 14.8 
mdx 24 10.58 ± 3.84 7.42 ± 3.59 3.00 ±1.20 
Table 4.2 Effects of temperature on glycoprotein mobility as measured by FPR. Comparison of 
mobility of S Con A labelled surface glycoproteins at 20±2 ° C and 29± I ° C. Values are mean ± s.e.m. 
of all pooled experiments. 20 ° C data reproduced from table 4.1. 
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Figure 4.6 Comparison of temperature dependent glycoprotein mobility in C57/BL 10 and 
mdx muscle fibre membranes. 
There was no significant difference in mobility of glycoproteins at ambient temperature and 29° C 
as determined by FPR. 
Live fibres were labelled with 25nM S Con A- FITC and the mobility of labelled glycoproteins tracked 
by fluorescence recovery after photobleaching at ambient and 29 o C. Sarcolemmal glycoproteins were 
immobile on the surface of mdx and C57BL I 0 muscle fibres at both temperatures, f <12% within the 
limitations of detection (DL ~lx l0- 12cm2/s) f, fluorescence recovery as a% of normalised pre-bleach 
levels; DL, diffusion coefficient (cm2/s-1). Values are mean± s.e.m. for all pooled data curves. 
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4.7.3 MobileS Con A receptors. 
A consistent fraction ofmobile S Con A receptors were observed in the fibres ofC57/Bl tissue (table 
4.2, figure 4.7) at 30°C. This observation could illustrate diffusion of a population ofmobile receptors 
within the membrane. However, several further lines of observation suggest this is not a mobile fluid 
phase in the surrounding gel phase. Firstly, the shape of mobile curves changes with time according to 
a characteristic pattern- a pattern that mirrored the mobility of glycoproteins on the surface of 
experimental fibres in the PBS system and which was interpreted as fibre breakdown (c.f. figure 4.1). 
Secondly, the mobile phases were never observed at the start of an experiment, only after around 15 
minutes or longer. Additionally, once the receptors appeared mobile, it was rare for an immobile curve 
to be observed. If the fibres contained simultaneous gel and fluid phases, both mobile and immobile 
recovery curves should have been obtained at all stages in the data collection- the patterning should not 
have been time dependent. Thirdly, quality of fit of the diffusion equation curves during analysis of 
these later stage mobile experiments was variable, suggesting recovery was possibly artefactual rather 
than true diffusion based recovery in some cases. 
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Figure 4.7 S Con A binding surface glycoproteins were mobile in some C57/BL muscle fibres at 
29±1 oc. 
FPR recovery curve from live C57/BL muscle fibre labelled with 25mM S Con A-FITC and 
photobleached at 29±1 °C. The point ofphotobleach is represented by the vertical line. y-axis, 
fluorescence recovery as a percentage of normalised pre-bleach levels. x-axis, time post-bleach in 
seconds. 
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4.7.3 a) Cytoskeletal breakdown. 
One explanation for these curves is fibre movement in the dish. If the fibre is touched by the water 
immersion lens during focusing it can become detached from the btu-tack holding it in the petri-dish 
and start to move. Movement of the bleached area away from the monitoring region can give the false 
impression of fluorescence recovery. However, the shape of curve following fibre movement is 
distinctive, and didn't always match up to the observed data. A possible alternative explanation is 
cytoskeletal degradation in the fibres. In PBS the fibres were assumed to have broken down when the 
sudden transition to mobile glycoprotein behaviour was observed (q. v. section 4.2.1 ). This was no 
longer observed under ambient conditions once Krebs buffer was substituted. The increased 
experimental temperature may be accelerating the onset of fibre breakdown in these cases. 
Evidence for the effects of cytoskeletal breakdown on membrane protein mobility has come from FPR 
experiments on Rous Sarcoma virus (RSV) infected chick embryo fibroblast cells (Boullier et a/, 1992). 
Diffusion constants for S Con A-TmRh receptors were 2 to 3 times faster in RSV transformed cells than 
in normal chick embryo fibroblasts. In transformation-defective temperature-sensitive virus 
transformed cells, the increase in mobility occurred between 6 and 12 hours after induction of the virus. 
This corresponded temporally with the observed morphological changes in these cells (rounding up) 
that took place as the virus induced cytoskeletal breakdown and /or loss of extracellular fibronectin. 
The diffusion coefficient for Di-1 was relatively consistent in these cells, indicating lipid fluidity was 
unchanged. Therefore loss of cytoskeletal interactions are proposed to have caused the observed 
increased in surface glycoprotein mobility. 
Further experiments need to be done in order to test this suggestion in the muscle tissue. The 
monitoring of recovery behaviour before and after addition of cytoskeletal disrupters would show if the 
pattern of recovery observed here matches that of cytoskeletal degradation. The addition of sodium 
azide would accelerate fibre death, and so induce cytoskeletal degradation. Spontaneous fibre twitching 
is a further possibility for the recovery. In this case, however, the observed recovery would be expected 
to be rapid throughout rather than rapid then slow. Boosting the Mg2+ concentration from 1.2 to -2mM 
in-the surrounding tissue""buffer would be sufficient to inhibit any spontaneous activity. 
Such mobility was occasionally observed in mdx tissue too. However, in this case the pattern of 
recovery consistently failed to fit the diffusion equations within statistical tolerance. Furthermore, there 
was little consistency in the shape of recovery curves. Fibre movement seems the most likely cause of 
the 'temperature dependent' recovery in this case. 
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4.8 Discussion, Part 2. 
Membrane surface glycoproteins were immobile in the tissues of both C57/BL and mdx dystrophic 
mice, at ambient temperature and 29°C. There was no significant difference in the extent or rate of 
fluorescence recovery in either system under either set of conditions. This suggests that in this system 
the diffusion of membrane surface glycoproteins is unaffected by an increase in temperature or the 
presence or absence of dystrophin. The absence of significant variation in dystrophin deficient mice is 
in accordance with the observations at 20°C. As discussed previously, this suggests that formation of a 
submembranous molecular fence is not a primary role of dystrophin and that dystrophin is not essential 
for restriction of glycoprotein mobility in muscle fibres. 
4.8.1 Cytoskeletal restrictions on temperature induced mobility. 
The lack of increased glycoprotein mobility with 9 o C rise in temperature suggests there was no overall 
increase in membrane fluidity at the greater temperature. It is possible that, as originally assumed, 
surface glycoproteins are greatly restricted in their ability to move in the sarcolemma. Restrictions 
imposed by an underlying cytoskeletal meshwork, the extracellular matrix and direct anchoring of 
surface proteins to the cytoskeleton would prevent movement of component proteins, irrespective of 
temperature and surrounding membrane lipid fluidity. Immobility would be the conclusion reached by 
FPR methodology if the glycoproteins were freely diffusing- and indeed diffusing faster at higher 
temperature- but within confined domains smaller than the size of the bleach spot. 
4.8.2 Pbase transitions and mobility. 
On the other hand, an observable increase in protein diffusion would be expected if the proteins were 
held in a semi-solid geVfluid matrix at ambient temperature. Increasing the temperature should increase 
the proportion of total membrane protein that is free to diffuse (assuming some membrane proteins are 
untethered and freely diffusible) as a fraction of total membrane protein with restricted diffusion in gel 
rafts at RTP become surrounded by fluid phase lipids at 29°C. If, as with the protoplast system the 
viscosity ofthe fluid phase lipid is uniform with temperature, the rate of protein diffusion may not be 
expected to change at 29°C COL --constant), but the mobile fraction would have been expected to 
increase. 
It was possible that the lipids in the experimental membranes exist within a mixture of gel and fluid 
phases over the temperature range, and the free diffusing proteins partition preferentially into the 
immobile gel phase [rather thWI equally distributed between gel and fluid phases- this would have 
produced two parallel patterns of protein recovery data, one fluid, one gel phase, which was not 
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observed]. In this case, as the temperature increases there will be limited increase in protein diffusion. 
However, as the proportion of gel phase lipid reaches a minimwn, spatial constraints will drive proteins 
into the lipid phase. Theoretically, this gel saturation point may not have been reached by 29°C and so 
the protein could have remained predominantly in the gel phase and appeared immobile. Physical 
observation of the fibres post-bleach argue against this, however. The surfaces of the muscle fibres 
appeared uniform.Jy stained with S Con A- FITC at both temperatures. Were the proteins partitioned 
preferentially into gel-phase domains, some irregularity in membrane staining might be expected-
especially at the higher temperature where the proportion of total membrane in the gel phase would be 
smaller and therefore S Con A-FITC fluorescence would be restricted to confined domains. To 
unequivocally rule this out the muscle fibres would have had to be warmed to greater temperature and 
the experiment repeated. Unfortunately, the heating apparatus on the FPR equipment was unable to 
facilitate this. 
4.9 Temperature conclusions. 
It seems from these experiments that temperature was not the main influence upon membrane surface 
glycoprotein behaviour in the original experimental system. Either the cytoskeleton is tethering or 
restricting protein diffusion in the membrane or some other as yet unidentified factor is having the same 
effect. However, the possibility remains that lipid phase fluidity could also be affecting the mobility of 
the glycoproteins. 
The only way to firmly establish whether the membrane fluidity was compromised in the experimental 
fibres and whether or not temperature was the main influence on surface glycoprotein mobility was to 
look at mobility of the membrane lipids under the same experimental conditions at 20 and 29°C. If two 
categories of membrane lipid behaviour were observed- one gel, one fluid- then temperature dependent 
protein partitioning could be an explanation for the glycoprotein data. Similarly, if the lipid matrix is 
more viscous at room temperature (or possibly in a gel state) and more fluid at 29°C, then a) protein 
diffusion could be limited by (geVfluid) lipid viscosity, b) preferential partitioning of proteins into the 
gel phase is a possible theory and c) cytoskeletal I ECM influences could be regulating surface 
glycoprotein immobility. 
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• Part 3- Effects of temperature on lipid fluidity in the experimental system. 
4.10 Introduction. 
Increasing the experimental temperature had little appreciable effect on the mobility of surface 
glycoproteins in plasma membranes of both mdx and C57 muscle. This could be a reflection of 
imposed restrictions upon membrane glycoprotein mobility in the system. Direct anchoring of 
membrane proteins to the cytoskeleton would render them immobile, irrespective of the measuring 
temperature. Similarly if the proteins were confined to micrometer scale domains smaller then the 
bleach spot, they would appear immobile by FPR- even though they may be diffusing faster within 
their small domains at the greater temperature. As discussed earlier, in plant protoplasts the melting of 
a mixture of co-existent gel and fluid domains ensures the mobile proteins diffuse at constant rate, 
regardless of external temperature constraints. It is theoretically possible that such a system is in place 
here, though such systems are rare in mammalian cells and have not previously been described for 
muscle. 
To fully differentiate between solid geVIipid phases in the membrane restricting protein mobility and 
the effects of tethering or the cytoskeleton it was necessary to measure mobility of membrane lipids in 
the two systems at different temperatures. Lipid mobility in the muscle fibres was monitored using the 
fluorescent lipid analogue 5-(N-octa-decanoyl) aminofluorescein (ODAF). Whilst 1,1 '-dihexadecyl-
3,3,3 ',3 '-tetramethylindocarbocyanine (Di-I) is commonly used as a lipid reporter, Ladha et a/ (1997) 
found that Di-1 only stained the membranes of dead or permeabilised cells. ODAF in contrast stained 
both live and dead cells, with differential staining patteming between the two cell types. Additionally, 
ODAF analysis can be performed using a fluorescein optical filter set and was therefore more suited to 
this experimental system. 
4.10.1 Lipid mobility in sperm plasma membranes. 
An indication of the expected results came from studies ofODAF lipid analogue mobility in the 
membranes of spermatozoa (Ladha et a/, 1997). In live sperm from several different species, increasing 
membrane temperature increases lipid phase fluidity as measured by FPR (figure 4.8). The magnitude 
of fluidity increase is non-linear with temperature, with --4 times greater increase in rates of lipid 
analogue diffusion over the sperm head domain between 20 and 37°C than between 5 and 20°C. The 
different cellular membrane domains demonstrated differing sensitivity to temperature suggesting that, 
in addition to proteins, the membrane lipids are arranged into specialised domains in these cell types. 
%recovery of fluorescence was high across all regions of the sperm at all temperatures (>90%). 
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4.10.2 Lipid mobility in muscle plasma membranes. 
1t would therefore be expected that the fluidity of membrane lipids in this experimental muscle 
membrane system would show similar regulation by temperature. The extrajunctional muscle 
membrane is currently believed to be homogeneous with respect to lipid composition therefore 
regionalised domain variations in temperature would not be expected, but some overall rise in fluidity 
would be expected. The 29°C limit on measuring temperature imposed by the apparatus would not 
give rise to complete membrane fluidity, but should produce some measurable increase over fluidity at 
ambient temperature if temperature is a limiting factor. Given that, despite regionalisation of the sperm 
membrane the lipids showed high levels of recovery throughout, it would be expected that lipid 
diffusion would be unhindered by cytoskeletal barriers under the muscle surface and so the levels of 
fluorescence recovery from the lipid analogue would be significant (>50%). 
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Figure 4.8 Effects of temperature on lateral diffusion coefficients of ODAF in live-pattern bull 
spermatozoa. ODAF diffusion was more temperature-responsive on the acrosome (circles) and 
postacrosome (hollow squares) cellular regions than on the midpiece (black circles). Values are means 
± s.e.m. of3 separate experiments. Figure reproduced from Ladha et a/, (1997). 
4.11 Results. 
To measure lipid phase dynamics in the experimental system, muscle fibres from C57 and mdx mice 
were extracted as for the glycoprotein studies. Fibres were labelled with a l: l ratio of oxygenated 
Krebs buffer: 3.5J.LM ODAF in 1% ethanoVoxygenated Krebs buffer for 15 minutes at monitoring 
temperature, then subjected to photobleach analysis. Levels of fluorescence reporter were kept to the 
minimum necessary to generate a signal for FPR so as to minimise the perturbing effects of the dye 
intercalating into the membrane. 
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4.11.1 Mobility of membrane lipids. 
The results of the experiments are shown in figure 4.9 and table 4.3. 
Incorporation of the lipid label appeared uniform across the fibres (figure 4.9 Live). Bright patches of 
unincorporated dye were minimal. There was no indication of unincorporated crystalline dye on the 
surface of the fibres- as is often found with Di-1 fluorescent lipid marker- therefore measurement of dye 
crystal mobility was avoided. 
As with the 29°C glycoprotein experiments, the small levels of fluorescence recovery obtained during 
many of the individual experiments prevented fitting of the recovery data to the diffusion equation 
within the limits of statistical tolerance. In these cases the % recovery was determined by eye from the 
experimental curves. Diffusion coefficients could not be calculated for curves where this was a 
problem, therefore noL <11ro181 and the diffusion coefficients given in table 4.3 have large errors. For two 
of the sets of data the proportion of non-analysable curves was considerably greater than those which 
could be fitted. In these cases, the diffusion coefficient and/or ha1ftime of recovery for the remaining 
data may not be a true representation of the whole and the value ofDL is given as 'immobile' in table 
4.3. 
Temperature Mouse n f, Fluorescence To, recovery O.., Diffusion 
Genotype. sample recovery (% ). (sec). coefficient 
size X] 0"10cm1 /sec. 
22±1 oc C57/BL 10 21 8.43 ± 3.86 8.01 ± 6.01- immobile 
23±1 oc mdx 25 19.2 ± 7.5 18.00 ± 8.26 1.44 ± 0.91 
29±1 oc C57/BL 10 20 10.3 ± 3.70 7.74 ± 4.07 3.58 ± 1.96 
29±1 oc mdx 22 10.3 ± 4.86 10.9 ± 6.6 iniiiiooile 
Table 4.3. Effects of temperature on lipid mobility as measured by FPR. Comparison ofmobility 
ofODAF fluorescent lipid analogue at ambient and 29±1 °C. Values are the mean± s.e.m. ofa1l 
pooled data curves. 
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Figure 4.9 Effects of temperature on ODAF lipid analogue mobility. 
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The-membrane lipid analogue ODAF-appeared immobile in~the membranes ofmouse~muscle-tissue at--
both 20 and 29°C as determined by FPR. a) C57/BL10, 20°C. b) C57/BL10, 29°C. c) mdx, 20°C 
and d) mdx, 29°C. 
Above. FPR recovery curves from live C57/BL 10 and mdx muscle fibres labelled with I.75J.LM 
ODAF fluorescent lipid analogue and photobleached at 20± I o C and 29± 1 o C. The point of 
photobleach is represented by the vertical line. y-axis, fluorescence recovery as a percentage of 
normalised pre-bleach levels. x-axis, time post-bleach in seconds. 
Right. Live- The same live ODAF stained muscle fibres photographed under fluorescence 
illumination post-photobleach. 
Dys- Confirmation of the presence of dystrophin in the tissue. Transverse sections of quadriceps 
muscle from the experimental animal, immunostained with l/75 dilution ofDURDC anti-dystrophin c-
terminal peptide antisera and anti-rabbit-FITC secondary antibody. 
Spec- Control stain for cytoskeletal integrity in the tissue sections. 1/40 anti-rat brain spectrin 
antibody. Scale bar represents IOOJ.Lm, all pictures to same scale. 
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Figure 4.10 Tbe fluorescent lipid analogue ODAF is immobile in tbe plasma membrane of 
experimental muscle fibres at ambient temperature and 29°C as measured by FPR. 
Comparison of lipid phase fluidity in C57/BL l 0 and mdx muscle fibre membranes. Live fibre 
membranes were labelled with l.75j.LM ODAF and the mobility of the fluorescent lipid analogue 
tracked by fluorescence recovery after photobleaching at ambient and 29°C. The ODAF marker was 
immobile on the surface ofmdx and C57BL 10 muscle fibres at both temperatures within the limitations 
of detection(~ ;;dxl0'12cm2/s) f, fluorescence recovery as a% of normalised pre-bleach levels; DLo 
diffusion coefficient (cm2/s' 1). Values represent mean± s.e.m. of all pooled data curves. 
The ODAF labelled muscle membranes ofC57 and mdx mice showed little recovery of fluorescence 
when subjected to FPR analysis at ambient temperature. (table 4.3, figure 4.9, figure 4.1 0). The lipid 
phase was therefore immobile in the membranes ofthese tissues (recovery -10% for C57 and 18% for 
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mdx muscle). The rate of diffusion of the lipid phase was significantly slower than that expected for 
membrane lipids (in the region of -2xl0- 10 cm2s-1 , c_f. expected values of -10-9 cm2s-1). Though care 
must be taken in interpreting rates of diffusion given such low levels ofrecovery, this suggests the lipid 
phase that was free to move was hindered in its passage- perhaps by the large regions of immobile 
phase. Increasing the labelling and photobleaching temperature to -29°C similarly had little effect on 
the mobility of the lipid phase- either upon the fraction of mobile species (lipid phase on the whole 
remaining immobile) or on the rate of diffusion for the small mobile fraction where this could be 
calculated. Mobility of the ODAF lipid analogue therefore indicated the lipid phase was immobile in 
the experimental membranes at 20 and 29°C. 
4.11.2 Effects of dystrophin on lipid mobility. 
The presence or absence of dystrophin made no significant difference to the mobility of the membrane 
lipid phase within the measuring errors of the experiment, (table 4.3, figure 4_9, figure 4.1 0). ODAF 
fluorescence showed only 10% recovery at 29°C, regardless of whether dystrophin was present or not, 
suggesting that dystrophin does not have a major influence upon lipid phase mobility in this particular 
system. 
4.11.3 Immobile lipid phases. 
The failure of the membrane constituents to show any sensitivity to external temperature was a matter of 
concern. Though membrane proteins could conceivably be anchored in place by an underlying matrix, 
direct binding to the cytoskeleton or ECM interactions, the immobility of the membrane lipid phase is 
harder to rationalise. Membrane lipids would have been expected to show considerably greater than 
I 0% recovery at room temperature. Had lipids been immobilised in gel phase states under ambient 
conditions, an increased mobile fraction and an increased diffusion rate would have been expected at 
29°C. However, this was not observed. Errors of membrane labelling, e.g. failure of probe to 
intercalate into the membrane or FPR measurement ofthe ECM constituents wou-lcriead to -spurious 
results and misinterpretation of membrane lipid behaviour. An alternative explanation pertains to the 
membrane itself- perhaps the probe immobility is indicative of the membrane fluidity, and the proteins 
and lipids have become immobilised in the experimental fibres. 
Such an immobilised state has been reported for spermatozoon membranes labelled with ODAF and 
subjected to FPR (Wolfe et a/, 1998). It was found that lipid diffusion in the plasma membrane of live 
spermatozoa varied significantly between surface domains, because of either compositional 
heterogeneity, or differences in bilayer disposition, or the presence of intramembranous barriers that 
impede free exchange between domains. This diffusion was temperature sensitive as would be 
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expected for intercalation ofthe reporter probe into the lipid phase. In dead orpenneabilised cells on 
the other hand, the position was completely different. The dead cells (illustrated by differential 
patterning ofODAF staining and permeability to propidium iodide vital dye) contained large immobile 
phases of lipid as measured by ODAF FPR. These immobile phases were virtually insensitive to 
experimental temperature. 
4.11.4 Viability of experimental muscle. 
Mdx muscle fibres from the completion of a 29°C ODAF experiment were vital stained with 0.1% 
trypan blue to see if the fibres were viable at the end of an experimental run. This was lhour 15 
minutes after the initial dissection from the animal (figure 4.11 ). The vast majority of muscle fibres 
took up the blue dye into both their nuclei and cytosol. By the end of the experiment, therefore, the 
majority of muscle fibres were no longer viable. 
Repeating the vital stain with freshly dissected and teased muscle showed that -50% of the fibres had 
taken up the blue dye. These were therefore compromised in integrity during preparation. Over the 
duration of the FPR experiment, the remainder of the fibres had died off. Deterioration of the tissue 
during mobility measurements was noted particularly for glycoproteins, as the pattern of recovery 
changed towards the ends of experiments - a sign taken to indicate fibre breakdown. As a consequence 
of this, care was always taken to collect data within lhr 20 min of dissection, and to place more 
emphasis on the data from early FPR experiments than those later on in a run. 
The fibres that remained viable were randomly distributed throughout the tissue sample. It would not 
therefore be possible to knowingly select a viable fibre from the mass under the microscope. This 
observation that 50% of the fibres had taken up the dye therefore fails to match the experimental data 
from FPR. It would be expected that 50% of the fibres would possess freely diffusing lipids 
concomitant with live healthy fibres and a fluid lipid phase. The remaining 50% might be expected to 
show immobile lipid rafts. Instead almost all fibres failed to recover fluorescence after photobleaching. 
Those fibres that did show some recovery appeared to have moved in the dish and their curves failed to 
fit the diffusion equation. The immobility data would match up to viability observations if the fibres 
were only damaged sufficiently to take up the dye at a late stage in fibre death, but the immobile lipid 
phases developed sooner. 
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Figure 4.11 Integrity of muscle fibres was compromised during experimental preparation. 
Dissected and teased muscle fibres vital stained with 0.5% Trypan blue, lhr 15 minutes after dissection. 
Permeabilised fibres take up the stain. Scale bar represents lOOJ.lm. 
Figure 4.12 Surface of live C57/BI muscle fibres stained with fluorescent lectin. 
The fluorescent S Con A lectin marker stains the glycoproteins of neurons and the extracellular matrix, 
in addition to the surface of the muscle fibre membrane. Scale bar represents IOOJ.lm. 
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4.12 Discussion Part 3, effects of temperature on lipid mobility. 
This study set out to quantify the contribution dystrophin makes to non-specific regulation and 
restriction of muscle membrane components through formation of a submembranous 'molecular fence'. 
Dystrophin shows high sequence and structural homology to the cytoskeletal protein spectrin and is 
found beneath the plasma membrane in muscle fibres. These characteristics suggested dystrophin, like 
spectrin, could be involved in organisation of the muscle membrane- acting as a direct anchor of 
specific membrane proteins or through steric restrictions on mobility. 
The experiments presented here found both glycoproteins and lipids were in a tempemture-insensitive 
phase in the muscle membranes. This was the case in the presence and absence of dystrophin. Whilst it 
is theoretically possible that 90% of the surface glycoproteins of mouse muscle are held rigidly in place 
by a specific tethering complex or by the underlying cytoskeleton, it seems unlikely that the lipid phases 
are also solid in the true physiological state. It was expected that membrane lipids would show at least 
some degree of mobility in the muscle fibre membranes. Instead, the ODAF experiment revealed the 
experimental membrane system to be rigid. 
4.13 Experimental shortcomings. 
It is highly unlikely that this FPR data truly reflects the physiological behaviour of live muscle 
membranes. It is more likely indicative of shortcomings in the experimental set up. 
4.13.1 FPR labelling procedure. 
It is possible that the lack of recovery observed results from failure of the fluorescent markers to 
incorporate into the membranes. In the case of the S Con A-FITC, extracellular regions and 
particularly regions of the ECtv!_ were s~en by confo£al microscopy to have taken up the probe. 
Extracellular staining was invariably several fold brighter than membranous staining as seen by FPR 
photon counts and fluorescence microscopy. Care was taken during data collection to avoid 
experiments in abnormally bright regions, so ECM measurements should not have unduly contributed to 
immobility. Similarly the myelin sheaths of neurons readily incorporated the dyes, but visualisation of 
the fibre before photobleaching prevented data acquisition from nerves. 
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4.13.2 Probe cross linking. 
Cross linkage of membrane proteins by the lectin could have lead to the observed glycoprotein 
immobility. Multivalent lectins have the potential to bind proteins together into large immobile rafts if 
added to the cells at high enough concentrations. 50J.lg/ml Con A was sufficient to completely 
immobilise the fluorescent components of spherocytic red blood cell membranes as measured by FPR 
(Sheetz et a/, 1980). Whilst this could provide an explanation for the immobility of glycoproteins in 
the system, the observed immobility of the lipid phase cannot be rationalised this way. The ODAF 
reporter probe does not cross link membrane proteins or lipids. Cross linking could have contributed to 
protein immobility, but is unlikely to be the main cause. 
4.13.3 Non specific FPR probe-membrane interactions. 
Electrostatic binding of the probes to the surface, rather than incorporation into the bilayers may have 
given rise to the observed data. Labels were added to fibres at concentrations and in carrier solvents 
previously reported to give successful membrane incorporation (e.g. Wolfe et a/, 1998) and 
visualisation of the fibres post-bleach suggested the membranes were labelled, but such a close 
electrostatic association cannot be ruled out completely. 
Electrostatic binding of probe to membrane could be proposed for the ODAF lipid analogue. The 
effects of temperature on ODAF mobility is used as a control for probe intercalation in FPR 
experiments- membrane inserted probe would be expected to show temperature dependent changes in 
mobility whereas non-specifically associated probe held in place by ionic interactions at the cell surface 
would be less temperature regulated (Ladha et a/, 1997, Wolfe et a/, 1998). However, the methodology 
used here for staining the tissue fibre membranes was applied successfully to lipid domains in other 
tissues which did show temperature dependent regulation (Ladha et a/, 1997). Whilst there is 
invariably some tissue-tissue variation in biological systems, it seems strange that this muscle system 
should be so unique that neither the glycoprotein probes nor the lipid marker associated specifically 
with membrane species under conditions that have labelled successfully in many other systems. 
Though lack of specific labelling cannot be ruled out, it is possible that other factors are contributing to 
the observed immobility. 
4.13.4 The FPR experimental focal plane and ECM measurements. 
The differentiation between the plane of the membrane and the ECM is less clearly defined during 
photobleaching than under a fluorescent microscope as a visual check of the focal plane is not possible. 
The photobleach focal plane was selected as the plane with the greatest photon counts- believed to 
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correspond to the plane of the membrane, as the probes are supposedly membrane markers. All fibres 
were checked under phase contrast to confirm approximate alignment with the membranes (the plane of 
focus with fluorescence and phase were marginally different therefore this could only be approximated). 
But, given the intimate relationship between membrane and ECM and the spatial resolution of the FPR 
optics, ECM photobleaching cannot be ruled out completely. If experiments were in fact on the 
extracellular matrix rather than the membrane, then perhaps the immobility is less surprising. The ECM 
is a highly cross linked latticework of proteins, glycoproteins, glycolipids and proteoglycans. The 
stability of the cross linkages imparts the structural integrity and rigidity to the ECM and surrounding 
cells. The constituents of this matrix would be expected to be fixed as a consequence of function, 
rather than freely diffusing. Immobility of matrix components as seen by FPR would be expected. 
If it is the case that ECM components have been studied here instead of muscle fibre membranes, it is 
interesting to note that the absence of dystrophin had no effect on the organisation of the matrix as 
determined by FPR. Dystrophin is associated with merosin (M-laminin) in the ECM of the muscle 
fibres, via a- and P-dystroglycan in the DAG complex (q. v. figure 1.3). This association, linking the 
integral actin contractile fibres of the muscle fibre with the surrounding extracellular matrix is 
understood to impart structural rigidity to the muscle fibre and prevent stress induced damage. Indeed, 
this is presently thought to be the primary function of dystrophin (section 1.1. 7 c, Petrof et a/, 1993). 
Merosin deficiency produces congenital muscular dystrophy (reviewed in Campbell, 1995). However, 
if this data pertains to the ECM, it suggests disruption of the contractile fibre-ECM link does not 
compromise the structural integrity of the ECM itself. Whilst DAG proteins are down regulated in mdx 
mice, this may not significantly affect the cross linking of the matrix. If the ECM has been studied 
here, it suggests the bridging function of the dystrophin/DAG complex is important for giving structural 
strength to muscle fibres, but not for organisation or function of the ECM components. 
Confirmation of the ECM nature of the results could come by stripping the ECM from the fibres and 
repeating the FPR experiments. If the patterns of lipid and protein mobility shift dramatically from the 
observations thus far, then it is possible that the ECM has been studied. However, confusion is then 
possible between this interpretation and the suggestion the ECM is anchoring membrane proteins in 
place. Acquisition of-fluorescent ECM component probes and repetition of the photobleach 
experiments would provide definitive data on the behaviour of the ECM in the fibres, and illustrate any 
significant effects of dystrophin deficiency and indicate whether this study parallels ECM behaviour. 
4.13.5 Role of the ECM in protein immobilisation. 
As discussed earlier, the extracellular matrix could be immobilising membrane components in this 
system. It is unlikely that the ECM would contribute directly to restriction of membrane lipids, but if 
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the ECM could significantly reduce protein lateral mobility, movement of lipids through the dense 
immobile proteins would be sterically hindered. 
High levels of extracellular matrix constituents can hinder measurement of mobile surface 
glycoproteins. For example the high levels offibronectin on Rous sarcoma virus transformed chick 
embryo fibroblasts masked mobility of the free membrane proteins as measured by FPR (Boullier et a/, 
1992). To overcome this problem the same spot was bleached four times on the membrane surface. 
The initial bleach gave an indication of the total portion of immobile proteins (understood to be ECM 
proteins such as fibronectin), about 60% for normal chick embryo fibroblast cells. Subsequent bleaches 
traced the mobility of just the freely diffusing proteins in the membrane (as the immobile proteins had 
been bleached irreversibly in the frrst round). By the fourth bleach 83% of the total fluorescence was 
recovering. The diffusion coefficients of the mobile fractions remained constant throughout and 
therefore behaviour of the same mobile protein species was studied in each case. 
As dystrophin is believed to interact directly with the extracellular matrix, the effects of dystrophin 
deficiency on the mobilities of ECM proteins is of interest. However, given the lack of observed 
differences, the complex ECM surrounding muscle fibres and the high levels of immobile proteins 
found in the glycoprotein study, this repeat bleach methodology is worthy of consideration for further 
experiments to measure mobility of the mobile fraction. 
4.13.6 Non-viability of experimental fibres. 
The most important fmding of this study was that tissue integrity could have been compromised during 
excision and preparation of the fibres, and was undoubtedly compromised by the end of data collection. 
In vitro muscle systems are notoriously difficult to sustain over time- particularly due to incomplete 
oxygenation of central fibres. The large shifts in membrane glycoprotein mobility, from immobile to 
rapid and then slow mobility were taken to indicate fibre death in a PBS buffer system. When this was 
no longer observed in oxygenated Krebs buffer the fibres were believed to be intact. The reappearance 
ofthis behaviour at 29°C was thought to reflect an accelerated rate of tissue breakdown at the greater 
temperature, and therefore data was only analysed before this point. Unfortunately it may be this 
observed shift in mobility was either artefactual (maybe as a result offibre motion), or indicative of a 
later stage in fibre breakdown, possibly cytoskeletal degradation. Cytoskeletal breakdown is a 
characteristic feature of cell death- dying cells in culture are often seen to round up shortly before they 
detach from the substratum , and as discussed earlier, will give rise to increased protein mobility. 
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4.13. 7 Lipid phase immobility and cell death. 
Likewise, the suggested presence of large areas of an immobile lipid phase points towards dead fibres. 
Immobile phase lipids are found in some specialised cells and organelles (Metcalf et a/, 1986), 
particularly those that function over a range of temperatures. Though immobility in the muscle fibres 
could be interpreted as low temperature partitioning between gel and fluid phases at ambient 
temperature, the vital staining and failure of the system to respond to temperature argues against this. 
Equivalent findings are apparent in dead or permeabilised spermatozoa. Upon cell death a large 
immobile lipid phase (recovery <15%) develops across the plasma membrane domains, in contrast to 
>90% lipid phase recovery in healthy motile sperm. (Ladha et a/, 1997, Wolfe et a/, 1998). It was 
impossible to calculate values of diffusion coefficients for the dead sperm as, like here, the small levels 
of recovery gave wide ranging values ofD. The sperm membrane rigidity was found to be completely 
temperature insensitive in the dead cells, even up to 50°C (R. Jones, personal communication). The 
membrane lipid phase in this study was also immobile and not reversed by increased temperature 
(although it was not possible to test at temperatures>30°C), indicative of fibre death. The immobility 
was not a feature of the ODAF probe in sperm membranes as fluorescein phosphatidyl-ethanolamine 
gave the same results in permeabilised sperm. 
Why lipids form immobile rafts in dead cells still remains to be answered. Possible explanations for the 
formation of the immobile fractions are reviewed in Ladha et a/ (1997) and Wolfe et a/ (1998). They 
include 1. Formation of stable non-bilayer lipid structures such as hexagonal 11-type lipids- formation 
of such structures is acyl chain length, pH and salt concentration dependent. The stability of the 
structures could account for their persistence over time. 2. Interaction of lipids with the 
submembranous actin cytoskeleton via transmembrane proteins. 3. Localised variations in cholesterol 
composition- cholesterol interacts with unsaturated fattyacyl chains and will consequently affect rates of 
lipid diffusion. 4. Loss of transmembrane asymmetry following depletion of ATP and inactivation of 
ATP dependent flippases. 5. Fatty acyl chain shortening, cross linking and decomposition induced by 
oxygen free radicals- cross linking of unsaturated acyl chains will give rigidification of the membrane. 
Finally, -6.- o?" mediateacrosslitiKing na.Sbeen-suggestea=-Ca2+-ions can cross-link negatively charged 
phospholipids and sulphogalactosylglycerolipids by forming salt bridges with the polar head groups. 
This leads to microaggregation into 'lipid blocks'. Leakage of calcium from damaged sarcoplasmic 
reticulum or the 25mM Ca2+ ions in the Krebs buffer could induce crosslinkage in the muscle. 
However, lipid blocks are temperature sensitive, unlike the immobile fraction here. 
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4.13.8 Potential causes of muscle fibre breakdown. 
4.13.8 a) Damage during dissection. 
Tissue viability could be compromised at several different points in the study. Firstly, fibres can 
become damaged during excision of the muscle. Care was taken to remove muscle by the tendon and 
minimise fibre cutting. Whilst this was a simple procedure at the achilles tendon it was more complex 
near the knee joint and some fibre damage was unavoidable. It may be best if future photobleach 
experiments concentrate exclusively at the regions of muscle near intact tendons where fibres are more 
likely to be whole. 
4.13.8 b) Buffer system. 
Secondly, the oxygenated Kreb's buffer may be unable to sustain the tissue for any length of time. As 
stated above, it was believed the absence of sudden time dependent shifts in glycoprotein mobility in 
the Krebs buffer system compared with a PBS/sucrose buffer indicated extended tissue life in the Krebs 
buffer. The composition of Krebs buffer, though more complex in metal ion constituents than PBS, 
may be inadequate for long time scales. Replacement with a tissue culture medialaminoacid/salt type 
buffer may be more appropriate for future experiments. The levels ofCa2+, 0 2 and pH of the buffer 
could be problematic too. The Ca2+ only dissolves in the Krebs once the buffer is adequately 
oxygenated with 95%02/5%C02• During the measuring stage, some Ca
2
+ ions did come out of solution. 
The pH of the buffer could have shifted and/or the oxygen been depleted by half an hour into the 
experiment. Re-oxygenation of the buffer, or replacement with fresh buffer mid-experiment is 
theoretically possible, but in practice tended to detach the tissue from the petri dish so that no more 
FPR data could be collected. 
4.13.8 c) Buffer system and calcium. 
The concentration ofCa2+ ions in the Krebs (25mM) may be too high. Ifthe tissue is already 
compromised, e.g. following damage during dissection, taking up elevated extracellular calcium may 
trigger cell death. 
It is now well established that uptake of abnormally high levels of extracellular calcium damages 
muscle fibres, and influx of calcium down an extra to intracelluar concentration gradient was proposed 
as a potential cause of DMD (reviewed in Jackson, 1993). A minor change in plasma membrane 
permeability could allow a relatively large amount of calcium to enter the cell. High external calcium 
concentrations ofthe order of3-lOmM increase cytosolic creatine kinase release from isolated animal 
and human muscle and are therefore sufficient to cause fibre damage. Within the muscle fibre calcium 
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causes ultrastructural damage to mitochondria, activates calcium dependent proteases in the cytoplasm 
and may damage the cytoskeleton. Additionally, calcium overload could trigger free radical mediated 
damage. (reviewed in Jackson, (1993). 
4.13.8 d) Fibre teasing. 
Thirdly, the method of physically teasing the fibres apart may be the main contributor to tissue damage. 
During the teasing the fibres are sheared relative to each other, squashed by the forceps and in some 
cases stretched. No matter how carefully this procedure is conducted some damage is inevitable. Vital 
staining showed which fibres had been damaged post-photobleach, but is not a feasible technique prior 
to data collection- any levels of fluorescence from the vital dye will increase the background signals 
during FPR analysis. Though only dead fibres should take up the dye to any significant extent, it is still 
a potential problem. Vital dyes are toxic to cells if left on for any length of time and the effects of such 
dyes on membrane structure are unknown. 
The use of diaphragm muscle was substituted for hind limb tissue in the hope that the thinness of the 
muscle would prevent the need for teasing the fibres apart. The overlying membrane still had to be 
removed before labelling to ensure labelling of muscle surface, not tissue partition. This, like teasing 
pulled the fibres to some extent. The main problem, however, arose during excision of the tissue. Vital 
staining showed 50% of the diaphragm fibres became permeabilised during dissection. Unlike the calf 
muscle, the dead fibres were adjacently situated in quadrant-like distributions rather than randomly 
distributed- but without a suitable stain for live of dead tissue, the FPR measurements could not be 
preferentially conducted on live fibres. 
Enzymatic separation of the fibres could be employed instead of physical separation. Muscle fibres 
could be pre-treated with collagenase to separate the fibres before photobleaching. In this case 
enormous care must be taken to keep enzymatic degradation to a minimum. Permeabilisation of the 
fibres must be avoided. Additionally, as stated above the ECM may contribute to regulation of surface 
protein distribution in muscle fibres: Removal of the inter-fibre collagen matrix may aflecrthe-basal 
lamina around the fibres and lead to increased glycoprotein mobility, as found following trypsinisation 
of chick embryo fibroblasts (Boullier et a/, 1992). This could affect not only the mobility of surface 
glycoproteins in general, but also affect the distribution, function or potential of the dystrophin/DAG 
complex to restrict protein mobility. 
102 
Chapter 4 The role of dystrophin as a 'molecular fence •. 
4.13.9 Alternative experimental system for future work. 
Separating muscle fibres from their bundJes seems difficult without damaging them unnecessarily. An 
alternative approach would be to use live cultured fibres. Primary cultures from neonatal mouse muscle 
failed to grow in preliminary experiments. However, Terry Partridge has developed a method of 
growing myofibres in culture that may prove useful for comparative photobleaching in future studies. 
Live fibre explants will grow when plated on a matrigel matrix. The explanted myofibres may die, but 
satellite cells from the fibres proliferate, grow out of the original fibre and fuse to give new myotubes. 
It is possible that the new fibres may have less well developed basal lamina than the original mature 
muscle, but thus far they appear to retain the all the characteristics of mature fibres (T.Partridge, 
personal communication, Beauchamp et a/, 1999). 
These fibres in culture would be advantageous over dissected teased fibres in that the fibres can be 
maintained in a live state during the experiments. Fixed fibres on a culture matrix are less likely to 
vibrate than teased stuck down fibres so data collection should be a simpler procedure with fewer 
ambiguous curves that may or may not show recovery, depending upon whether the fibre is slowly 
moving or not. Autofluorescence from tissue culture plastic is always a problem with FPR of cultured 
cells, as is fluorescence from phenol red in the culture medium. These difficulties should be 
sunnountable by growing the cells on glass coverslips and transferring the coverslips to glass dishes for 
experimentation; and growing cells in phenol-red free media. 
Hopefully it will then be possible to further investigate the contribution of dystrophin to immobilisation 
and organisation of muscle fibre membrane constituents. 
4.13.10 FPR conclusions. 
Muscle membrane lipids and glycoproteins were immobile and temperature insensitive in dystrophic 
and normal muscle tissue as measured by FPR. Membranes may theoretically contain immobile lipid 
rafts in the physiological state. However, the data is more likely indicative of experimental artefacts-
either of the labelling procedure, FPR equipment or tissue viability. 
Lipid mobility data was consistent with observations in dead sperm cells, suggesting the muscle fibres 
were damaged during dissection and teasing, and were not sustained by the chosen buffer. This 
severely limited the capacity ofthis experimental system to study dystrophin's effects on restraining 
muscle glycoprotein mobility. The contribution of dystrophin to the subplasmamembranous 
cytoskeletal 'molecular fence' could therefore not be measured. 
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As discussed previously, the amino acid sequence and cellular location of dystrophin suggest a 
cytoskeletal function for the protein. It would therefore be interesting to pursue studies into 
dystrophin's role in organising and stabilising the muscle membrane. A viable tissue system is required 
to facilitate further work. 
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5.1 Introduction. 
Dystrophin and other cytoskeletal proteins may regulate the structure and organisation of the muscle 
fibre membrane in two ways, as discussed in detail in section 1.4. Firstly, dystrophin could act non-
specifically. In this hypothesis dystrophin would adopt a general 'molecular fence' role. By forming a 
physical barrier to protein diffusion, the dystrophin fence would restrict free movement of integral and 
peripheral membrane proteins. Secondly dystrophin could directly binding and tether membrane 
proteins. A protein bound either directly to dystrophin or indirectly via a complex of proteins, would 
be restricted in its ability to move within the membrane. 
To investigate how dystrophin could regulate the distribution, behaviour and function of particular 
integral membrane proteins, this work looked at the capacity of dystrophin to bind specifically to two 
such proteins, tethering them at the membrane and restricting their lateral mobility. In the light of the 
reported direct binding interactions between dystrophin and the members of the dystrophin associated 
glycoprotein complex, the first study addressed the ability of dystrophin to regulate mobility of adhalin 
(a-sarcoglycan I 50 DAG), known from co-irnmunoprecipitation experiments to bind dystrophin via~­
dystroglycan (figure 1.3). 
5.1.1 Dystrophin and adbalin localisation. 
The absence of dystrophin protein in DMD leads to a reduction of all the DAGs from the sarcolemma 
of affected individuals (Ohlendieck et a/, 1992). The DAG chosen for the study was adhalin, a member 
of the sarcoglycan complex, figure 1.3. Adhalin is a 50kDa novel transmembrane spanning protein 
(Roberds et a/, 1993). Together with ~. y and~ sarcoglycans it makes up the sarcoglycan complex of 
the DAG (complex reviewed in Duggan and Hoffman, 1996). Adhalin does not bind directly to 
dystrophin, but co-immunoprecipitates with anti-dystrophin antibodies (and the reverse is also true-
anti-adhalin antibodies pull down dystrophin) and is therefore in tight association (Ervasti et a/, 1990). 
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Adhalin deficiency is the primary cause of severe childhood autosomal recessive muscular dystrophy 
(also called limb girdle muscular dystrophy type 20). Adhalin levels are reduced in the sarcolemma of 
affected patients, despite normal levels of dystrophin (Matsumara et a!, 1992). 
Measurements ofadhalin protein mobility were chosen to illustrate mobility ofthe whole DAG 
complex. This was because firstly, adhalin is closely associated with the other members of the DAG 
complex. Monoclonal antibodies against adhalin pull down the whole DAG complex (Ervatsi and 
Campbell, 1991). Secondly, adhalin has a large extracellular domain (Roberds et al, 1993). The 
protein should therefore be accessible on the surface oflive fibres, so avoiding the need to permeabilise 
the tissue. Thirdly, whilst adhalin levels are reduced in dystrophic muscle, the distribution of the 
protein is unchanged (Cullen et a/, 1996). Fourthly, an antibody was available to the extracellular 
domain ofadhalin (gift ofDr L.V.B. Anderson, University of Newcastle, U.K.). This could therefore 
be used as the base for a specific probe for the protein in FPR studies. 
Dystrophin expression affects the distribution of adhalin protein in muscle tissue. In DMD patients, the 
lack of dystrophin leads to reduced levels of adhalin in the plasma membrane. Though levels of adhalin 
protein are low, the protein is still localised to the sarcolemma (Cullen et a/, 1996), suggesting 
dystrophin is not essential for DAG protein targeting. The reduced levels indicate dystrophin could be 
required to stabilise adhalin at the membrane. Perhaps by binding free adhalin and sequestering it at the 
plasma membrane, dystrophin prevents adhalin re-internalisation and degradation. 
The ability of dystrophin to bind specifically to the DAG complex in the muscle fibre membrane and 
hold the complex in place was therefore measured by tracking the mobility of the DAG complex with 
FPR. 
5.1.2 Dystrophin and NaCh localisation. 
The parallel investigation looked at the role of dystrophin in tethering or restricting NaCh mobility at 
the neuromuscular jiuiction~ In ihfs case, w:ilike tfie DA.Gs, no airecfbmdiiig jfi:te-raction oetween:-
NaChs and dystrophin has yet been proven. However, as outlined in section 1.6.4, dystrophin and 
NaChs eo-localise to the pits of the junctional folds in mature NMJs (Sealock et a/, 1991 ). As NaChs 
become immobilised at the NMJ during maturation of the junction (Angelides, 1986); different spectrin 
isoforms are localised to specific subcellular locations where they could perform different functions 
(Vybiral et a/, 1992); dystrophin shares high sequence homology with spectrin; dystrophin appears at 
the NMJ at the same developmental stage as NaChs (Bewick et a/, 1996); and P-spectrin and ankyrin 
have been shown to be required for localisation ofNaChs at the nodes of Ranvier in neurons 
(Srinivasan et a/, 1988); dystrophin could conceivably contribute to the localisation and immobilisation 
of neuromuscular junctional NaChs. Immunocolocalisation studies allow potential interactions between 
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proteins to be inferred, but cannot give direct evidence for protein-protein interaction, nor illustrate the 
true physiological/ functional relevance of such close proximity. Fluorescence photobleach recovery 
of live fibres provides a real time insight into the precise contribution of dystrophin to ion channel and 
DAG complex tethering. 
The FPR study of glycoproteins on the muscle cell surface was conducted using fluorescently tagged 
lectins bound to sugar moieties on surface proteins. This methodology, whilst informative, is not 
specific to any one particular protein. In order to study the mobility of individual protein species, a 
fluorescent marker which exclusively recognises the protein of interest is required. In the cases of the 
NaCh and the DAG complex, no high specificity fluorescent markers were available commercially. 
Consequently, fluorescently tagged probes had to be synthesised de novo before the FRP experiments 
could be performed. 
5.1.3 Fluorescent probe characteristics. 
In order to produce an effective fluorescent molecular marker, certain characteristics were desired in 
the synthesised probe (reviewed in Angelides, 1989). Firstly, the probe should show similar binding 
characteristics to the unlabelled marker. The probe must still be able to interact with the receptor 
binding site, binding with high specificity to the protein of interest (>80%) to minimise levels of 
background signal. Spectroscopically, the fluorescent component of the molecule should have a high 
extinction coefficient (E 2! 50,000M-1cm-1) and a high quantum yield (lll 2! 0.4). Together these ensure 
maximum light output at the desired wavelength, so that small numbers of bound receptors may be 
detected experimentally. In addition, the absorption and emission wavelengths should exceed 480nm, 
so that probe signals are not lost amongst autofluorescence from the tissue. Finally, the probe should 
have a non-perturbing effect on the labelled cell so that observations of probe behaviour truly reflect 
physiological behaviour of the target molecule. 
5.1.4 Voltage gated NaCh probe. 
It is often difficult to visualise specific receptors on cell surfaces due to their low density. 
Conveniently, NaChs are clustered at high density at NMJs. They should therefore be easily detected 
with an effective probe. 
The base for the synthesised voltage gated NaCh marker was the 22aa peptide neurotoxin J.t-conotoxin 
GIIIB (J.t·Cgtx). This neurotoxin (also known by the name geographutoxin 11 or GTX-11) is derived 
from the venom of the piscivorous cone snail Conus geographus and is used by the snail to paralyse its 
more agile prey when hunting. The toxin binds specifically to the muscle isoform of the NaCh, with 
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essentially no binding to the neuronal fonn (Oiivera et a/, 1985). This high speciticity makes Jl-
conotoxin GTIIB an ideal marker to visually label NaChs at the neuromuscular junctions of normal and 
dystrophic mice. The toxin binding domain is on the extracellular face of the NaCh (Olivera et a/, 
1985), so fluorescent toxin free in solution should gain unhindered access to the binding site during the 
labelling reaction. 
5.1.5 Neurotoxins as ion channel markers. 
The use of fluorescent neurotoxins as probes of ion channels is not without precedent. For example, 
tetramethylrhodamine (TmRh) derivatives of conotokin-G have been used to measure the mobility of 
neuronal N-methyl-D-aspartate receptors (Benke et a/, 1993). In muscle tissue, NaChs on the surface 
of chick myotubes were labelled with TmRh- Leiurus quinquiestriatus toxin to investigate the effects of 
innervation on NaCh mobility (Angelides, 1986). Toxins are attractive for this purpose as their high 
receptor affinity and specificity gives high receptor and low background signals. Toxins do not cross 
link like antibodies and are small in size, so they are particularly well suited to mobility studies. 
Toxins are considered suitable non-perturbing probes as, thought they exert an effect on their receptors, 
they are non-lethal to the cell. Fluorescent a-bungarotoxin for example inhibits muscle contraction. 
The other properties of the muscle cell are essentially unaffected by the bungarotoxin- action potentials 
are still generated and cell death rate is unchanged. This situation is proposed to result from the high 
specificity of toxins for their receptors, such that the other cellular processes remain undisturbed 
(Angelides, 1989). 
5.1.6 Adhalin probe. 
There are no neurotoxins found to date which interact with members of the dystrophin associated 
glycoprotein complex. To study the mobility of the DAG complex a monoclonal antibody to adhalin 
(a-sarcoglycan) was used as the base for a membrane protein probe. Monoclona] antibodies, -like 
neurotoxins, bind with high specificity to the epitope they were raised against. They can therefore be 
used to highlight particular proteins amongst the many on a membrane surface. Antibodies, unlike 
neurotoxins, can be cross linked together- by secondary antibodies in particular. Cross linking restricts 
mobility of the bound species and give rise to anomalous diffusion data. To restrict the extent of cross 
linking, the monoclonal antibody was fluorescently modified directly- as with the neurotoxin- rather 
than using a secondary antibody visualisation step. 
Adhalin is a transmembrane spanning component of the DAG complex,. The chosen monoclonal 
antibody [clone Adli20A6, a gift from Dr L.V.B.Anderson, University ofNewcastle] binds an epitope 
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on the extracellular domain of adhalin, between amino acids 217 and 289. The epitope should therefore 
be accessible by the antibody when added to the surface of live fibres, making this a suitable starting 
reagent for a membrane probe. 
5.1.7 Probe synthesis strategy. 
Fluorescent modification of molecular probes may be done either indirectly, via a reactive probe 
intermediate, or directly in one step. For the indirect approach, the molecular probe has a reactive 
group added during the initial step (such as a thiol group). This is then reacted further to produce the 
final product (e.g. with a fluorescent maleirnide). This method is advantageous as more than one 
derivative can be added to the thiol intermediate for different purposes if desired (such as biotinylation/ 
fluorescein/ rhodamine) and the thiol group can be used to separate intermediate from native toxin on a 
column. The net positive charge on the molecule (often needed for activity) is retained. On the other 
hand, the increased steps can lead to reduced yield of final product. 
In order to generate the fluorescent markers as simply, cheaply and efficiently as possible a one-step 
modification strategy was adopted. Amino groups on lysine residues and at the N-tenninus of the 
peptide/antibody were reacted with a fluorescent succinirnidyl ester according to the mechanism below, 
figure 5.1. There are 5 potential reactive sites in Jl conotoxin GIIffi-lys 8,9,11 and 16 plus theN-
terminal amino group (Oiivera et a/, 1985). The NMR structure ofGIIIB shows the lys residues to be 
arranged radially around the exterior of the toxin, projecting into the solvent and forming potential sites 
of interaction with anionic sites on the NaCh (Hill et a/, 1996). All five sites are therefore theoretically 
accessible for modification by the succinirnidyl ester. The immediate environments of the amino 
groups affects their pKs and hence relative reactivities. This, combined with steric constraints dictates 
the final nature of the reaction products. 
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Figure 5.1 Reaction mechanism of peptides with succinimidyl esters. 
0 
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Lysine side chain and N-tenninal amino groups react by addition-elimination with the fluorescent 
succinimidyl ester, leaving the fluorophore coupled to the peptide. Fl* represents the fluorophore. 
5.1.6 BODIPY fluorophore. 
The use of fluorescent succinimidyl esters to couple fluorescent species to proteins, and in particular 
toxins, has been previously reported. For example, Joe and Angelides ( 1993) generated fluorescent 
tityus toxin y to label neuronal NaChs. The fluorescent molecule of choice in these previous 
experiments has been carboxytetramethylrhodamine- Succinimidyl ester (T AMRA-SE). For this study 
the novel fluorescent reagent 4,4-difluoro-1 ,3,5, 7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-
propionic acid, succinimidyl ester (BODIPY (Fl) -SE) (figure 5.2) was chosen. 
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Figure 5.2 4,4-difluoro-1 ,3,5, 7-tetramethyl-4-bora-3a,4a-diaza-s-indacene-8-propionic acid 
succinimidyl ester [BODIPY(Fl)- SEJ. 
a) Structure, b) absorption spectra and c) spectral characteristics of BODIPY (Fl). Absorption spectral 
peaks are l: 2.968 A.U. @ 224.8nm, and 2: 0.152 A.U. @ 495.3nm at 5J.lg/ml in O.lM NaHC03 
buffer pH 8.5. Structure a) and data for figure c) obtained from Molecular Probes handbook of 
fluorescent probes and research chemicals. 
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BODIPY (FI) is an analogue of fluoresce in, absorbing the 488nm blue line from an argon laser and 
emitting in the green range. Fluoresce in is photochemically unstable, being susceptible to 
photobleaching even in room light. This is undesirable in an FPR probe as fading during recovery 
observation can mask the true extent of diffusion. BODIPY shows greater photostability than 
fluorescein. Additionally, BODIPY's emission bandwidth is narrower. This leads to higher emission 
peak intensity therefore BODIPY probes should give off sufficient photon counts, even at low 
concentrations of receptors. 
T AMRA is also photostable in comparison to fluorescein, and has been the fluorophore of choice for 
several toxin molecular probes (e.g. Joe and Angelides, 1993). However, during TAMRA synthesis, 
two isomers, (5) and (6)- carboxytetramethylrhodamine are formed. Consequently during fluorescent 
modification ofpeptides, both the (5) and (6) fluorescent isomers of modified peptides are produced. 
For a peptide such as Jl·Cgtx with multiple lysine residues and hence many potential sites of 
esterification, the number of different reaction products (in this case, 1 0) becomes too numerous for 
effective separation and characterisation. BODIPY -SE has just one isoform. The potential number of 
reaction products is therefore halved by using BODIPY. (Note- for the adhalin antibody, where the 
number of potentially modifiable sites is too large to practicably separate the different modified 
isoforms, the choice ofBODIPY over TAMRA was less critical. BODIPY was used to prevent 
reconfiguring the laser between experiments). 
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Results. 
5.2 Production of fluorescent anti-adhalin monoclonal antibody. 
5.2.1 Verification of unmodified antibody specificity. 
To visualise adhalin molecules on the surface of muscle fibres for FPR experiments the anti-adhalin 
monoclonal antibody clone Ad 1/20A6 was used as a specific marker of ad.halin protein. The antibody 
was tested to confirm its specific activity prior to modification by western blotting skeletal muscle 
protein extracts. The monoclonal antibody recognises a 50k.Da protein consistent with recognition of 
50k.Da adhalin on a western blot of muscle protein extract from Balb C dystrophin positive mice (figure 
5.3). The recognition pattern is in accord with the presence of50k.Da adhalin in muscle tissue ofBalb 
C control mice. The staining is not due to the anti-mouse secondary antibody, but instead is specific to 
adhalin . 
The intensity of staining of Balb C muscle is significantly greater than that observed for mdx muscle. 
Adhalin is detectable in tissues ofmdx mice, but is significantly reduced relative to the control. Given 
the similar intensity of secondary antibody bands in the two lanes, it may be assumed this difference is 
not due to differences in protein loading, but instead reflects the down regulation of DAGs in 
dystrophk tissue. 
Allli-a.dhalin Allli-:mruse secardazy kDa. 
Mdx BC Mdx BC 
Adhalin-
Figure 5.3 Skeletal muscle tissue immunoblot to verify activity of anti-adhalin monoclonal 
antibody. 
Nitrocellulose blot of total skeletal muscle protein from Balb C (BC) dystrophin positive control and 
mdx dystrophic mouse. 7.5% polyacrylamide gel I !Omg protein per lane. Skeletal muscle blot was 
immunostained with 1/400 dilution ofanti-ad.halin monoclonal antibody clone Ad1 /20A6 and 
visua 1 ised with 1/3000 anti-mouse -horseradish peroxidase conjugated secondary antibody. Anti-
mouse secondary blot was immunostained with 1/3000 secondary antibody alone. 
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5.2.2 Synthesis and purification ofadhalin probe. 
Following verification ofthe anti-ad.halin specificity of the monoclonal antibody, the anti-ad.halin 
antibody was fluorescently modified by reacting at 1:10 molar ratio with BODIPY -SE under alkaline 
conditions. 
To minimise the background signal from the ad.halin marker, the probe was purified from the reaction 
mixture post-modification. The antibody supematant/BODIPY mixture was passed through a GIO 
column to separate the high MW antibody from unreacted low MW free dye. The mixture was spun 
rapidly through the column, rather than eluted through under gravity to prevent undue dilution of the 
antibody. To restrict contamination by free BODIPY dye, the column was not washed after the spin, 
thus ensuring the majority of free dye remained within the column. 
To test that the antibody had been successfully modified and purified from free dye, and also to give a 
crude indication of the yield of the reaction, the modified antibody fraction from the column was run on 
a 7.5% polyacrylamide gel. To allow identification of the gel components the unmodified ad.halin 
monoclonal culture supematant and free hydrolysed BODIPY dye were run alongside the reaction 
products. Coomassie blue staining of the gel showed the column spun reaction mixture contained many 
of the protein fractions present in the original culture supematant including IgG anti-ad.halin 
monoclonal antibody (figure 5.4 a). 
To illustrate the presence of the BODIPY fluorophore, the same SOS gel was visualised under uv light 
(figure 5.4 b). The unmodified monoclonal culture supematant did not fluoresce under uv illumination 
(figure 5.4 b, unmod.). Strong uv excitation was observed from the column spun reaction mixture 
(figure 5.4 b, mod.). The larger molecular weight fluorescent species eo-migrated with the tissue culture 
supematant protein. This, together with the molecular weight, indicates the antibody had been 
fluorescently tagged by the BODIPY SE. Serum in the culture media contributes significantly to the 
total protein as eo-migration with BSA illustrates. 
The lower molecular weight band at the leading edge of the gel front in the modified lane co-migratecf -
with free hydrolysed BODIPY dye (though clear to see on the gel, the band was too faint to pick up on 
the photograph). This is therefore unreacted dye remaining after purification. The proportion of 
unreacted dye was less than that in the reaction mixture prior to column spinning, therefore the G 10 
column removed a significant percentage of free hydrolysed BODIPY. 
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Figure 5.4 Eluorescent modification and purification of anti-adhaJ.in monoclonal antibody. 
The modified antibody can be seen to fluoresce under uv light. The fluorescent band eo-migrates with 
unmodified antibody and not free BODIPY dye. 
a) Coomassie blue stained 7.5% SDS gel of adhalin monoclonal antibody tissue culture supernatant 
before reaction with BODIPY -SE (Unmod), after modification and G 10 column purification (mod), 
free hydrolysed BODIPY -SE alone (BODIPY) and BSA. Molecular weight markers (M) are in kDa. 
b) The same 7.5%SDS gel visualised under uv light to illustrate the presence of the BODIPY 
fluorophore in the modified fractions. 
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5.3 Use of anti-adbalin-BODIPY antibody for FPR. 
An absence of detectable dystrophin protein in DMD and mdx mice leads to down regulation ofDAGs 
in the sarcolemma. In order to measure the effects of dystrophin deficiency on DAG tethering and 
hence the ability of dystrophin to restrict the movement of specific membrane proteins, live fibres from 
C57/BI 10 and mdx mice were teased and labelled with 1130 dilution of column purified adhalin-
BODIPY construct. The labelled fibres were then subjected to FPR analysis to measure adhalin lateral 
mobility. 
Detectable photon counts from the tissue were low- of the order of -2,000-5,000 counts per second 
(cps), compared with >25,000 counts for glycoprotein studies. 2000 cps is only -1500 counts above 
background PMT dark levels. In order to test whether the low level counts were due to specific 
fluorescence of the ll-cgtx-BODIPY probe, or down to background fluorescence from the experimental 
set-up, live fibres from mdx and C57/BI 10 mice were teased, held down with Blu-tak in a glass petri 
dish and immersed in oxygenated Krebs buffer as for the NaCh labelling experiments. Autofluorescent 
laser counts from the experimental system were of the order of2,000-3,500 cps, as for the adhalin 
antibody-BODIPY labelled tissue. The detected photon counts from probe labelled tissue were 
therefore autofluorescence, rather than specific labelling by the fluorescent antibody. 
5.4 Immunohistochemical analysis of adhalin probe activity. 
To investigate why the adhalin marker failed to give a high fluorescent signal under the FPR apparatus, 
the labelled fibres were observed under a fluorescence microscope (fluorescein optical filter set 488nm 
excitation, 520nm emission). The fibres appeared green, consistent with adhalin detection, but the 
signal was low (figure 5.5 a). The green staining could have been in the extracellular matrix of the 
muscle fibres, or specifically located at the plasma membrane. To see if the probe staining was at the 
level ofthe plasma membrane, as expected for visualisation ofadhalin, transverse sections of muscle 
fibres were stained at 1/20 dilution with the anti-adhalin-BODIPY construct. 
Adhalin, with its plasma membrane localisation, is seen around the edges of immunostained muscle 
fibres in normal tissue. This staining is observed successfully in transverse sections of rat5 quadriceps 
muscle stained with unmodified adhalin antibody and anti-mouse rhodamine secondary antibody (figure 
5.5 b). The monoclonal antibody can therefore detect native adhalin. However, the anti-adhalin-
BODIPY mixture failed to show comparable staining when placed directly on mdx tissue sections at 
1/10 dilution (figure 5.5 c). The negative stain was not due to the down regulation ofadhalin protein in 
mdx tissue - the same lack of distinctive, bright adhalin rings was observed with C57/Bl mouse sections 
5 Rat muscle was stained in preference to mouse muscle to avoid the high background staining of anti-
mouse antibodies on mouse muscle sections. 
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too (figure 5.5 d) suggesting the probe was inactive. Increasing the concentration and incubation time 
of adhalin probe made no difference to the staining pattern. 
To test if the anti-adhalin antibody supematant was still active following the modification procedure, 
the column spun modified supematant was added to rat muscle sections at 1/20 dilution and visualised 
with anti-mouse rhodamine secondary antibody. Bright rings of adhalin detection were seen in the 
muscle tissue (figure 5.5 e). The modified anti-adhalin antibody supematant is therefore capable of 
binding specifically to native adhalin in tissue sections. However, from the intensity ofBODIPY 
fluorescence on tissue sections it appears the extent of fluorescent modification is low. Fluorescent 
signal intensity from the anti-adhalin antibody marker is too weak for this preparation to be an effective 
FPR molecular probe. 
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Figure 5.5 Anti-adhalin antibody-BODIPY probe activity. 
Live fibres stain weakly with the anti-adhalin -BODIPY construct. The modified probe supernatant 
retains anti-adhalin antibody activity, but levels of BODIPY fluorescence are too weak for FPR 
experiments. 
a) Live fibres stained with adhalin-BODIPY probe. 
Transverse quadriceps muscle sections, b) from rat, immunostained with unmodified anti-adhalin 
antibody and anti-mouse-rhodamine secondary antibody. c) from mdx and d) C57/Bl mice, stained with 
1/10 adhalin-BODIPY probe. e) from rat, immunostained with 1110 adhalin-BODIPY probe and anti-
mouse-rhodamine secondary antibody. 
Scale bars represent 200J.Lm. 
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5.5 Production of fluorescent NaCh marker. 
To generate the NaCh marker, Jl·Cgtx GIIIB was reacted at 2:1 ratio ofBODIPY-SE to lysine side 
chains (10: I molar ratio) using a modification of Joe and Angelides (1993l and protocol supplied on 
request from Molecular Probes. A large excess ofBODIPY was avoided to prevent multiple 
modification ofthe toxin. Multiple modification increases steric bulk and reduces likelihood of a 
biologically active product. The reaction was carried out in O.lM NaHC03 buffer at alkaline pH to 
catalyse the esterification reaction. 
5.5.1 Purification of Jl·Cgtx GIIIB-BODIPY by HPLC. 
Following the fluorescent modification reaction, efficient separation of modified from unmodified toxin 
was needed. Native toxins bind with high specificity to their target receptors and are typically active at 
low concentrations. Residual unmodified toxin may bind preferably to the receptor molecule, blocking 
entry of the fluorescent derivative and so preventing the fluorescent signal. Traditionally HPLC has 
been employed to separate reactants from products (e.g. Benke et a/, 1993) as this allows not only 
removal ofunreacted starting materials, but also resolution of the different individual modified 
isoforms. The different species can be determined spectroscopically due to their differing absorption 
properties. BODIPY absorbs strongly in the 480-550nm range, but poorly at 240/260nm. The alkyl 
chain backbone and side chain carbon-carbon bonds of the peptide absorb strongly at 214nm. The lack 
of extended 1t conjugation in the peptide leads to poor absorption at higher ( -500nm) wavelengths. It is 
therefore simple to resolve toxin, modified toxin and free BODIPY from their relative absorptions at 
214 (or 260/280nm) and 500nm. 
The usual solvent system for toxin I TmRh HPLC is 5-95% acetonitrile (AcCN) in 0.1% trifluroacetic 
acid. This was found to be inappropriate in this instance. The BODIPY dye hydrolysed under acidic 
conditions, forming an insoluble red precipitate. O.IM triethylammoniumacetate (TEAA) was therefore 
substituted for 0.1% trifluroacetic acid. 
5.5.1 a) Reverse phase HPLC purification. 
Traditional reverse-phase HPLC, whilst proven for rhodamine coupled toxin resolution was unsuitable 
for resolution of the toxin and BODIPY starting materials. The small (2,640MW) peptide toxin could 
be clearly resolved on a C 18 column, 5-95% AcCN, 0.1 M TEAA at 260nm detection (figure 5.6 a). 
6 This protocol describes fluorescent modification of a scorpion toxin with a tetramethylrhodamine -
succinimidyl ester to produce a specific neuronal voltage gated NaCh marker for FPR. This is in no 
way connected to the disputed production of antibodies against the NaCh, and no such connections 
should be made. 
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However, the BODIPY fluorophore is extremely hydrophobic. The dye bound irreversibly to a C 18 
column, making it unsuitable for separation of free dye and toxin-dye conjugates. 
A less hydrophobic C4 reverse phase column was substituted for the C 18 (5-95% AcCN, O.IM TEAA). 
The C4 gave excellent resolution of the BODIPY fluorophore at 500nm detection wavelength (figure 
5.6 b). Unfortunately, the peptide 1-1-conotoxin failed to adhere to the short C4 alkyl chains. The 
peptide was carried through in the void volume at the start of the HPLC run and could not be detected 
amongst the initial surge from the column. Although the peptide protonation state could be altered by 
changing the pH of the TEAA, the extent of incompatibility is such that the peptide would still fail to 
stick. The well established reverse-phase alkyl chain column method is thus unsuitable for purification 
and resolution of BODIPY modified toxins. 
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Figure 5.6 Reverse phase HLPC profiles for starting reagents of NaCb probe synthesis. 
a) 214 and 493 run HPLC profile ofJ.t-conotoxin GIHB. C18 reverse phase column. Solvent A, 0-40% 
acetonitrile over 35min. Solvent B, 0.1% TF A. x-axis, retention time (min). y-axis, absorption. 
b) HPLC profile ofBODIPY (FI) SE. C4 reverse phase column. Solvent A, 0-100% acetonitrile. 
Solvent B, 0.1 M TEAA pH7. x-axis, retention time (min). y-axis, absorption. 
Monitoring wavelength, 493nm. 
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5.5.1 b) CN column purification. 
Taking into account the incompatible hydrophobicity characters of the modification starting reagents, 
either the HPLC column could have been changed for something more compatible, or the fluorophore 
could have been altered to a more hydrophilic reagent. BODIPY was retained over the less 
hydrophobic TmRh-SE to restrict the number of fluorescent derivatives. Instead the HPLC column was 
switched from an alkyl to a cyano (CN) column. Resolution of both native toxin and BODIPY dye was 
possible with the cyano column. Native toxin eluted after 6.1 minutes on a 30 minute gradient of0-
95% AcCN (figure 5.7 a). The BODIPY dye and hydrolysed derivatives eluted after 9.1 minutes, 
(figure 5.7 b). The difference in retention times was large enough to separate the two starting reagents 
by this method. Though the column detector was unable to monitor at both 260 and -500nm, the 
appearance of a peak over and above the starting reagents in the modified reaction mixture profile, at 
either wavelength would indicate toxin-BODIPY conjugate. 
The initial analytical run of reaction product mixture indicated the toxin had been modified successfully 
by BODIPY-SE in the coupling reaction. At 514nm an extra peak was detected after 8.57 minutes 
when compared to the dye hydrolysis profile (figure 5.7 c). CN columns are therefore more suited than 
alkyl reverse phase columns for separation of hydrophobic BODIPY coupled peptides by HPLC. 
The gradient did not resolve different modified peptide isoforms. It could be that just one fluorescent 
derivative of the toxin was generated during the esterification reaction because of thermodynamic or 
steric constraints. Alternatively, the solvent gradient and column system in this first trial separation 
may have been too harsh or too insensitive to differentiate between the isoforms. Before a preparative 
run could be conducted on the reaction products, however, the HPLC detector broke down. Column 
time could not be obtained again on a reasonable timescale and so a different method of reagent 
separation had to be adopted. 
5.5.2 Gel column purification. 
Following the difficulties with HPLC separation of reactants and products, a cruder gel column 
purification method was adopted. Whilst gel columns are less sensitive, time consuming and lead to 
dilution of the sample, the likelihood of obtaining some workable probe was higher than persisting with 
HPLC. The labelled toxin was purified by passing through a 1 ml, 25cm sephadex G 10 column, eluting 
with PBS. To detect the presence of products and reactants in the fractions, 9 minute eluents were 
pooled and analysed spectroscopically at 514nm for BODIPY absorbance and 260run for toxin 
absorption. 
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Figure 5.7 CN column HPLC profiles for starting reagents and products ofNaCh probe 
synthesis. Solvent A, 0-95% acetonitrile over 30min. Solvent 8, 0.1 M TEAA pH7. x-axis, retention 
time (min). y-axis, absorption. Numerical values indicate retention times. 
a) 220 nrn HPLC profile of 11-conotoxin GIIIB. b) 514 nrn HPLC profile of BODIPY (FI)-SE. c) 514 
nrn HPLC profile of 11-conotoxin GIIIB/ BODIPY (FI)-SE mixture, post-coupling reaction. Additional 
peak corresponding to BODIPY tagged 11-cgtx marked with asterisk. 
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Figure 5.8 Sepbadex GlO column elution profile ofBODIPY-SE/ J.L-cgtx GIIIB modification 
reaction mixture. 
514 and 280nm spectroscopic analysis of 1/6 diluted column fractions, collected and pooled every 9 
minutes. Unreacted toxin and toxin-BODIPY conjugates passed through the column in under an hour. 
Small molecular weight unreacted BODIPY tluorophore and free dye were restricted in their passage 
through the column and eluted 3-4 hours later. 
From the HPLC profiles ofunreacted and modified toxin it can be seen that native toxin had little 
detectable 514nm absorption but high 214~280nrn absorption. The absorption spectra of the GlO gel 
column fractions shows high A260 absorbance, in accordance with the presence of J.L-cgtx, after 
approximately 45 minutes (figure 5.8). Thls was the same time as the void volume takes to clear 
through the column, therefore the toxin passed straight through with little resistance. The high A260 
absorbance toxin fraction also possessed a significant 514nm peak. This suggested the BODIPY 
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fluorophore had conjugated to some proportion of the toxin. This peak fraction was therefore kept as a 
potential fluorescent NaCh marker. 
The free hydrolysed and unreacted BODIPY (relatively high As14 : A261J ratio) took over 4 times as long 
to pass through the column, (figure 5.8). The smaller molecular weight dye was retained by the pores 
of the gel matrix whilst the larger toxin conjugated dye variants carried straight through. The 
fluorescent species with longer retention time were deemed to be free dye and discarded. 
5.6 NaCb mobility measurements. 
The aim of the Jl-Cgtx modification reaction was to generate a fluorescent marker of muscle NaChs, so 
that NaCh mobility could be measured and compared by FPR. From the elution profile of the G 10 
column it could be concluded that: a) at least a proportion of the Jl-Cgtx had been successfully 
conjugated to the BODIPY succinimidyl ester to make a fluorescent NaCh FPR probe, and b) The 
majority of the free BODIPY dye had been separated from the toxin-BODIPY conjugate by the gel 
filtration column purification. Following this successful isolation of the modified Jl-Cgtx from the 
sephadex column, the 45 minute G 10 column fraction Jl-Cgtx-BODIPY construct was added to teased 
live muscle fibres ofC57/Bl 10 mice at 1/35 dilution in oxygenated Krebs buffer. The live fibres were 
transferred to the FPR instrument for NaCh mobility measurements. 
Under the laser the photon counts from the labelled tissue were of the order of -2,000-5,000 c.p.s, as 
found with the adhalin probe. Additionally, the levels of counts were uniform across the tissue. This 
was contrary to expectations for a NaCh marker. Though low counts across the body of the fibre is not 
unusual, regions of higher counts would be anticipated when scanning across the tissue, corresponding 
to increased probe binding at areas of high NaCh density such as NMJs. It consequently seemed that 
autofluorescence was once more the main source of photon counts. 
5.7 Fluorescent histological tests for J.L-cgtx-BODIPY activity. 
5.7.1 Jl-cgtx-BODIPY staining of live fibres. 
In order to ascertain whether the lack of photon counts reflected too little label on the tissue, or an 
absence of effective high intensity NMJ staining by the probe, teased live fibres stained with 1135 Jl-
cgtx-BODIPY were observed under a fluorescence microscope. Neuromuscular junctions can be seen 
in live fibres by staining nicotinic acetylcholine receptors with fluorescently coupled a-bungarotoxin 
(a-bgtx). Under the fluorescence microscope these stained NMJs take the form of bright rounded spots 
on the surface of the plasma membrane - often in a line, corresponding to multiple points of innervation 
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at adjacent sites along the fibres (figure 5.9 a). The pattern of a-bgtx-FITC staining on live fibres was 
compared with that of Jl-cgtx-BODlPY to reveal whether the probe successfully highlights 
neuromuscular junctional NaChs. 
The observed pattern of live fibre staining from the Jl-cgtx-BODIPY differed from the a-bgtx-FITC. 
Many conotoxin stained fibres possessed a uniform green stain along their length. The expected clear, 
rounded NMJ spots were not apparent. Instead, diffuse patches of staining were observed on the fibre 
surfaces. These brighter patches were clustered, as would be expected for a NaCh marker. The staining 
colour on the other hand was yellow, rather than fluorescein green. The colour hinted that the patches 
could be non-specific background in nature. (figure 5.9 b). These patches were also visible with a red 
514/560nm filter set, but true BODIPY -FL derived fluorescence should give minimal signal intensity 
with red emission filters. Increasing the concentration of probe increased the intensity of the uniform 
green stain along the fibre lengths. Clear bright rounded NMJ spots were still undetectable, but could 
have been lost amongst the brighter background stain. The diffuse green/yellow patches remained. 
It was possible that the diffuse patches of staining were NaChs at neuromuscular junctions. Their 
diffuse appearance could have been a consequence of compromised fibre integrity/ breakdown. NaChs 
could have been present throughout the plasma membrane, hence the uniform green staining. 
Alternatively, the toxin could have lost biological activity during the modification procedure and so be 
unable to bind muscle NaChs. 
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Figure 5.9 f.l-conotoxin-BODIPY probe on live fibres. 
Fibres of C57/Bl mouse muscle, stained with a) a-bungarotoxin-FITC for acetylcholine receptors at 
NMJs, and b) f.l-conotoxin-BODIPY for equivalent staining ofNaChs. f.l-Conotoxin stains diffusely, 
rather than at clearly defined NMJ sites. Outlines of individual fibres may just be made out. Scale bar, 
IOOf.lm. 
Figure 5.10 f.l-conotoxin-BODIPY probe on mouse muscle sections. 
Transverse sections of a) C57 181 and b) mdx mouse muscle, stained with I /20 f.l-Conotoxin-BODIPY 
construct. The construct does not specifically stain NMJs. Scale bar in f.lm . 
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Figure 5.11 Failure of 11-cgtx-BODIPY to bind neuromuscular junctional NaChs. 
Transverse sections ofunfixed C57/BI quadriceps muscle, eo-stained with 1-1-cgtx-BODIPY and a -bgtx-
rhodamine. NMJs are stained by a-bgtx-Rh, but not ll-cgtx-BODIPY. a) red channel, b) green 
channel, c) both channels. 1-1-cgtx-BODIPY stains outside NMJ regions. d) green channel, e) red 
channel, f) both channels. 
Scale bar represents I 001-!m . 
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5. 7.2 J..L-cgtx-BODIPY staining of tissue sections. 
To confinn if the observed staining was actually NaCh in nature, IOJ..Lm transverse sections ofmdx and 
C57 BL quadriceps muscle were labelled singly with J..L-cgtx-BODIPY (Fl), and double labelled with J..L~ 
cgtx-BODIPY (Fl) and rhodamine n-bgtx. Colocalisation of red and green fluorescence was analysed 
by confocal microscopy. J..L-cgtx-BODIPY alone labelled unevenly across the tissue (figure 5.10). 
Particularly bright staining was found around the edges of some muscle fibres, with isolated fibres 
staining more brightly in their interior than others. Similar patterns were seen in both C57/BL and mdx 
mouse sections. The diffuse yellow patches of staining observed on live fibres did not localise 
specifically to the membranes of sectioned fibres. This, together with the yellow colour and the red 
channel detection, indicates the diffuse staining is not a result of J..L-cgtx-BODIPY binding NMJ NaChs. 
It is more likely to be non-specific background staining. 
n-bgtx -Rh clearly labelled acetylcholine receptors at NMJs within the tissue ofmdx and C57/BI mice 
(figure 5.11 a). No colocalised green J..L-cgtx -BODIPY staining was found at the same NMJ. This eo-
staining would have been expected had the J..L-cgtx bound specifically to NaChs (figure 5.11 band c). 
J..L-cgtx -BODIPY therefore does not bind with high affmity to NMJ NaChs. 
J..L-Cgtx -BODlPY did stain some regions of the tissue sections with high specificity (figure 5.11 d). 
Although this appeared to be signs ofNaCh detection and binding, no corresponding n-bgtx-Rh 
staining was present (figure 5.11 e and f) therefore it is unlikely to be NMJ specific. It seems, given the 
morphology of the BODIPY stained regions, that the dye is taken up by blood vessels and the lipid rich 
myelin sheaths of neurons, but not by NMJs. 
J..L-cgtx GlliB binds slowly and reversibly to NaChs. The final possibility remained that the absence of 
staining reflected the short incubation period of tissue and label (15 minute (live) and 30 minute 
(sections)). To study this, sections were labelled overnight with the J..L-cgtx -BODlPY. This increased 
the extent of non-specific binding by the BODlPY dye. Levels of stain increased at the fibre 
membranes and interiors, but NMJ staining did not increase. Short labelling-time was therefore not the 
cause. 
5.8 J..l-cgtx-BODIPY synthesis- summary. 
The spectroscopic data from the sephadex column implied that the J..L-cgtx GIIIB had been successfully 
coupled to the BODlPY flurophore, and the modified toxin separated from the free unmodified dye 
(dye alone eluting at a later time). However, the modified toxin failed to high1ight NaChs in teased live 
fibres and transverse muscle sections. NMJs were present in the tissue, as seen with the n-bgtx, but the 
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1..1-cgtx.-BODIPY was unable to bind strongly and specifically to junctional NaChs. The lack of probe-
NaCh binding resulted in insufficient photon counts for FPR analysis ofNaCh mobility in nonnal and 
dystrophic muscle. 
Discussion. 
5.9 Synthesis of fluorescent anti-adhalin antibody. 
The level of direct BODIPY signal from the modified anti-adhalin culture supematant was too low for 
successful application as an FPR probe. The immunohistochemical analysis suggests the lack of 
fluorescent signal obtained during FPR studies on adhalin protein mobility was due to insufficient 
fluorescent modification ofthe anti-adhalin antibody, but not due to loss ofadhalin-binding affinity 
during the modification. The lack of direct adhalin-BODIPY signal in tissues could arise because the 
anti-adhalin antibody was not modified at all, or because it was modified but not at sufficiently high 
levels. The presence of the fluorophore may compromise the ability of the antibody to recognise and 
bind the antigen, reducing the binding affinity of the modified antibody. If modified antibody is not 
present at high enough levels relative to unmodified, the unmodified antibody, with its greater binding 
affinity, will bind to adhalin molecules. Unmodified antibody will thus prevent binding of the 
fluorescent fonn and therefore prevent detectable fluorescence. It was not clear whether the adhalin 
antibody was inactivated completely by the modification process as the levels of modification were too 
low to tell. 
The column spinning purification process by itself was adequate for separation of free dye from 
antibody- levels of dye post-spin were significantly reduced compared to reaction mix levels, and from 
the immunohistochemistry results the spun fraction specifically recognised adhalin protein. Some free 
dye was carried through the column in the spin procedure. Given the 'sticky' nature ofBODIPY (both 
hydrophobicity- BODIPY bound with great affinity to eppendorftubes- and reactivity of the SE group), 
free dye would bind to surface residues on the muscle fibre. As adhalin distribution is even across the 
sarcolemma, it would be difficult to distinguish between adhalin signal and that from bound dye. 
However, as the autofluorescence from the tissue was of similar magnitude to the adhalin probe labelled 
tissue, the levels of free dye carried through in the spun culture supematant must not call for great 
concern. 
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5.9.1 Cross reactivity. 
From the uv visualised gel of modified antibody supematant it is clear that the antibody was not the 
only protein modified in the esterification reaction. The serum proteins have reacted with the 
fluorophore too. This will generate high levels of background signal from free modified proteins in the 
antibody labelling solution (though many of these unbound fluorescent proteins should be removed 
during the post-labelling washing of the tissue). In addition, and more significantly, reaction of the 
BODIPY -SE with proteins other than the IgG in the supematant, will titrate out the reactive BODIPY 
from the reaction mix- lowering the concentration ofBODIPY-SE available for esterification of the 
antibody. Boosting starting levels ofBODIPY-SE would increase the fmallevel of modified antibody. 
Difficulties may arise in separating the increased levels of free BODIPY dye from the antibody post-
reaction, but several extra column spinning steps should reduce this. Similarly, the levels of non-
specific protein modification would rise if the concentration ofBODIPY -SE were increased. 
Enrichment of the antibody fraction, e.g. with protein A beads, would reduce non-specific protein levels 
and hence the extent of BODIPY -SE titration from the reaction mix, although some antibody would be 
lost during the purification. 
5.9.2 Suitability of a monoclonal antibody as a DAG probe for FPR. 
The possibility remains that the lack of fluorescent signal reflected an inability of the fluorescently 
tagged probe to access the protein epitope on live fibres. The anti-adbalin antibody recognises an 
epitope in the extracellular domain of the protein. It is possible that the adhalin molecule is surrounded 
by ECM proteins when in situ on the muscle membrane. Bulky ECM matrices may block access of the 
antibody to the epitope and therefore prevent specific binding of probe to target molecule. If this were 
to be the case, smaller Fab' antibody fragments may be able to squeeze through the matrix and access 
the adhalin molecule where complete antibodies are hindered. Fluorescently modified Fab' antibody 
fragments have been used successfully to measure the mobility of GABA A receptors on the surface of 
cerebellar granule cells. In these cells the mobility of fluorescent Fab' labelled receptors was 
comparable to fluorescent ctrug fabelledreceptors (Peran et al, 1999, submitted). Fab' fragments are 
advantageous over full antibodies in that they are less susceptible to antibody- antibody cross linking. 
Additionally, they are smaller in size. The mass and bulk of an Fab' fragment is therefore less likely to 
slow diffusion of the receptor than the complete antibody molecule. 
The assertion that the adhalin molecules were inaccessible on live fibres conflicts with the tissue section 
observations. Ifadhalin was closely associated with other proteins around the antibody binding site, 
then the same should be true in sections (although the ECM would not form such a tight seal). The 
secondary antibody experiments revealed the epitope was accessible in sections. Given that identical 
concentration of labelled probe gave no fluorescent signal on the same sections, insufficient fluorescent 
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modification is more likely the cause of inadequate adhalin probe fluorescence than epitope 
inaccessibility. 
5.10 Synthesis of fluorescent NaCb marker. 
5.10.1 Effects of modification on biological activity. 
Whilst the NaCh probe has been synthesised, it appears to be biologically inactive. Perhaps this is not 
surprising given the small size of the toxin- just 22aa, 2640.2 mol.wt. The addition of a 350mol. wt. 
fluorophore will have a significant impact on the size, structure and behaviour of the peptide. In 
particular, the steric hindrance of the dye could restrict entry of the toxin to the binding site on the 
NaCh, or active site modification could prevent recognition altogether. The binding activity of ~-t­
conotoxins has been reported to be susceptible to modification. For the GIIIA fonn of the toxin, the 
replacement of amino acid residues with alanine affects activity as shown in the following table (Sato et 
a/, 1991). 
Residue modified--.Aia. Effect on EDso-
Arg 13 J.. 200 fold 
Arg 19 J.. 25 fold 
Lys 16 J.. 6 fold 
Hyp 17 J.. 6 fold 
Arg 1 J.. 5 fold 
Lys 11 J.. 4 fold 
Lys 8 J.. 2 fold 
Table 5.1 Effects of chemical modification on biological activity for ~-t-conotoxin GIIIA. 
Amino acid residues were chemically replaced with alanine during de novo synthesis of the synthetic 
toxin, and the effects on the ED50 values for rat diaphragm twitch contraction inhibition compared. 
(Adapted from Sato et a/, 1991.) 
No equivalent chemical modification study has yet been perfonned on 1-1-cgtx GIIIB. However, from 
sequence comparisons and the 3 dimensional structure of the Gllffi molecule, the critical residues for 
receptor interaction are believed to be Arg l3, Lys 16, Hyp 17 and Arg 19, whilst Arg 8 and Lys 9 are 
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proposed to make the first lose interaction with the NaCh. Had either BODIPY- modified Lys 16 or 
Lys 9 been major products of the fluorescent coupling reaction, the biological activity of the fluorescent 
toxin would be severely compromised. 
5.1 0.2 Purification of modified toxins. 
The sephadex column purification method employed is unable to resolve the different modified toxin 
isoforms. Consequently, active fluorescent species could not be separated from inactive ones. During 
muscle labelling, non-specific binding of inactive isoforms could override the signal from active toxin, 
preventing visualisation of the NMJs. Likewise, unmodified toxin carried through from the column will 
compete with modified toxin for the NaCh binding site. If, as postulated, modified toxin binds with 
lesser affinity, the unmodified toxin will occupy the receptors and block access by the fluorescent 
forms. 
HPLC remains theoretically the best prospect for resolution and separation of the different modified 
isoforms. Had more time and the equipment been available, the use of the cyano-column could have 
been pursued further for BODIPY resolution. Alternatively, carboxytetramethylrhodamine-
succinimidyl ester modification could have been tried, with Cl8 reverse-phase columns to separate the 
extra modified isoforms. On the other hand, if toxin modification results in lack ofNaCh recognition 
(regardless of the fluorophore), HPLC resolution of the isoforms will merely give rise to several 
inactive products rather than one inactive mixture. 
The uniform green staining along the lengths of live fibres is most probably caused by residual 
BODIPY dye carried through with the toxin during column purification. Any unhydrolysed BODIPY-
SE will cross react with amino groups of molecules on the surface of the muscle fibre. However, cross 
reacting ester is unlikely to be the major cause of the staining. The succinimidyl ester is highly reactive. 
It would be expected that ester groups which didn't react with lysine residues would have been 
hydrolysed by water- catalysed by the alkaline environment of the NaHC03 buffer. As has been stated 
above, ·aUDIPY ·is eXtremely hydrophobic. Free dye-from.tlie reaction miXti.ife could mtercalate in to 
the hydrophobic lipid bilayer and colour the membrane green. Thermodynamically, this membrane 
solubilisation of the dye is favourable to remaining free in aqueous solution. It is therefore most likely 
that free hydrolysed BODIPY dye is the source of the live membrane staining. 
Similarly, the specific bright green staining of nerves and blood vessels in muscle sections is probably a 
result of hydrophobic free hydrolysed BODIPY dye incorporating into the lipid rich domains of the 
tissue. 
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5.11 Implications for further studies. 
The aim ofthese experiments was to generate fluorescent probes for monitoring the mobility of specific 
classes of membrane proteins in the presence and absence of dystrophin. The hydrophobic nature of the 
novel BODIPY fluorophore enforced changes to the traditional modification protocols, but in both the 
case of the anti-adhalin antibody and the f.!-conotoxin, the probes appeared to have been synthesised by 
reacting with the novel fluorophore BODIPY -SE. Unfortunately, neither probe proved effective once 
placed on the tissue. 
Levels of modification were too low to tell whether the adhalin antibody was inactivated by the 
modification process and therefore whether the antibody is still a potential marker of adhalin on live 
muscle tissue. Purification of the IgG fraction prior to modification may lead to better labelling. These 
experiments have not shown direct need for Fah' fragments thus far, but papain digestion of the 
antibodies may yet be important if a fluorescent antibody proves unable to break through the ECM or 
hinders protein diffusion with its large size. 
5.12 Dystrophin as a direct anchor of membrane proteins. 
The overwhelming technical difficulties of this study have left unanswered the question of how 
dystrophin contributes directly to organisation of the muscle fibre membrane through specific 
associations with membrane proteins. lfadhalin is inaccessible to antibodies in Jive fibres, the 
modification and membrane labelling techniques used here can be applied to antibodies directed against 
other extracellular members of the DAG complex so that the contribution of dystrophin to DAG 
anchoring may still be studied. 
As it appears fluorescent modification offi·Conotoxin renders the toxin inactive, the problem ofhow to 
study the mobility ofNaChs on the surface of muscle fibres persists. Previous reports have described 
the successful fluorescent modification oftetrododoxin (TTX), saxitoxin (STX),and Toxin V from 
Leiurus quinquiestriatus (Lqq V) (e.g. Joe and Angelides, 1993) all ofwhich bind NaChs in both 
muscles and nerves. (5) and (6) carboxytetramethylrhodamine coupled Toxin V from Leiurus 
quinquiestriatus (TmRhd-Lqq V) was used successfully to illustrate by FPR the immobilisation of 
NaChs on muscle fibres upon innervation (Angelides, 1986). Whilst the use of a muscle-specific fi· 
conotoxin is preferable, fluorescent Lqq V, TTX or STX could be used to measure the mobility of 
muscle NaChs. The use of epi-fluorescence illumination prior to photobleach should ensure muscle 
rather than neuronal NaChs are aligned under the bleach spot. 
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Discussion. 
6.1 Aims. 
The experiments in this thesis addressed the notion that dystrophin, with its structural and sequence 
homology to cytoskeletal proteins, imparted structural integrity and mechanical strength to muscle 
membranes by acting as a either a specific linker ofDAGINMJ membrane proteins and/or as a 
constituent of the membrane skeleton fence in accordance with the "membrane skeleton fence model" 
(Kusumi et a/, 1993, Simson et a/, 1998). This model proposed 'the membrane associated cytoskeleton 
(membrane skeleton) provides a barrier to free diffusion of membrane proteins due to steric hindrance, 
thus compartmentalising the membrane into many small domains for diffusion of membrane proteins' 
(Kusumi et al, 1993). 
It has been demonstrated by FPR that there is little appreciable difference in the mobility of 
sarcolemmal glycoproteins in the dystrophic and normal muscle tissue of the experimental system. 
Both glycoproteins and lipids were immobile in the membranes studied. Unfortunately, due to the 
potential non-viability of the photobleached fibres shown by lipid immobility and vital staining, care 
must be taken in interpreting the data. 
6.2 Suitability and limitations of the FPR approach. 
FPR remains a suitable method for testing the hypothesis that dystrophin organises and stabilises 
membranes, as it allows real-time analysis of membrane tluid_ity on a micrometer scale. There are 
however, serious limitations with the experiments. 
6.2.1 Fluorescent labels 
Firstly the FPR technique is only as good as the fluorescent label. The ratio of mobile to immobile 
species measured is greatly affected by the strength of specific label signal compared with non-
specifically bound label, background room light levels and tissue/ dish /culture media autofluorescence. 
If the specific signal is too small, low level mobility of labelled molecules will be lost amongst the 
background (which will not recover after bleaching). When monitoring the direct effects of dystrophin 
135 
Chapter 6 Discussion 
mobility on specific classes of membrane proteins, it was proven that the specific membrane protein 
probes had been synthesised (figures 5.4, 5.6, 5.8). However, due to either loss of biological activity 
during modification, or high levels of reactants carried through to the labelling mixture, the specific 
level of fluorescence signal was too low to facilitate the FPR measurements. 
lfthe labels bind outside the desired region e.g. to the ECM instead ofthe membrane, or if access ofthe 
label to the target site is blocked, mobility characteristics of an undesired region will be measured and 
the data misinterpreted. As discussed earlier, the equipment cannot finely resolve the plane of 
photobleach as the focal plane alignment of the laser beam was not identical to that seen by phase 
microscopy. The plane of highest photon counts was taken as that of the labelled membrane surface, 
but measuring of extracellular matrix cannot be ruled out. Electrostatically bound probes can be 
differentiated from specifically bound probes in terms of behaviour- often with minimal recovery- but if 
the expected behaviour is unknown confusion can result. 
Similarly, photostability of the label influences the magnitude of measured recovery. Fluorescein is 
susceptible to photolysis. During pre-bleach this is seen as falling photon counts. Bleaching during the 
recovery phase masks the full extent of recovery and hence mobile fraction. In the light of the 
immobility of the FITC conjugated Iectins and the improved photostability ofODAF and BODIPY, this 
shouldn't have affected this study adversely. 
6.2.2 Limitations imposed by the FPR apparatus. 
FPR results and the sensitivity of measurement are influenced by the FPR apparatus in addition to the 
membrane label. Limitations are found with the photomultiplier tube (PMT) aperture, beam alignment 
and the size of the bleach spot. Ifthe aperture on the PMT is set too large, photons from tissue regions 
outside the bleach spot and room levels will form the bulk of the photon counts, drowning out specific 
signals from recovering tissue and giving the impression of immobility. The alignment ofthe incoming 
monitoring beam, bleach beam and emitted fluorescence must be checked at each experimental run. 
Misalignment results in non-spherical bleach spots and/or failure to measure recovery across the whole 
bleached area. Consequently the recovery produced is non-gaussian so fails to fit the diffusion 
equations. 
Bleach spot size is important when data is interpreted as 'immobile'. The FPR definition of immobile 
is o::::;I0-12cm2s-1, defmed by the sensitivity ofthe monitoring apparatus. This definition does not allow 
for domain size. Fluorescent molecules may be freely diffusing within a domain smaller than the size of 
the bleach spot. In this case the FPR interpretation will always be one of immobility, even though the 
molecules are unrestricted in their motion (Yechiel and Edidin, 1991, Edidin, 1993). Likewise, if the 
bleach spot overlaps two adjacent small domains the extent of recovery will be dependent upon the 
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proportion of each domain within the spot. This phenomenon was explored by Edidin and Stroynowski 
( 1991) who were able to define membrane domains on the scale of micrometers following the observed 
relationship between increasing bleach spot size and decreasing percentage fluorescence recovery. A 
truer indication of diffusion domain scale, especially where domains are small would come from the 
alternative method of single particle tracking. 
The 25ms dead time between bleaching and monitoring fluorescence recovery is significant, especially 
for lipid studies. Where recovery is rapid the dead time can cause problems, particularly as the curve 
fitting equations weight the initial recovery points more heavily. If the first stages of recovery are 
missed the fibre is interpreted as having bleached insufficiently and the software will not analyse the 
curve. 
Whilst FPR data is often given as definitive, it is subject to personal interpretation. The decision to 
include a recovery curve in the final analysis or not for example is based upon experience rather than 
clear guidelines. In this study, data with x2 for curve fitting :s;1x104 was included whilst the rest was 
discounted. The visual interpretation of fibre movement was usually confirmed by high x2 values. 
6.2.3 Experimental tissue. 
Finally, no matter how good the FPR technique or data interpretation the tissue must be viable. 
Modification of the tissue buffers or setting up a culture fibre system was not possible here due to time 
limitations. F'titure experiments should bear these fmdings in mind and include a suitable test to 
monitor fibre integrity. The ODAF FPR experiment is a simple way to test the general system, though 
for muscle it does not allow clear visual distinction between live and dead fibres. Indications of 
viability timescale would then have to be extrapolated to other fluorescent labels. 
6.3 Dystrophin as a regulator of membrane protein lateral mobility. 
Sadly, the numerous technical problems encountered during this work prevented quantification of the 
capacity ofdystrophin to organise components ofthe muscle fibre membrane and set up subcellular 
domains. 
6.3.1 The potential for dystropbin to form and reinforce molecular fences. 
The FPR experiments presented in chapter 4 found no significant difference in glycoprotein and lipid 
mobility in mdx and normal muscle tissue. Were the data to be a true representation of muscle 
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membrane dynamics, the glycoprotein immobility in both the presence and absence of dystrophin could 
suggest that dystrophin is not vital for the setting up of sarcolemmal membrane domains or the 
restriction of sarcolemmal glycoprotein diffusion. This observation does not unequivocally rule out a 
fencing action of dystrophin when present in healthy tissue. The high levels of redundancy in the 
cytoskeletal and ECM systems may compensate for dystrophin loss of function with respect to 
restriction of protein mobility. Immunohistochemistry of the mdx fibres showed the underlying spectrin 
network to be present and apparently intact within dystrophic tissue (figure 4.2). Spectrin could 
therefore have restricted protein mobility in these experiments. It is possible that dystrophin may 
complement the existing cytoskeletal network in healthy fibres. Although it would have been possible 
to add cytochalasin or brefeldin A to the fibres to remove the spectrin cytoskeleton and therefore 
measure dystrophin directly, their dramatic effects on protein mobility are wen documented (e.g. Sako 
and Kusumi, 1994) and the dystrophin network may also have been be disrupted. 
Extra rigidity wi11 be imparted to the cytoskeletal network in the presence of dystrophin, through a more 
dense, more highly cross linked array of proteins. Given the proximity of dystrophin to the 
sarcolemmal membrane and the sizes of the dystrophin molecule and DAG complex, it is likely that 
dystrophin will form a steric barrier to the diffusion of some membrane species. All these actions 
would reinforce an existing cytoskeletal system, but due to the presence of the remaining cytoskeleton, 
would not necessarily give rise to an altered mobility phenotype if the dystrophin reinforcement were 
removed. If significant, the results do suggest that a membrane fence role is not a primary function of 
skeletal muscle dystrophin. 
On the other hand, the immobility of membrane glycoproteins and lipids can be interpreted as a sign of 
a non-viable experimental system. In this case it is premature to draw major conclusions from the 
immobile glycoprotein and lipid phases in the dystrophic and normal fibres. Further study on viable 
fibres may reveal that the original hypothesis stands and dystrophin may yet contribute significantly to 
the regulation and organisation of membrane proteins into defined functional domains. 
6:3~2 Support for the molecular fence hypothesis. 
Parallel studies using either completely alternative methods or variations on the FPR technique suggest 
there may be some truth in the molecular fence hypothesis, or at least that there's a measurable change 
in membrane conformation or fluidity when dystrophin is absent. 
Cultured rat and mouse myotubes expressing an anti-sense dystrophin construct have significantly faster 
mobility of Con A receptors on the myotube surface than normal myotubes as measured by FPR. The 
proportion ofmobile receptors seemed unchanged (Zs-Nagy et al, 1995). Whilst there were many 
errors in the design of this experiment (small size of data samples, inclusion of data from twitching 
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myotubes and unusually small margins of error), the results do suggest a barrier to rapid diffusion could 
be missing in dystrophic fibres and therefore dystrophin could be restricting protein mobility. 
Similarly, membrane phospholipids show altered mobility in DMD compared to normal tissue when 
measured by 13C NMR. In normal healthy muscle tissue, 15-23.2% ofphospholipids appeared mobile, 
compared with 43.2-81.3% in Duchenne dystrophy patients (Barany and Venkatasubramanian, 1988). 
Both observations are consistent with increased membrane fluidity in the absence of dystrophin. 
Whether this is indicative of a molecular fence, and whether this is a specific and essential function 
remains open to interpretation- proteins diffused faster when dystrophin expression was knocked out, so 
a restriction upon diffusion was undoubtedly removed. Dystrophin could be a submembranous barrier, 
holding up the passage of diffusing molecules. In this case the micro (sub domain) scale rate of 
diffusion would have been approximately constant in the presence or absence of dystrophin and the 
FPR measured rate of macro-scale diffusion would be expected to increase after knockout (assuming 
the detected non-mobile fraction were not completely anchored to other membrane skeleton 
components. If this were to be the case, removal of dystrophin barriers would not affect tethering and 
therefore would not increase mobile fraction). A completely impermeable dystrophin barrier does not 
perfectly fit the observations- in this case the mobile fraction might have increased in dystrophic cells 
(as diffusion domain size relative to size of bleach spot would be no longer limiting}, but the mobile 
fraction did not increase. Instead, it seems proteins may become momentarily tangled up in the 
dystrophin network, but then be free to diffuse away in any direction. 
6.3.3 The potential for dystrophin to organise/anchor specific membrane proteins. 
The fluorescent probes synthesised to study mobility of specific membrane proteins were inactive, 
leaving the ability of dystrophin to regulate organisation and lateral mobility of specific membrane 
proteins open to question. 
6.3.3 a) Dystropbin as a regulator of DAG complex mobility. 
The association between dystrophin and the DAG complex is now well established, but the function of 
the complex remains unclear. Localisation of the subsarcolemmal domain of the dystrophin protein and 
the DAG complex to the membrane is insufficient for full function. Transgenic mdx mice expressing a 
cysteine rich and C-terminal domain construct of dystrophin have localisation of the DAG complex 
restored, but their dystrophic phenotype remains (Greenberg et al, 1994). Localisation ofthe large 
DAG complex to the plasmalemma in these cases may be sufficient to hinder mobility of some inter and 
trans- membrane proteins. However, the inevitable restrictions on diffusion imposed by the physical 
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bulk of dystrophin and the DAG complex are insufficient to override the dystrophic phenotype without 
the remainder of the dystrophin molecule. In this transgenic system and in dystrophic tissue the DAG 
could be anchored by the ECM. Successful formation of an active fluorescent DAG marker could 
illustrate by FPR whether the DAG complex is actually tethered, and hence if direct anchoring of the 
DAG is an essential functional requirement for dystrophin. 
6.3.3 b) Dystropbin as an organiser oftbe NMJ. 
The study into the role of dystrophin in regulating NaChs at the NMJ was based upon the eo-
localisation of dystrophin and NaChs, the homology of dystrophin to spectrin and the role of spectrins 
in anchoring NaChs in the nervous system. 
During the course of these experiments reports have been published which cast doubt on an exact 
dystrophin!NaCh relationship. Wood and Slater (1998) used observational and quantitative 
immunofluorescence of muscle sections and en-face NMJs to show that there were fine differences in 
the patteming of dystrophin and NaChs, particularly in the peri-junctional region. The concentration 
and distribution of P-spectrin and ankyrin 0 on the other hand showed direct parallels to NaChs. They 
proposed that an ankyrin 0 I p-spectrin latticework could be essential for NaCh immobilisation-
providing a universal ankyrin/spectrin mechanism for ion channel localisation across all excitable cells 
[c.f. ankyrinlspectrin in brain/CNS- Sirinivisan et a/, 1988, Joe and Angelides, 1992]. 
If dystrophin is not binding NaChs, as these observations suggested, its function at the NMJ is unclear. 
Dystrophin is not essential for formation of the folds, though it may stabilise them (Lyons and Slater, 
1991) nor for correct localisation ofthe NaChs (mdx mice possess correctly distributed NaChs (Wood 
and Slater, 1998)). Perhaps the function lies with the junctional DAGs, especially since the ECM at the 
NMJ is highly specialised. p-dystroglycan colocalises with AChR and utrophin throughout 
development of the NMJ and with dystrophin at the mature junction (Be wick et a/, 1996). Given that 
the AChR clustering protein rapsyn eo-associates with P-dystroglycan (Cohen et a/, 1995), it has been 
proposed that the P-dystroglycan serves to stabilise the ion channel clusters. In the absence of 
dystrophin the levels ofutrophin could be such that utrophin!P-dystroglycan can compensate for a lack 
of dystrophin and mask dystrophin 's true function. If utrophin can compensate for dystrophin 
deficiency, FPR offluorescently tagged DAGs should reveal little difference in mobility at the NMJ. If 
utrophin is truly responsible for this anchoring and lack of dystrophic phenotype, mobility 
measurements away from the NMJ should show a difference in mdx mice- as utrophin expression is too 
low outside the NMJ to compensate for dystrophin absence. Then again, neuromuscular transmission is 
unaffected by dystrophin deficiency, so perhaps the presence of dystrophin at NMJs is just evolutionary 
redundancy. 
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6.4 The extracellular matrix and membrane protein diffusion. 
The extracellular matrix remained attached to the muscle fibres throughout the photobleach 
experiments. The capacity of this highly crosslinked latticework to restrict the motion of membrane 
proteins has not been fully elucidated, but must not be overlooked in this particular system. The DAG 
complex has been shown to bind the extracellular matrix protein merosin (Ervatsi, and Campbell, 
1993). A fully functional dystrophin-actin contractile network- DAG link is not necessary for complex 
formation, and the DAG complex is fully restored by a dystrophin C-terminal construct (Rafael et a/, 
1996). Although down regulated, the DAG proteins are still free to form a multimolecular assembly in 
the absence of dystrophin, and associate with merosin through a-dystroglycan. Such highly specific 
associations must serve to restrict the lateral motion of complexed proteins. Furthermore, a 
consequence of the specific anchoring of large protein complexes to regions of the plasma membrane 
by the ECM is a steric restriction upon the mobility of neighbouring membrane components. Mutations 
within the extracellular macromolecular complexes that serve to anchor cells to the basal lamina 
continue to be identified as causative in both muscular dystrophies (for example a7 integrin chain in 
congenital myopathy) andjunctional epidermolysis bullosa (a6 integrin chain) (reviewed in Gorski and 
Olsen, 1998). This must indicate that the role of intracellular and sarcolemmal proteins in maintaining 
the structural integrity of muscle fibres is only half the story, the extracellular matrix plays an equally 
important part. 
6.5 Dystrophin, lipid domains and tight junctions. 
Perhaps the organisational role of dystrophin and it's associated proteins will lie in setting up lipid 
domains, rather than directly influencing membrane proteins. The increased lipid fluidity in dystrophic 
fibres could account directly for the increased rates of protein diffusion seen by FPR - it would be 
interesting to see if the results ofODAF FPR mobility comparisons in live normal and mdx muscle 
fibres agree with the NMR data. Formation of cholesterol rich domains and/or regions high in charged 
phospholipid will influence localised viscosity and mobility within those domains, compared to 
diffusion over a homogeneous surface. Evidence is mounting for the role of cytoskeletal proteins in 
lipid domain delineation. Returning to the spermatozoon, the membrane lipid domains of these cells 
are determined by specialised structures such as the posterior ring between the head and mid-piece, and 
annulus between midpiece and principle piece (reviewed in Ladha et a/, 1997). The posterior ring and 
annulus appear as electron dense regions within and below the lipid bilayer. They are thought to be 
analogous to tight junctions- whose capacity to prevent diffusion of proteins and lipids between the 
apical and basolateral surface of epithelial cells is well accepted. 
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Drawing further comparisons between the muscle cell and the spermatozoon, formation of the tight-
junction like boundaries in the sperm cell is developmentally regulated, with greater restrictions 
imposed as the sperm matures (James et a/, 1999). Diffusion of Con A receptors within muscle fibre 
membranes is also temporally regulated, with larger mobility restrictions in mature myofibres than 
immature myotubes (Zs-Nagy et a/, 1995), 
Personally, I favour the suggestion that the major role of dystrophin and its associated glycoproteins 
may be formation of similar tight-junctional (or adherens junctional) like complexes in the membrane 
(possibly within close contacts) (Michalak and Opas, 1997). In epithelial cells the tight and adherens 
junctions are essential for maintaining tissue integrity. Loss ofplectrin from the hemidesmosome 
plaque, for example results in epidermolysis bullosa of the skin and an associated muscular dystrophy 
(Smith et a/, 1996). In Duchenne muscular dystrophy, the connections through the intermediate basal 
lamina are lost between adjacent muscle fibres. In DMD applied external abrasions do not provide the 
disruptive force between cells. Instead, muscle contractions pull upon the fibres. Consequently, 
contractile shear stress disrupts the intercellular connections within the tissue and leads clinically to the 
observed muscle degeneration. Such a model is reliant upon a fully functioning junctional complex, not 
just on any individual molecule. It can therefore be seen how mutations in any constituent of the DAG 
complex can give rise to a diseased phenotype- with disease severity dependent upon a proteins 
significance within the junction. 
As in epithelial cells and spermatozoa, the tight-junction like dystrophin complex may serve to 
delineate functional membrane domains. In excitable cells of the muscles and nervous system, this 
domain demarcation may be essential for function. Although neither dystrophin nor utrophin are 
essential for formation of specialised structures like NMJs, the junctional complex may help retain ion 
channels and receptors at the site of neurotransmitter release- and just as importantly, prevent dilution 
of receptors at the site by restricting inward diffusion of extrajunctional species into the area. The 
ability of tight junctions to hold two cells closely together would have structural importance at the 
synapse and NMJ, where close cell-cell proximity is essential for function. (Perhaps whilst rapsyn is 
essential for localisation of AChRs, it is utrophin that pulls the motor neuron and muscle together at the 
NMJ). Similarly, this structural element ofTh--edystfopnllt!DAG complex-and-the basa:namma 
associations could give 3 dimensional stability to junctional folds. The presence of dystrophin outside 
the region of voltage gated sodium channels at the NMJ may therefore provide a rigid boundary around 
the junctional domain of the muscle membrane. 
Such speculation can only be confirmed through further experimentation, for example to ask are NaChs 
fixed at the neuromuscular junction, or are extrajunctional channels able to diffuse into the postsynaptic 
folds? Despite its limitations and the inherent difficulties in probe synthesis, FPR remains one of the 
best methods available to address this type of question. 
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6.6 Consequences of this study for proposed functions of dystrophin. 
During the timescale of this PhD study, many papers have been produced investigating the roles of 
dystrophin and it's associated proteins. However, despite knowing dystrophin's sequence, seeing the 
clinical consequences of dystrophin protein deficiency, predicting regions of protein structure, and 
finding further associated proteins, the question still remains unanswered- what is dystrophin doing? 
It seems that knowledge of protein-protein interactions and of further members of the DAG continues to 
grow, but the true functional significance of that knowledge remains elusive. 
Whether dystrophin is or is not an essential molecular fence constituent, the results presented here do 
not negate any of the models of dystrophin function proposed so far. Of these models, the notion of 
dystrophin as a molecular 'shock absorber' is still the favoured role- modulating contractile shear stress 
in muscle fibres through the actin contractile fibre/dystrophin!DAGIECM link (Petrof et a/, 1993). 
6. 7 DMD- future prospects and directions. 
In contrast to the continuing ambiguity over dystrophin's true function, considerable progress has been 
made recently towards a possible therapeutic strategy for DMD. Satellite cell transplantation into mdx 
muscle (e.g. Beauchamp et al, 1999) results in the order of500 new myonuclei generated from each 
transplanted stem cell nucleus. Transplantation of single myofibres containing around 7 myonuclei can 
potentially give rise to around 3,000 new fibres. These dystrophin positive fibres remain in the 
transplanted tissue over several months (T. Partridge, 1999). These results are encouraging, though for 
now the physical logistics of transplanting myoblasts into every skeletal muscle in the body limits the 
capabilities of the technique. 
A more promising therapeutic area is upregulation of the dystrophin related protein utrophin. 
Upregulation ofutrophin expression in transgenic mdx mice has been demonstrated to ameliorate the 
dystrophic phenotype (Tinsley et a/, 1996). DMD/BMD patients possess a fully functional utrophin 
gene. If this gene can be induced to overexpress utrophin protein, it could compensate for dystrophin 
deficiency- though the technology needed to do this is still some way off. Similarly, the discovery of 
naturally occurring revertant dystrophin positive fibres in DMD patients and mdx mice could be a 
starting point for future therapies. Hopefully during the coming years the puzzle ofdystrophin's 
function and with it the problem of how to effectively compensate for its absence will be solved. 
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6.8 Summary. 
The aim of this study was to investigate the ability of dystrophin to stabilise the muscle fibre membrane 
and set up subcellular membrane domains by regulating the distribution and diffusion of membrane 
components. 
The pathology of DMD indicates that muscle fibre membrane integrity is compromised by a lack of 
dystrophin protein. Membrane prostaglandin metabolism, for example, is dramatically influenced by 
perturbations in the membrane, and is found to be impaired in DMD (reviewed in Jackson, 1993). 
Dystrophin, with structural and spatial similarities to spectrin, could stabilise the membrane by acting 
non specifically as a cytoskeletal 'molecular fence'- a steric barrier to membrane protein diffusion- or 
alternatively by binding specifically to membrane proteins and restricting them to specialised membrane 
domains. 
Whilst direct linkages between dystrophin and its associated glycoprotein complex had been identified; 
and eo-localisation of dystrophin and voltage gated muscle NaChs had been observed, no study had 
tested whether dystrophin regulates the distribution of these proteins on the cell surface. This study 
therefore set out to quantity the restraints on lateral mobility of non-specific membrane glycoproteins 
and specific DAGINMJ proteins imposed by dystrophin. 
During the course of the mobility experiments it was shown that the presence of dystrophin was not the 
main influence upon mobility of glycoproteins and lipids within the membranes. Unfortunately, due to 
the many technical problems encountered during the work, the precise nature of dystrophin's 
interactions with membrane proteins could not be quantified. Difficulties with tissue labelling, FPR 
data acquisition and/or tissue viability prevented measurement of the molecular fence contribution of 
dystrophin. Similarly, traditional methods to produce fluorescent markers to specific membrane protein 
proved unsuitable in this instance. The role of dystrophin in restricting mobility of DAG complex 
proteins and sodium channels therefore remains open to question. 
The unfortunate technical problems encountered during this work should not spell the end of 
investigations into dystrophin's contribution to the regulation of membrane protein diffusion. 
Regulation of membrane structure is a universal feature of eukaryotic cells. It is worthy of note that 
dystrophin protein expression is not restricted to muscle tissue. lsoforms of dystrophin are expressed 
throughout the body, particularly in excitable cells. Additionally, dystrophin is highly conserved across 
species. The universality of dystrophin expression may lend support to a general role for the dystrophin 
isoforms as organisers of cell membranes. 
Three polyclonal antibodies to dystrophin peptides were produced in this study. These are effective 
dystrophin markers in a range of species. They have been distributed to other Muscular Dystrophy 
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Group funded projects so that research into the role of dystrophin and its associated proteins may 
continue. 
In conclusion, whilst dystrophin has been shown to be essential for stabilising the muscle cell 
membrane and imparting mechanical strength, the influence of dystrophin upon membrane fluidity and 
protein diffusion remains speculative. Further experimentation to produce a viable muscle fibre system 
is necessary before FPR experiments can properly address the issues of dystrophin, molecular fences 
and protein tethering. 
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FPR recovery data. 
Pooled sets of data from individual FPR recovery curves. 
'Removed' refers to the time passed between removal of the tissue from the animal and acquisition of 
the photobleach recovery curve was obtained. 'Pre cps' is the level of photon counts in counts per 
second from the tissue prior to photobleaching. '%bleach' gives the extent of fluorescence bleaching 
each time, relative to normalised pre-bleach levels. '%recovery' (f), ' tl /2' (T0 ) , the halftime for 
diffusion and ' Diff. Coefr , the diffusion coefficient were all determined from the diffusion equation, DL 
= w'1 /4To. 
Data from individual experiments was pooled for analysis according to fluorescent label and tissue 
type. Sets of curves were analysed to determine the mean, standard deviation and standard error of the 
mean using Microsoft Excel for Windows 95, version 7. Individual curves were preselected for quality 
of fit to the diffusion equation, before inclusion in the analysis tables (curve x2 < 104 ) . The date of 
each experiment is given. 
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lensmdx 
mdxmale Removed pre cps o/o bleach %recover) t 1/2 (sec) Dlff. Coeff.-
Treatment: E-1 0 cm2/sec 
Lens Culinaris 
5.8,97 low X2. 50 min 2566 52 5 1.9 8.64E-10 
n=36. 55 min 2743 53 9 1.1 1.40E-09 
1hr 5 8260 48 9 2.6 6.20E-10 
1hr 5 4366 62 1 4.8 3.53E-10 
1hr 10 3975 58 4 2.4 6.80E-10 
1hr 15 4640 58 9 5.7 2.80E-10 
1hr 15 4827 58 12 0.4 3.90E-09 
22.7.97 50 min 2630 68 6 2 8.10E-10 
1hr 3139 58 10 2.6 6.10E-10 
1hr 4147 74 8 1.2 1.29E-09 
1hr 5 4087 56 8 0.9 1.78E-09 
1hr 5 4344 59 6 2 8.04E-10 
1hr10 4553 58 6 1.7 9.30E-10 
1hr20 4564 65 7 2.8 5.70E-10 
1hr20 4635 61 6 3.6 4.40E-10 
21.7.97 50 min 2789 60 12 2.7 6.00E-10 
50 min 3101 66 8 2.7 5.90E-10 
55 min 4226 67 9 2.3 6.90E-10 
55 min 4366 67 8 4.1 3.90E-10 
55 min 4881 62 10 4.2 3.80E-10 
55 min 3567 60 9 4.9 3.3QE-10 
1hr 5 4163 77 6 1 1.60E-10 
1hr 10 4691 65 10 6.2 2.60E-10 
1hr10 3903 69 9 3.3 4.80E-10 
1hr 15 2039 59 11 3.5 4.50E-10 
29.7.97 1hr 6218 60 7 1.7 9.30E-10 
1hr 5 4010 65 3 2 7.96E-10 
7.8.97 55 min 2008 63 10 2.9 5.60E-10 
1hr 5 4446 53 2 5.2 3.10E-10 
1hr40 2730 65 7 3.2 4.96E-10 
19.1.99 am 1hr 2483 72 6 0.9 1.80E-09 
1hr 5 2763 72 5 0.8 1.90E-09 
1hr 5 2684 82 8 3.2 5.10E-10 
1hr 15 4020 66 11 4.3 3.80E-10 
1hr 10 2004 73 8 0.5 3.30E-09 
1hr10 1973 67 12 1.7 9.30E-10 
Mean 3792.806 63.27778 7.694444 2.694444 8.77E-10 
Standard Deviation. 1280.601 7.300141 2.702585 1.504079 8.01E-10 
Standard error of mean. 981.838 5.79321 2.134259 1.194136 5.22E-10 
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C57BI 6 months old. Removed pre cps % bleach %recover) t 1/2 (sec) Dlff. Coeff.-
Treatment: E-10 cm2/sec 
Lens Culinarls 
19.1.98 (pm) 45min 9560 64 10 4.4 3.67E-10 
n=28 50min 6701 73 8 4.9 3.25E-10 
50 min 16744 71 7 2.3 6.84E-10 
55 min 3769 70 11 3.8 4.17E-10 
55min 6219 80 7 7.4 2.17E-10 
1hr 5520 78 8 6.5 2.47E-10 
1hr 6395 77 7 5.4 2.96E-10 
1hr 12097 87 5 2.9 5.50E-10 
1hr 5 10595 84 6 3 5.35E-10 
1hr 5 4626 78 9 5.9 2.69E-10 
1hr 10 4515 76 9 5.5 2.92E-10 
1hr 10 6357 81 8 5.1 3.17E-10 
1hr 15 4977 79 10 4.9 3.29E-10 
1hr 15 5380 80 8 4.6 3.50E-10 
1hr 15 6259 77 11 6.2 2.60E-10 
1hr 20 8008 82 7 4.5 3.53E-10 
1hr20 8572 80 8 3.2 5.07E-10 
19.1.99pm 40min 962 58 10 1.1 1.44E-09 
45min 2052 79 8 4.1 3.90E-10 
45min 2229 78 6 1.2 1.40E-09 
50 min 2865 76 5 0.4 4.00E-09 
50 min 3251 73 10 2 7.90E-10 
1hr 6369 60 9 0.3 5.90E-09 
1hr 5 1421 69 13 7.2 2.20E-10 
1hr 5 1317 74 10 2.2 7.10E-10 
1hr 10 4096 82 4 0.2 6.77E-09 
1hr 15 1648 75 5 1.2 1.35E-09 
1hr 20 859 60 8 5.9 2.70E-10 
Mean. 5477.25 75.03571 8.107143 3.796429 1.06E-09 
Standard Deviation. 3679.849 7.325663 2.114137 2.151396 1.67E-09 
Standard error of mean. 2727.982 5.59949 1.630102 1.82551 1.04E-09 
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mdx male 8 months old. Removed pre cps % bleach %recover') t 1/2 (sec) Dlff. Coeff .• 
Treatment: E-1 0 cm2/sec 
SconA 
14.7.97 50 min 7971 79 a 3.4 4.69E-10 
55 min a761 73 11 11 1.40E-10 
n= 3a 1hr 5592 77 10 11 1.39E-10 
1hr 11261 76 7 6.3 2.54E-10 
1hr 5 9546 77 a a.7 1.84E-10 
1hr10 5627 76 11 6.5 2.45E-10 
1hr 15 a037 73 9 5.2 3.0aE-10 
1hr15 9a35 70 9 7 2.30E-10 
1hr20 3432 64 11 3.a 4.26E-10 
1hr20 5376 70 10 4.3 3.74E-10 
1hr 25 14522 61 12 4.5 3.50E-10 
1hr 30 421a 73 9 2.1 7.70E-10 
1hr 30 6347 70 a 1.9 a.61E-10 
1hr 35 9707 72 a 2.7 5.90E-10 
1hr 35 9621 73 6 1.1 1.47E-09 
12.06.98 55 min 2a04 65 14 4.a 3.30E-10 
55 min 3177 71 9 2.2 7.20E-10 
1hr 2696 65 6 1.9 a.60E-10 
1hr 5 635a 77 7 2.7 5.90E-10 
1hr10 4069 77 a 2.9 5.50E-10 
1hr 10 2725 72 11 3 5.30E-10 
1hr15 3494 61 15 5.6 2.90E-10 
1hr 20 4aao 60 13 4.1 3.90E-10 
1hr 20 4207 76 a 1 1.50E-09 
1hr 25 3255 73 10 4.1 3.90E-10 
1hr 25 2a9a 66 11 6.3 2.60E-10 
1hr 25 3261 71 a 1.3 1.20E-09 
1hr30 23ao 57 13 2.3 7.10E-10 
1hr 30 4659 79 a 2.2 7.20E-10 
1hr40 3769 77 10 3.a 4.20E-10 
1hr40 4064 70 a 3.2 5.00E-10 
7.1.98 40 min 1561 63 7 1.9 a.20E-10 
55 min 50a2 72 5 3.a 4.20E-10 
1hr 3796 66 9 7.3 2.20E-10 
1hr 5 2184 64 a 6.2 2.60E-10 
1hr 5 1640 66 a 6.4 2.50E-10 
1hr 10 2176 71 7 1 1.57E-09 
1hr 15 2697 70 3 1.3 1.2aE-09 
Mean. 5202.237 70.34211 9.026316 4.17a947 5.6aE-10 
Standard Deviation. 3047.92a 5.74351 2.454a56 2.573793 3.89E-10 
Standard error of mean. 2406.a25 4.621a84 1.a75346 2.021aa4 3E-10 
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C57BI 6 months old. Removed pre cps % bleach %recover') t 1/2 (sec) Diff. Coeff.-
Treatment: E-10 cm2/sec 
SconA 
12.1.97 (pm)/(am) 45min 3750 82 6 2.6 6.22E-10 
n=28 45min 2250 80 10 7.3 2.18E-10 
50 min 3413 82 7 5.7 2.83E-10 
50 min 2538 72 10 6.1 2.61E-10 
55 min 4155 81 8 4.6 3.45E-10 
55min 2351 74 12 4.3 3.73E-10 
1hr 2639 71 12 6.7 2.40E-10 
1hr 5 3779 78 8 4.3 3.69E-10 
1hr 10 3130 76 8 2.8 5.73E-10 
1hr 15 2747 77 11 5.3 3.02E-10 
1hr25 3662 70 8 6.1 2.61E-10 
1hr 30 3399 72 9 2.7 5.91E-10 
1hr 35 2702 83 12 3.3 4.89E-10 
40min 3644 87 9 2.8 5.60E-10 
40min 3467 82 15 4.7 3.43E-10 
45min 2255 84 14 7.7 2.07E-10 
50min 2489 84 13 7.1 2.25E-10 
50min 6520 91 6 2.1 7.70E-10 
50min 3306 87 8 5.8 2.75E-10 
1hr 2711 85 11 3.5 4.56E-10 
1hr 10 2653 81 12 3.1 5.10E-10 
1hr 10 5307 88 7 4 4.05E-10 
1hr15 1880 81 14 4.1 3.94E-10 
1hr 15 2452 84 13 3.2 4.95E-10 
1hr 20 2452 84 13 3.2 4.95E-10 
1hr 20 3109 84 11 3.6 4.48E-10 
1hr 25 2864 78 13 3.8 4.20E-10 
1hr 30 3002 73 14 2.5 6.30E-10 
Mean. 3165.214 80.39286 10.5 4.392857 4.13E-10 
Standard Deviation. 968.9409 5.560038 2.673602 1.613124 1.47E-10 
Standard error of mean. 684.6173 4.522959 2.321429 1.341327 1.21E-10 
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controls RCA 120 
C5781 6 months old. Removed pre cps % bleach %recover) t 1/2 (sec) Dlff. Coeff.-
Treatment: E-10 cm21sec 
RCA 120 
19.1.98 (am) 50 min 6001 82 13 6.1 2.62E-10 
n=31 50min 5161 76 12 3.3 4.88E-10 
1hr 5470 88 6 3.4 4.67E-10 
1hr 4055 93 9 4.2 3.85E-10 
1hr 5 4122 86 8 2.5 6.34E-10 
1hr 5 5235 81 8 3.1 5.10E-10 
1hr 10 4863 83 9 6 2.65E-10 
1hr 10 4068 80 11 3.9 4.13E-10 
1hr 15 5039 83 9 4.7 3.43E-10 
1hr 15 9879 82 6 4.9 3.28E-10 
1hr 15 4537 79 10 3.2 5.06E-10 
1hr 20 7479 82 9 2.2 7.45E-10 
1hr 20 7570 87 8 2.1 7.45E-10 
1hr 20 4534 82 9 4.5 3.53E-10 
1hr 25 7664 87 6 3.7 4.36E-10 
1hr 25 4247 84 9 3.3 4.82E-10 
1hr 25 6199 84 7 2.6 6.16E-10 
20.1.99 am 40min 922 75 14 2.4 6.60E-10 
45min 1337 73 10 3.6 4.40E-10 
50min 538 65 19 8.2 1.96E-10 
55min 604 68 12 1.7 9.64E-10 
1hr 794 79 11 3.2 5.00E-10 
1hr 10 719 74 14 3 5.40E-10 
1hr 10 681 75 13 2.5 6.46E-10 
1hr 15 2302 78 7 1.1 1.50E-09 
1hr 15 1874 69 12 1.3 1.20E-09 
1hr 20 1390 73 11 2 7.80E-10 
1hr 20 1506 74 11 1.7 9.10E-10 
20.1.99pm 2015 87 7 1.6 1.00E-09 
45min 772 70 14 1.4 1.10E-09 
X2<1.5 55min 477 80 16 2.7 6.00E-10 
1hr 1319 77 12 5.5 2.90E-10 
Mean. 3542.91 79.2500 10.3750 3.3000 6.03E-10 
Standard Deviation. 2596.789 6.4907 3.0665 1.5990 3.00E-10 
Standard error of mean. 2243.35 5.234375 2.460938 1.19375 2.29E-10 
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mdxmale Removed pre cps % bleach %recover) t 1/2 (sec) Dlff. Coeff.-
Treatment: E-1 0 cm21sec 
RCA 120 
9.6.98 55 min 1504 68 12 6.5 2.40E-10 
n=21 55 min 1589 70 14 5.5 2.90E-10 
1hr 1168 58 16 4.2 3.80E-10 
1hr 5 1047 61 16 4.8 3.40E-10 
1hr10 1718 72 12 3 5.20E-10 
1hr 10 1450 71 14 7.9 2.00E-10 
1hr 15 2023 73 11 2.7 5.90E-10 
1hr 15 2479 74 10 3.2 5.10E-10 
1hr20 1552 68 9 2 8.20E-10 
1hr20 1698 68 11 3.9 4.10E-10 
1hr20 2253 73 10 2.9 5.50E-10 
1hr 30 2156 74 13 1.5 1.10E-10 
1hr 30 2876 71 13 4.3 3.80E-10 
1hr 35 4899 69 9 3.9 4.10E-10 
1hr40 2463 75 14 0.8 2.10E-10 
17.6.98 55 min 3810 69 5 1.1 1.47E-09 
1hr 3846 70 11 6.7 2.37E-10 
1hr 10 3649 66 12 7.2 2.21E-10 
1hr 20 2598 59 12 6.4 2.48E-10 
1hr 30 19496 68 11 5.5 2.91E-10 
1hr 35 8474 70 11 6.5 2.40E-10 
Mean. 3464.19 68.90476 11.71429 4.309524 4.13E-10 
Standard Deviation. 4032.096 4.668027 2.492847 2.094255 2.94E-10 
Standard error of mean. 2227.51 3.356009 1.823129 1.734694 1.89E-10 
All samples pooled 
X2<E-4 
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30oC SconA C57 
C57BI12 months old. Removed pre cps %bleach %recover) t 1/2 (sec) Diff. Coeff.-
Treatment: E-9 cm2/sec 
Scon A. 29+/- 1oC 
22.6.99pm 55min 3360 77 61 0.9 1.79E-09 
55min 1096 59 67 1.1 1.46E-09 
1hr 2749 77 66 1.1 1.41E-09 
1hr 5 1525 70 69 1 1.60E-09 
1hr 5 907 69 81 0.3 4.94E-09 
1hr 5 622 67 70 0.4 4.30E-09 
1hr 10 1323 76 60 0.4 3.94E-09 
1hr 10 1850 77 59 0.8 1.90E-09 
1hr 15 1271 73 51 1.2 1.35E-09 
mobile 25.6.99pm 45 min 1961 76 67 1.9 8.24E-10 
1hr 5 703 77 77 2.5 6.35E-10 
9.6.99am 
30min 552 56 59 1.1 1.45E-09 
35 min 1300 74 68 0.3 6.21E-09 
40min 1118 72 78 1.5 1.06E-09 
45min 623 61 74 0.8 1.90E-09 
45min 545 68 73 0.3 5.57E-09 
50 min 910 69 83 0.9 1.87E-09 
n=17 
Mean.- mobile 1318.529 70.47059 68.41176 0.970588 2.48E-09 
Standard Deviation. 787.1634 6.643772 8.689497 0.594522 1.77E-09 
Standard error of mean. 571.391 5.266436 6.788927 0.427682 1.48E-09 
Immobile. 
22.6.99 pm 35 min 2457 84 7 2.4 6.60E-10 
25.6.99 pm 25 min 5120 84 16 18 8.70E-11 
25 min 1801 63 14 14 1.11 E-10 
* 40min 461 60 12 
* 55 min 339 75 4 
* 55min 504 71 6 
1hr 236 74 12 5 3.23E-10 
n=7 
Mean.- Immobile 1559.714 73 10.14286 9.85 2.95E-10 
Standard Deviation. 1784.332 9.309493 4.488079 7.363649 2.65E-10 
Standard error of mean. 1342.531 7.142857 3.836735 6.15 1.96E-10 
153 
30oC SConA mdx 
mdx 9 months old. Removed pre cps % bleach %recover') t 1/2 (sec) Dlff. Coeff.-
Treatment: E-1 0 cm2/sec 
SconA. 29+/- 1 oC 
24.6.99 pm 35 min 256 60 16 
n=24 35min 1084 70 9 3.4 4.75E-10 
35min 806 71 17 14 1.11E-10 
40min 2261 88 4 7.1 2.26E-10 
45min 4036 90 5 3.7 4.30E-10 
25.6.99am 25min 997 81 15 5.4 3.00E-10 
25min 1603 79 15 6.3 2.53E-10 
30min 1638 77 9 3.1 5.24E-10 
* 30min 1241 78 13 2.9 5.50E-10 
30min 611 63 19 4.8 3.35E-10 
4.5.99 30min 5416 87 8 8.2 1.96E-10 
35min 2373 83 14 31.7 5.00E-11 
40min 1019 81 15 7.2 2.28E-10 
40min 1624 81 16 10 1.59E-10 
45min 1328 84 12 5.6 2.88E-10 
45min 2686 88 9 6 2.67E-10 
50 min 2651 84 6 11 1.49E-10 
50 min 3585 87 6 4.8 3.34E-10 
1hr 2049 80 9 4.1 3.92E-10 
1hr 1989 88 7 3.8 4.21E-10 
1hr 5 1803 86 8 6.7 2.39E-10 
1hr 10 3463 80 10 8.3 1.90E-10 
1hr 15 4121 86 4 2.6 6.22E-10 
1hr 15 3055 82 8 10 1.57E-10 
Mean. 2153.958 80.58333 10.58333 7.421739 3E-10 
Standard Deviation. 1273.72 7.762321 4.43226 6.037154 1.49E-10 
Standard error of mean. 1008.951 5.604167 3.847222 3.586767 1.2E-10 
*analysed by eye 
No recovery. Difficult to fit to curves. 
154 
RTPODAFC57 
C57 BL 9 months old. Removed pre cps o/o bleach %recover) t 1/2 (sec) Diff. Coeff •• 
Treatment: E-1 0 cm21sec 
ODAF. 22+/-1oC 
18.6.99 am 25min 327 89 4 25 6.40E-11 
30min 376 90 2 1.1 1.39E-09 
n=21 35min 1053 90 8 11 1.47E-10 
* 35 min 519 71 25 
40min 508 85 2 7 2.28E-10 
* 55 min 232 78 19 
* 1hr 10 259 77 3 
* 1hr 10 377 78 9 
* 1hr 15 419 82 5 
* 1hr 15 192 65 8 
21.6.99 * 30 min 187 81 11 
30min 290 79 12 0.7 2.41E-09 
* 35 min 175 74 6 
* 35 min 194 65 4 
* 35 min 291 75 11 
* 40 min 263 73 8 
40min 343 82 8 9.4 1.70E-10 
40min 200 67 5 1.9 8.45E-10 
* 55min 124 63 12 
* 55 min 141 61 6 
* 1hr 256 81 9 
Mean. 320.2857 76.47619 8.428571 8.014286 7.51E-10 
Standard Deviation. 200.6712 8.755678 5.536889 8.55442 8.77E-10 
Standard error of mean. 129.4966 7.07483 3.863946 6.102041 6.84E-10 
* analysed by eye 
No recovery. Difficult to fit to curves. 
155 
30oC ODAF C57 
C57 2 months old. Removed pre cps % bleach %recover) t 1/2 (sec) Diff. Coeff.-
Treatment: E-10 cm21sec 
ODAF. 29+/-1oC 
Pooled* 30 min 486 84 14 0.5 3.49E-10 
22.6.99 am * 35 min 3707 94 5 6 2.68E-10 
n=20 35min 1479 95 11 10.3 1.60E-10 
40min 753 91 5 5.3 3.00E-10 
45min 779 81 6 2.4 6.69E-10 
50 min 1696 94 10 17 9.28E-10 
1hr 1382 93 7 11 1.43E-10 
* 1hr 240 78 11 
1hr 5 1472 88 14 11 1.45E-10 
1hr 10 791 79 20 6.2 2.57E-10 
23.6.99 am * 30min 486 84 14 0.5 3.49E-10 
* 35min 3707 94 5 6 2.68E-10 
35min 1479 95 11 10.3 1.60E-10 
40min 753 91 5 5.3 J.OOE-10 
45min 779 81 6 2.4 6.69E-10 
50min 1696 94 10 17 9.28E-10 
1hr 1382 93 7 11 1.43E-10 
* 1hr 240 78 11 
1hr 5 1472 88 14 11 1.45E-10 
1hr 10 791 79 20 6.2 2.57E-10 
Mean. 1278.5 87.7 10.3 7.744444 3.58E-10 
Standard Deviation. 953.1178 6.489668 4.680306 4.92105 2.6E-10 
Standard error of mean. 668.7 5.76 3.7 4.071605 1.96E-10 
*analysed by eye 
No recovery. Difficult to fit to curves. 
156 
RTPODAF mdx 
mdx 9 months old. Removed pre cps % bleach %recovel') t 1/2 (sec) Dlff. Coeff.-
Treatment: E-10 cm2/sec 
ODAF. 23+/- 1oC 
16.6.99 am 30min 722 87 16 31 5.15E-11 
n=25 35 min 577 78 22 30 5.42E-11 
35 min 526 75 5 5.7 2.83E-10 
40min 576 80 15 10 1.57E-10 
recovered 50min 241 70 48 2 7.85E-10 
50min 346 70 34 7.7 2.07E-10 
55 min 1116 90 10 12 1.38E-10 
55 min 1069 87 12 14 1.17E-10 
55 min 516 80 23 13 1.24E-10 
1hr 761 89 19 29 5.48E-11 
1hr 5 377 81 16 7.4 2.17E-10 
1hr 10 479 85 16 20 7.91E-11 
• 1hr 15 295 55 2 
• 1hr 15 219 52 4 
16.6.99 pm 30min 419 90 24 38 4.22E-11 
40min 327 87 27 22 7.38E-11 
40min 528 86 22 29 5.47E-11 
45min 593 87 20 18 8.75E-11 
50 min 316 82 23 27 5.87E-11 
1hr 517 86 14 25 6.53E-11 
1hr 5 719 87 14 6.5 2.45E-10 
1hr 5 797 85 15 20 7.83E-11 
1hr 10 346 75 40 9.6 1.67E-10 
1hr 15 405 84 17 22 7.23E-11 
1hr15 323 71 22 15 1.04E-10 
Mean. 524.4 79.96 19.2 17.99565 1.44E-10 
Standard Deviation. 235.0564 10.02696 10.42433 9.778338 1.55E-10 
Standard error of mean. 177.248 7.4944 7.504 8.265406 9.14E-11 
* analysed by eye 
No recovery. Difficult to fit to curves. 
157 
30oC ODAF mdx 
mdx 9 months old. Removed pre cps % bleach %recover') t 1/2 (sec) Dlff. Coeff.-
Treatment: E-1 0 cm2/sec 
ODAF. 29+/-1oC 
17.6.99 pm+am * 30min 390 90 11 
* n=22 35 min 540 60 7 
40min 1628 90 10 26 6.05E-11 
45min 670 86 9 3.8 4.20E-10 
50min 524 85 16 14 1.13E-10 
55 min 3321 94 11 28 5.70E-10 
* 1hr 202 74 12 
1hr 281 78 16 7.5 2.13E-10 
1hr 5 358 81 9 4.5 3.56E-10 
* 1hr 10 218 6 
* 1hr 10 244 74 5 
* 1hr 15 382 75 4 
am 35min 204 4 
40min 186 48 2 12 1.30E-10 
45min 375 84 11 0.3 5.19E-09 
45 min 218 68 25 14 1.17E-10 
50min 239 51 2 
55min 585 88 8 1 1.60E-09 
55min 217 7 
1hr 5 1049 90 19 8.9 8.21E-11 
1hr 10 397 82 25 15 1.05E-10 
1hr 15 1004 93 7 7.3 2.19E-10 
Mean. 601.4545 78.47368 10.27273 10.94615 7.06E-10 
Standard Deviation. 702.5765 13.49225 6.482077 8.601804 1.41E-09 
Standard error of mean 424.0661 10.50416 4.867769 6.665089 8.27E-10 
* analysed by eye 
No recovery. Difficult to fit to curves. 
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